
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Strategic advances in liposomes technology: translational paradigm in transdermal delivery for skin dermatosis - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4A38C8AF2095305A38C0048BD1868.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="nanobio">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369165/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Nanobiotechnology">
<meta name="citation_title" content="Strategic advances in liposomes technology: translational paradigm in transdermal delivery for skin dermatosis">
<meta name="citation_author" content="Anmol Choudhury">
<meta name="citation_author_institution" content="KIIT School of Biotechnology, KIIT University, 751024 Bhubaneswar, Odisha India">
<meta name="citation_author" content="Apoorv Kirti">
<meta name="citation_author_institution" content="KIIT School of Biotechnology, KIIT University, 751024 Bhubaneswar, Odisha India">
<meta name="citation_author" content="Sudakshya S Lenka">
<meta name="citation_author_institution" content="KIIT School of Biotechnology, KIIT University, 751024 Bhubaneswar, Odisha India">
<meta name="citation_author" content="Shaikh Sheeran Naser">
<meta name="citation_author_institution" content="KIIT School of Biotechnology, KIIT University, 751024 Bhubaneswar, Odisha India">
<meta name="citation_author" content="Adrija Sinha">
<meta name="citation_author_institution" content="KIIT School of Biotechnology, KIIT University, 751024 Bhubaneswar, Odisha India">
<meta name="citation_author" content="Shalini Kumari">
<meta name="citation_author_institution" content="Markham College of Commerce, Vinoba Bhave University, Hazaribagh, 825001 Jharkhand India">
<meta name="citation_author" content="Nagendra Kumar Kaushik">
<meta name="citation_author_institution" content="Plasma Bioscience Research Center, Department of Electrical and Biological Physics, Kwangwoon University, Seoul, 01897 South Korea">
<meta name="citation_author" content="Aishee Ghosh">
<meta name="citation_author_institution" content="Department of Physics and Astronomy, Uppsala University, Box 516, Uppsala, SE-751 20 Sweden">
<meta name="citation_author" content="Suresh K Verma">
<meta name="citation_author_institution" content="KIIT School of Biotechnology, KIIT University, 751024 Bhubaneswar, Odisha India">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="23">
<meta name="citation_firstpage" content="576">
<meta name="citation_doi" content="10.1186/s12951-025-03660-z">
<meta name="citation_pmid" content="40835930">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369165/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369165/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369165/pdf/12951_2025_Article_3660.pdf">
<meta name="description" content="Liposomes, spherical vesicles made of phospholipids and cholesterol, have captivated researchers for their encapsulation abilities, biocompatibility, and versatility. This review delves into the core aspects and benefits of liposomal technology for ...">
<meta name="og:title" content="Strategic advances in liposomes technology: translational paradigm in transdermal delivery for skin dermatosis">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Liposomes, spherical vesicles made of phospholipids and cholesterol, have captivated researchers for their encapsulation abilities, biocompatibility, and versatility. This review delves into the core aspects and benefits of liposomal technology for ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369165/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12369165">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12951-025-03660-z"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12951_2025_Article_3660.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12369165%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12369165/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12369165/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369165/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-nanobio.png" alt="Journal of Nanobiotechnology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Journal of Nanobiotechnology" title="Link to Journal of Nanobiotechnology" shape="default" href="https://jnanobiotechnology.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Nanobiotechnology</button></div>. 2025 Aug 21;23:576. doi: <a href="https://doi.org/10.1186/s12951-025-03660-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12951-025-03660-z</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Nanobiotechnology%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Nanobiotechnology%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Nanobiotechnology%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Nanobiotechnology%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Strategic advances in liposomes technology: translational paradigm in transdermal delivery for skin dermatosis</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Choudhury%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Anmol Choudhury</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Anmol Choudhury</span></h3>
<div class="p">
<sup>1</sup>KIIT School of Biotechnology, KIIT University, 751024 Bhubaneswar, Odisha India </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Choudhury%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Anmol Choudhury</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kirti%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Apoorv Kirti</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Apoorv Kirti</span></h3>
<div class="p">
<sup>1</sup>KIIT School of Biotechnology, KIIT University, 751024 Bhubaneswar, Odisha India </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kirti%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Apoorv Kirti</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lenka%20SS%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Sudakshya S Lenka</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Sudakshya S Lenka</span></h3>
<div class="p">
<sup>1</sup>KIIT School of Biotechnology, KIIT University, 751024 Bhubaneswar, Odisha India </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lenka%20SS%22%5BAuthor%5D" class="usa-link"><span class="name western">Sudakshya S Lenka</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Naser%20SS%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Shaikh Sheeran Naser</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Shaikh Sheeran Naser</span></h3>
<div class="p">
<sup>1</sup>KIIT School of Biotechnology, KIIT University, 751024 Bhubaneswar, Odisha India </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Naser%20SS%22%5BAuthor%5D" class="usa-link"><span class="name western">Shaikh Sheeran Naser</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sinha%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Adrija Sinha</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Adrija Sinha</span></h3>
<div class="p">
<sup>1</sup>KIIT School of Biotechnology, KIIT University, 751024 Bhubaneswar, Odisha India </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sinha%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Adrija Sinha</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kumari%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Shalini Kumari</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Shalini Kumari</span></h3>
<div class="p">
<sup>2</sup>Markham College of Commerce, Vinoba Bhave University, Hazaribagh, 825001 Jharkhand India </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kumari%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shalini Kumari</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kaushik%20NK%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Nagendra Kumar Kaushik</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Nagendra Kumar Kaushik</span></h3>
<div class="p">
<sup>3</sup>Plasma Bioscience Research Center, Department of Electrical and Biological Physics, Kwangwoon University, Seoul, 01897 South Korea </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kaushik%20NK%22%5BAuthor%5D" class="usa-link"><span class="name western">Nagendra Kumar Kaushik</span></a>
</div>
</div>
<sup>3,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ghosh%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Aishee Ghosh</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Aishee Ghosh</span></h3>
<div class="p">
<sup>4</sup>Department of Physics and Astronomy, Uppsala University, Box 516, Uppsala, SE-751 20 Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ghosh%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Aishee Ghosh</span></a>
</div>
</div>
<sup>4,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Verma%20SK%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Suresh K Verma</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Suresh K Verma</span></h3>
<div class="p">
<sup>1</sup>KIIT School of Biotechnology, KIIT University, 751024 Bhubaneswar, Odisha India </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Verma%20SK%22%5BAuthor%5D" class="usa-link"><span class="name western">Suresh K Verma</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>KIIT School of Biotechnology, KIIT University, 751024 Bhubaneswar, Odisha India </div>
<div id="Aff2">
<sup>2</sup>Markham College of Commerce, Vinoba Bhave University, Hazaribagh, 825001 Jharkhand India </div>
<div id="Aff3">
<sup>3</sup>Plasma Bioscience Research Center, Department of Electrical and Biological Physics, Kwangwoon University, Seoul, 01897 South Korea </div>
<div id="Aff4">
<sup>4</sup>Department of Physics and Astronomy, Uppsala University, Box 516, Uppsala, SE-751 20 Sweden </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 9; Accepted 2025 Aug 7; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12369165  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40835930/" class="usa-link">40835930</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Liposomes, spherical vesicles made of phospholipids and cholesterol, have captivated researchers for their encapsulation abilities, biocompatibility, and versatility. This review delves into the core aspects and benefits of liposomal technology for enhancing transdermal drug delivery in treating skin dermatosis. It offers an extensive overview of liposomes, emphasizing various preparation methods, classification, and encapsulation techniques. The encapsulation of therapeutic compounds by liposomes boosts their utility as a stable and efficient drug delivery vehicle. Transdermal delivery presents a non-invasive alternative to oral and parenteral routes, allowing for controlled and sustained release of drugs while bypassing hepatic first-pass metabolism and minimizing systemic side effects. However, the stratum corneum acts as a formidable barrier to drug permeation. Liposomes, owing to their lipid bilayer structure that mimics skin composition, enhance drug solubility and partitioning, facilitate deeper skin penetration, and improve therapeutic efficacy, making them ideal carriers for transdermal applications. Transdermal delivery, favoured for its active and passive approaches and advantages over topical delivery, has been extensively studied and employed for therapeutics. Liposomes as delivery vehicles have significantly improved drug delivery efficiency and stability in transdermal applications. This review comprehensively examines the utility and mechanistic applications of liposomes. It also addresses the limitations and challenges in liposomal formulation that must be overcome for successful clinical trials.</p>
<section id="sec1"><h3 class="pmc_sec_title">Graphical abstract</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369165_12951_2025_3660_Figa_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/12369165/9182716a82e8/12951_2025_3660_Figa_HTML.jpg" loading="lazy" id="d33e218" height="499" width="669" alt="graphic file with name 12951_2025_3660_Figa_HTML.jpg"></a></p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Liposome, Encapsulation, Transdermal, Drug delivery, Skin diseases</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par3">Nanotechnology has enhanced drug-delivery methods for the diagnosis and treatment of diseases. Owing to its multidimensional properties, researchers and industries have significantly emphasized liposome synthesis and design as drug delivery systems (DDSs). These DDSs may be customized to target drugs to the intended site of action precisely enhancing their half-life [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. Alec D. Bangham, a prominent researcher at the Babraham Institute, University of Cambridge, discovered liposomes in the 1960 s, characterizing them as enlarged phospholipid structures [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. The term liposome originates from the Greek words ‘lipos,’ signifying fat, and ‘soma,’ denoting body. It relates to phospholipid molecules, which function as the structural components of the body [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Liposomes have been extensively studied over the past fifty years due to their structural similarity to biological membranes and their ability to deliver various therapeutic substances [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. A liposome is a self-assembled, bilayered lipid nanoparticle featuring an aqueous interior compartment, predominantly composed of biocompatible phospholipids and cholesterol. Comprehensive structural characteristics are detailed in Section"<a href="#Sec2" class="usa-link">Liposome</a>"[<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>].</p>
<p id="Par4">Dermatosis is a skin condition that involves irritation and swelling, with symptoms including dry skin, rash, white patches, or blisters and flakes [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. Skin dermatosis is initiated because of different reasons including viral, bacterial, fungal, or parasitic infections. Certain factors such as stress, allergies, and immune deficiency also play a major role in skin dermatosis [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. The treatment of dermatosis has been explained through topical drug administration techniques over a century; however, transdermal delivery of drugs has been popularised because of the ability of the process to allow drugs to traverse across the stratum corneum, penetrating the dermis and epidermis, avoiding any drug accumulation.</p>
<p id="Par5">Liposomes have been extensively explored as effective delivery vehicles for transdermal administration of drugs and organic compounds, owing to their structural similarity with biological membranes, excellent biocompatibility, and storage stability. They act as repositories for the gradual release of active substances and can penetrate the lipid bilayers of the epidermis and stratum corneum (SC) through individual phospholipids [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>, <a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Incorporating phospholipids into liposomal formulations enhances skin penetration and facilitates targeted drug delivery to specific sites of action. In dermatological applications, liposomes have demonstrated significant promise for both cutaneous and subdermal drug delivery, and their use in cosmeceuticals and cosmetics is steadily increasing. Their ability to be surface-modified allows for targeted delivery, while their biocompatibility, biodegradability, and minimal immunogenicity make them ideal carriers for both therapeutic and diagnostic agents [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Liposomes also show a strong affinity for keratin in the stratum corneum, promoting deeper skin infiltration, higher absorption, and better drug retention, and they have been utilized as local anesthetics [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. Additionally, nanotechnology-enabled vesicles such as transferosomes have proven effective in enhancing skin penetration of drug molecules. Liposomes have shown potential in improving the therapeutic outcomes of topically administered drugs for conditions such as psoriasis [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>], while related systems like niosomes have demonstrated efficacy in treating psoriasis and hyperpigmentation [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>, <a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. In acne treatment, lipid-based nanocarriers such as liposomes have been widely investigated for their ability to overcome the limitations of conventional formulations by enhancing permeation, targeting, solubility, and providing sustained release [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>].</p>
<p id="Par6">The literature on liposomes as transdermal drug delivery methods for skin dermatosis has experienced a significant rise in research studies over the last decade, indicating a growing interest in using these vesicular-carrying agents. Although much research focuses on liposomes in general, their use in the treatment of skin disorders is still an area with gaps that require additional investigation as evidenced by the literature published in the past decade (Fig. <a href="#Fig1" class="usa-link">1</a><strong>)</strong>. Although current research highlights the bioavailability and therapeutic effectiveness of liposomes, comparative studies indicate that there is currently a limited amount of literature specifically addressing liposomes for transdermal delivery in skin dermatosis. This indicates that while considerable advancements have been achieved, there is still much opportunity for further investigation, namely in the enhancement of formulations and comprehension of their intricate process of action. Emphasis on specific research could result in enhanced therapy approaches for a range of skin diseases, therefore addressing both effectiveness and patient adherence to treatment plans. This review delves into the properties of liposomes and their applications in transdermal drug delivery in skin diseases specifically skin dermatosis.</p>
<figure class="fig xbox font-sm" id="Fig1"><h3 class="obj_head">Fig. 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369165_12951_2025_3660_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/12369165/29cdb20e48c4/12951_2025_3660_Fig1_HTML.jpg" loading="lazy" id="d33e317" height="557" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>A detailed representation of the literature and studies done in the last 10 years on the topic <strong>(A)</strong> Liposomes in transdermal drug delivery for skin dermatosis, <strong>(B)</strong> Liposome, <strong>(C)</strong> transdermal drug delivery, and <strong>(D)</strong> Dermatosis</p></figcaption></figure></section><section id="Sec2"><h2 class="pmc_sec_title">Liposome</h2>
<p id="Par8">Liposomes are spherical vesicles formed by the fusion of different phospholipids. These are amphiphilic lipid nanoparticles, allowing the inclusion of hydrophilic and hydrophobic substances [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. The primary components of a liposome are cholesterol and a non-toxic phospholipid. It has been reported to have a size range of 50–400 nm. The liposomes with a diameter of 150 nm ~ 200 nm have been demonstrated to be more spherically stable compared to those with sizes of less than 70 nm [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. Studies are being conducted to develop techniques for optimizing the properties of liposomes for different applications [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. The physicochemical properties of liposomes may be altered by varying the cholesterol and lipid concentration, method of synthesis, surface charge, and liposome size [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. Liposome molecules are composed of a hydrophilic head with two polar hydrophobic chains forming a membrane-like structure. The hydrophilic head of the lipid molecule can be classified as anionic, cationic, and neutral based on their respective charges (Fig. <a href="#Fig2" class="usa-link">2</a><strong>)</strong> [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>–<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. The positively charged cationic head of the liposome enhances its attraction to the negatively charged cell membrane, hence increasing the efficiency of cell inclusion. Anionic liposomes have superior solution stability, reduced aggregation in comparison to neutrally charged liposomes, and enhanced endocytosis compared to neutral and cationic liposomes [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. According to research, the hydrophobic tail can influence the volume of the hydrophobic cavity and the ratio of the hydrophobic portion to the hydrophobic part of the liposome, hence influencing the liposome’s structure [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>, <a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>].</p>
<figure class="fig xbox font-sm" id="Fig2"><h3 class="obj_head">Fig. 2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369165_12951_2025_3660_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/12369165/7df733b6ceb5/12951_2025_3660_Fig2_HTML.jpg" loading="lazy" id="d33e387" height="502" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic diagram showing the structure of the liposome and the various compounds encapsulated in the liposome</p></figcaption></figure><p id="Par9">Lipid vesicles are categorized based on their lamellarity into unilamellar vesicles (UVs), oligolamellar vesicles (OLVs), multilamellar vesicles (MLVs), and multivesicular vesicles (MVVs). Furthermore, unilamellar vesicles (UVs) can be further subcategorized based on their size into small unilamellar vesicles (SUVs) with diameters less than 100 nm, large unilamellar vesicles (LUVs) ranging from 100 to 1000 nm, and giant unilamellar vesicles (GUVs) exceeding 1 μm in size [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. SUVs are characterized by a mono-phospholipid bilayer, whereas LUVs demonstrate an onion-like structure. Typically SUVs range from 20 to 100 nm in size, whereas LUVs vary from 0.1 to 1 μm, enabling significant encapsulation of hydrophilic substances within the aqueous compartments of the liposome [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. MLVs range from 0.1 to 20 μm comprising of number of successive phospholipid bilayers. Several liposomes are combined to generate MVLs, which have a multilamellar structure with concentric phospholipid spheres [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. For hydrophobic compounds, encapsulation efficiency is governed by both the liposome size and the number of bilayers. Typically, larger unilamellar vesicles provide greater bilayer surface area, facilitating enhanced drug incorporation. In contrast, multilamellar vesicles, with multiple concentric bilayers, may exhibit reduced loading efficiency due to restricted accessibility and lower available surface area per unit volume. The phase transition temperature (T<sub>M</sub>) of different natural and synthesized phospholipids differs, which is an essential metric in determining efficiency, drug encapsulation, stability, storage, and in vivo stability [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>].</p>
<p id="Par11">The physicochemical and colloidal properties of liposomes including their size, composition, loading efficiency, and stability are responsible for the benefits and limitations of liposomes as carriers for drugs [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. The cell membrane interaction is also important in determining the benefits and limits of liposomes [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. Liposomes and cells interact in four ways: phagocytosis, selective (receptor-mediated) or nonspecific endocytosis, absorption into the cell membrane, and local fusion (adhesion). Adsorption and endocytosis are the most predominant interactions among all. With endocytosis, liposomes and their contents are indirectly placed in the cytoplasm. Adsorption occurs when attractive forces prevail over repulsive forces, which is mostly determined by liposome surface characteristics [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>, <a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. Another responsible interaction involves lipid exchange, a long-range process facilitating the transfer of bilayer components including cholesterols, lipids, and membrane-bound molecules between liposomes and cell membrane components [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>, <a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>].</p>
<section id="Sec3"><h3 class="pmc_sec_title">Liposome preparation</h3>
<p id="Par12">The preparation of liposomes is followed by different approaches, including the use of different types of phospholipids. With each type of fabrication process and the phospholipid type, the final characteristics of liposomes can be altered. The first artificial liposomes were created by J. Y. Johnson in the 40’s and further patented the process for its application in the pharmaceutical sector (I. G. Farbenindustrie Aktiengesellschaft). When different types of fats or fatty oils were combined with varying water solutions, the resulting structures known as “depots” were created [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. The liposomes can be prepared by employing various methods, some of which are mentioned below and in Table 1.</p>
<section id="Sec4"><h4 class="pmc_sec_title">Thin film hydration method</h4>
<p id="Par13">The Bangham method, a commonly used approach in liposome synthesis, involves depositing lipid thin films on the inner surface of a rotary evaporator flask. During this procedure, lipids and hydrophobic compounds are dissolved in an appropriate organic solvent within a round bottom flask. Heterogenous liposomes are obtained on addition and mixing of the dispersion medium, above at the T<sub>M</sub> [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. The substance that needs to be encapsulated is either introduced into the lipid formation or mixed with the buffer solution. The thin film hydration process is very reproducible, even with small amounts of chemicals, however, it has a low encapsulation efficiency.</p></section><section id="Sec5"><h4 class="pmc_sec_title">Reverse-phase evaporation method</h4>
<p id="Par14">This is an alternative approach for the hydration method utilizing thin films, instead of employing a water-oil emulsion formation process. It encompasses the hydration of phospholipids dissolved within an organic phase, followed by the addition of water under intensive agitation [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Typically, a decreased concentration of phospholipids in the aqueous suspension results in higher production of LUVs relative to MLVs [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. However, this method may induce denaturation in the therapeutic peptides due to exposure to organic solvents and sonication parameters, and is suitable only for molecules with high molecular weight. Extrusion can be employed to diminish both the average size as well as the polydispersity of preformed vesicles.</p></section><section id="Sec6"><h4 class="pmc_sec_title">Solvent injection method</h4>
<p id="Par15">In 1973, Batzri and Kornfirst described the ethanol injection technique [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. The general classification of solvent injection methods is based on the organic solvents employed. The phospholipids and their hydrophobic active agents are disseminated in an organic solvent. This mixture is then combined with an aqueous buffer, leading to the spontaneous formation of SUVs [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. The addition of ethanol below its critical concentration to water induces the self-assembly of phospholipids, facilitating the formation of SUVs. Injecting ether leads to the formation of SUVs due to the evaporation of ether [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>].</p></section><section id="Sec7"><h4 class="pmc_sec_title">Detergent removal method</h4>
<p id="Par16">The method for liposome preparation was initially proposed for reconstituting the integral membrane proteins into phospholipid bilayers [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. Here, surfactants with high micelle concentration (CMC) and lipids are dissolved in an organic solvent [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>, <a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. Upon vigorous mixing, the detergents associate with the phospholipid forming the micelle structures. The surfactants are removed thereafter by dialysis, chromatography, size exclusion, dilution, or absorption onto hydrophobic beads giving richer lipids forming unilamellar vesicles [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>].</p></section><section id="Sec8"><h4 class="pmc_sec_title">Heating method</h4>
<p id="Par17">The heating method, developed by Mortazavi and Mozafari, is an organic solvent-free procedure [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. Here, the lipids undergo hydration by an aqueous solution and are subjected to heating above the Tm of phospholipids in the solution in the presence of 3–5% hydrating agents like glycerine or propylene glycol [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. The hydrating agent serves a dual purpose, acting both as a stabilizer and an ionizing additive, inhibiting the aggregation or settling of nanoparticles [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. The Mozafari technique is an improved heating method for enhancing the stability of liposomes, in which the lipid components are hydrated in the aqueous medium before being heated in the absence of organic solvents [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>].</p></section><section id="Sec9"><h4 class="pmc_sec_title">pH jumping method</h4>
<p id="Par18">This is another solvent-free method that was first reported by Hauser and colleagues where SUVs were formed because of pH jump to MLVs [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. It is also known as the curvature-tuned method where phenomena such as the curvature theory of lipid bilayers and spontaneous vesiculation aid liposome formation. This method is comparatively faster with the production of stable liposomes [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>]. In this curvature method, temperature, the duration of pH jump, and lipid composition are critical parameters that influence the polydispersity of the liposome and its size and shape.</p>
<section class="tw xbox font-sm" id="Tab1"><h5 class="obj_head">Table 1.</h5>
<div class="caption p"><p>Lists of various methods for liposomes formation and their encapsulation efficacy</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Method of liposome preparation</th>
<th align="left" colspan="1" rowspan="1">Description of method</th>
<th align="left" colspan="1" rowspan="1">Vesicles produced</th>
<th align="left" colspan="1" rowspan="1">Size of vesicles</th>
<th align="left" colspan="1" rowspan="1">Encapsulation efficiency</th>
<th align="left" colspan="1" rowspan="1">Reference</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1"> Bangham Method</td>
<td align="left" colspan="1" rowspan="1">
<p>The original liposome preparation</p>
<p>the method involved the hydration of</p>
<p>lipid film in an aqueous solution</p>
<p>to form multilamellar vesicles.</p>
</td>
<td align="left" colspan="1" rowspan="1">MLVs</td>
<td align="left" colspan="1" rowspan="1">100–1000 nm</td>
<td align="left" colspan="1" rowspan="1">Moderate</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Ethanol/Ether injection</td>
<td align="left" colspan="1" rowspan="1">The lipid solution, consisting of lipids dissolved in a mixture of ethanol and ether, was introduced into an aqueous solution while being vigorously stirred. The outcome of this approach led to the creation of a solitary bilayer liposome, without the need for sonication.</td>
<td align="left" colspan="1" rowspan="1">
<p>SUVs</p>
<p>LUVs</p>
</td>
<td align="left" colspan="1" rowspan="1">70–200 nm</td>
<td align="left" colspan="1" rowspan="1">High</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>–<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Reverse phase evaporation</td>
<td align="left" colspan="1" rowspan="1">
<p>A method where an organic</p>
<p>solvent containing lipids is</p>
<p>emulsified with an aqueous phase</p>
<p>containing drugs and then</p>
<p>evaporated to form liposomes.</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>MLVs</p>
<p>LUVs</p>
</td>
<td align="left" colspan="1" rowspan="1">100–1000 nm</td>
<td align="left" colspan="1" rowspan="1">High</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>, <a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Curvature Tuning Method</td>
<td align="left" colspan="1" rowspan="1">
<p>A solvent-free technique that uses</p>
<p>both charged and zwitterionic</p>
<p>lipids combined with lyso-</p>
<p>palmitoylphosphatidylcholine to</p>
<p>create monodisperse solutions of</p>
<p>very stable tiny unilamellar</p>
<p>Vesicles. It involves the control of</p>
<p>liposome size and shape by</p>
<p>adjusting lipid composition to</p>
<p>influence the curvature of the</p>
<p>lipid bilayer by quick pH shift and</p>
<p>equilibration interval.</p>
</td>
<td align="left" colspan="1" rowspan="1">Monodisperse SUVs</td>
<td align="left" colspan="1" rowspan="1">20 nm to 200 nm</td>
<td align="left" colspan="1" rowspan="1">Moderate to high</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>, <a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Heating Method</td>
<td align="left" colspan="1" rowspan="1">
<p>Here, Lipids are heated above</p>
<p>their transition temperature with</p>
<p>glycerol, and PEG allowing them</p>
<p>to form a homogeneous mixture.</p>
<p>Upon cooling, the mixtures self-</p>
<p>assemble into liposomes.</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>SUVs</p>
<p>LUVs</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>50 nm-</p>
<p>500 nm</p>
</td>
<td align="left" colspan="1" rowspan="1">Low</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Detergent Depletion</td>
<td align="left" colspan="1" rowspan="1">
<p>Detergents are gradually removed</p>
<p>from a mixed micelle solution by</p>
<p>dialysis, leading to the</p>
<p>spontaneous formation of</p>
<p>liposomes.</p>
</td>
<td align="left" colspan="1" rowspan="1">SUVs and LUVs</td>
<td align="left" colspan="1" rowspan="1">
<p>&gt; 500</p>
<p>nm</p>
</td>
<td align="left" colspan="1" rowspan="1">Low</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>, <a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Microfluidic channel</td>
<td align="left" colspan="1" rowspan="1">
<p>Liposomes are formed in this method by controlled mixing of</p>
<p>lipid and aqueous phases present</p>
<p>at the centre of dual channels,</p>
<p>offering precise control over size</p>
<p>and composition.</p>
</td>
<td align="left" colspan="1" rowspan="1">Monodisperse SUVs, GUVs, LUVs, MLVs</td>
<td align="left" colspan="1" rowspan="1">100–300 nm</td>
<td align="left" colspan="1" rowspan="1">Low</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Freeze Drying of double emulsions</td>
<td align="left" colspan="1" rowspan="1">
<p>Double emulsions, composed of</p>
<p>water droplets encapsulated</p>
<p>within oil droplets, are subjected</p>
<p>to freeze-drying (Lyophilization)</p>
<p>to remove water, resulting in the</p>
<p>formation of solid lipid</p>
<p>nanoparticles or liposomes. It is</p>
<p>used to encapsulate hydrophilic</p>
<p>drugs with controlled release.</p>
</td>
<td align="left" colspan="1" rowspan="1">Monodisperse SUVs</td>
<td align="left" colspan="1" rowspan="1">
<p>200</p>
<p>nm- 5</p>
<p>µm</p>
</td>
<td align="left" colspan="1" rowspan="1">High</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>, <a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p> Superficial fluids</p>
<p> (SCFs) method</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Liposomes are produced using</p>
<p>supercritical fluids, such as</p>
<p>carbon dioxide, to dissolve lipids,</p>
<p>resulting in controlled size</p>
<p>liposomes without organic</p>
<p>solvents.</p>
</td>
<td align="left" colspan="1" rowspan="1">Monodisperse LUVs</td>
<td align="left" colspan="1" rowspan="1">
<p>100–300 nm or Or</p>
<p>0.2-4</p>
<p>µm</p>
</td>
<td align="left" colspan="1" rowspan="1">High</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Modified electroformation method</td>
<td align="left" colspan="1" rowspan="1">
<p>The process of liposome synthesis involves applying an alternating electric field to a lipid bilayer, which can be dry or damp, on an electrode made of ITO-coated glass slides. The</p>
<p>electric field induces the</p>
<p>membrane curvature and vesicle</p>
<p>formation, followed by hydration</p>
<p>to form liposomes.</p>
</td>
<td align="left" colspan="1" rowspan="1">Polydisperse GUVs</td>
<td align="left" colspan="1" rowspan="1">
<p>50 nm</p>
<p>to &gt; 100 μm</p>
</td>
<td align="left" colspan="1" rowspan="1">High</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>–<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Size reduction of MLVs and GUVs</td>
<td align="left" colspan="1" rowspan="1">
<p>In this method, MLVs are resized</p>
<p>to produce smaller liposomes by</p>
<p>sonication, freeze-thaw extrusion,</p>
<p>homogenization, and other</p>
<p>techniques to produce either</p>
<p>LUVs or SUVs.</p>
</td>
<td align="left" colspan="1" rowspan="1">Monodisperse SUVs and LUVs</td>
<td align="left" colspan="1" rowspan="1">40 nm to 200 nm</td>
<td align="left" colspan="1" rowspan="1">High</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>–<a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Biomimetic reaction for vesicular self-assembly</td>
<td align="left" colspan="1" rowspan="1">
<p>To replicate biological processes,</p>
<p>biomimetic principles are used to</p>
<p>produce liposomes, frequently</p>
<p>with the assistance of catalyst</p>
<p>enzymes. With the help of this</p>
<p>method, vesicle production in</p>
<p>aqueous solutions may be</p>
<p>precisely controlled.</p>
</td>
<td align="left" colspan="1" rowspan="1">Polydisperse GUVs</td>
<td align="left" colspan="1" rowspan="1">20 nm to 10 μm</td>
<td align="left" colspan="1" rowspan="1">Moderate to high</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>, <a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Hydration of phospholipids deposited on nanostructured material</td>
<td align="left" colspan="1" rowspan="1">
<p>The technique is used to create</p>
<p>supported lipid bilayers through the deposition of phospholipids</p>
<p>onto nanostructured materials (</p>
<p>electrospun amphiphilic nanofibre</p>
<p>), forming lipid bilayers through</p>
<p>hydration.</p>
</td>
<td align="left" colspan="1" rowspan="1">Monodisperse SUVs and LUVs</td>
<td align="left" colspan="1" rowspan="1">
<p>50 nm-</p>
<p>500 nm</p>
</td>
<td align="left" colspan="1" rowspan="1">High</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section></section><section id="Sec10"><h3 class="pmc_sec_title">Types of liposomes</h3>
<section id="Sec11"><h4 class="pmc_sec_title">Conventional liposomes</h4>
<p id="Par20">Conventional liposomes are spherical vesicles composed of a phospholipid bilayer. They are not coated with polyethylene glycol (PEG), which results in lower bioavailability compared to other well-established and emerging PEGylated liposomal formulations [<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>]. However, there are specific scenarios where non-PEGylated liposomes (NPLs) are preferred. Elan Pharmaceuticals has developed Myocet<sup>®</sup>, a non-PEGylated liposomal formulation of doxorubicin (NPLD), which has demonstrated reduced cardiotoxicity and enhanced bioavailability. Notably, NPLD has also mitigated the incidence of Hand-Foot Syndrome (HFS), a common side effect of conventional formulations. When combined with cyclophosphamide, NPLD is effectively used in the treatment of metastatic breast cancer [<a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>]. Although PEG is not incorporated in conventional liposomes, the addition of cholesterol plays a critical role in maintaining liposomal membrane integrity. It modulates the conformational organization of lipid chains, thereby enhancing the stability of drug-loaded liposomes [<a href="#CR72" class="usa-link" aria-describedby="CR72">72</a>, <a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>]. Cholesterol influences key membrane characteristics such as strength, fluidity, stiffness, and permeability. It has been slos shown to impact the drug retention capability of liposomes through assistant in phospholipid packing (Fig. <a href="#Fig3" class="usa-link">3</a><strong>)</strong>.</p>
<figure class="fig xbox font-sm" id="Fig3"><h5 class="obj_head">Fig. 3.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369165_12951_2025_3660_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/12369165/f051af17ce5f/12951_2025_3660_Fig3_HTML.jpg" loading="lazy" id="d33e1142" height="669" width="669" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic depiction of various types of liposomes offering significance advantages for targeted delivery, therapeutic efficiency, and biocompatibility</p></figcaption></figure></section><section id="Sec12"><h4 class="pmc_sec_title">Charged liposomes</h4>
<p id="Par21">Cationic liposomes are lipid-based carriers that have undergone extensive research for their varied applications, notably in drug delivery and gene therapy. They exhibit the potential to enhance the pharmacokinetics of drugs, such as tacrolimus, for the treatment of ocular diseases like dry eye [<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>]. Cationic liposomes have also been used as vectors for nucleic acids, including DNA and mRNA, in gene therapy applications [<a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>]. Nevertheless, utilising these liposomes in cancer gene therapy faces limitations, both extracellular and intracellular, compromising their effectiveness [<a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>, <a href="#CR77" class="usa-link" aria-describedby="CR77">77</a>] Additionally, cationic liposomes have been found to enhance chemiluminescence reactions, and their positive charge plays a significant role in this process [<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>]. Overall, the properties of cationic liposomes, such as lipid composition, surface modification, and size, influence their performance and potential applications [<a href="#CR79" class="usa-link" aria-describedby="CR79">79</a>].</p>
<p id="Par22">Anionic liposomes, which have a negatively charged surface, are being investigated extensively for drug delivery applications. They provide perks such as greater stability, improved drug protection, and extended drug release. They can be produced in various kinds of techniques, including organic solvents and dendrimer synthesis. These liposomes can be tailored for targeted administration to specific tissues or cells. Anionic liposomes, notably those made with glycerol or dendrimers, are widely recognized as safe and effective delivery vehicles because they have minimal toxicity and aid in the stability of nucleic acid drug therapies [<a href="#CR80" class="usa-link" aria-describedby="CR80">80</a>–<a href="#CR82" class="usa-link" aria-describedby="CR82">82</a>].</p></section><section id="Sec13"><h4 class="pmc_sec_title">Stimuli-responsive liposomes</h4>
<p id="Par23">Stimuli-responsive liposomes are nanocarriers capable of releasing drugs in response to pH or temperature changes. One of the critical components in the synthesis of pH sensitive liposome is 1,2-dioleoyl-sn-glycero-3-phosphoenthanolamine (DOPE), however, DOPE being a non-bilayer lipid with a cone-shaped structure, does not form a bilayer alone. It can be stabilized in a bilayer by utilizing bilayer lipids such as phosphatidylserine (PS) or a weakly acidic amphiphile, cholesteryl hemisuccinate (CHEMS) [<a href="#CR83" class="usa-link" aria-describedby="CR83">83</a>]. Thermosensitive liposomes are synthesized by dipalmitoyl phosphocholine (DPPC), a phospholipid of 16 carbon atoms. Furthermore, its permeability and drug release capability can be enhanced by supplementing the liposome formation with distearoyl phosphocholine (DSPC) and hydrogenated soy phosphocholine (HSPC) [<a href="#CR84" class="usa-link" aria-describedby="CR84">84</a>]. Stimuli-responsive liposomes have low toxicity and excellent absorption in injured tissues, making them suitable for drug administration [<a href="#CR82" class="usa-link" aria-describedby="CR82">82</a>]. Liposomes that exhibit responsiveness to stimuli have a wide range of cargo release mechanisms. When triggered, a delicate characteristic in the liposomal bilayer causes the liposome to become unstable [<a href="#CR85" class="usa-link" aria-describedby="CR85">85</a>]. Parameters such as pH, temperature, light, ions, enzymes, and magnetic fields have the potential to induce the release of the payload [<a href="#CR86" class="usa-link" aria-describedby="CR86">86</a>]. The acidic environment of tumours can induce the release of the medication from pH-responsive liposomes. Ultrasound, as an external stimulus, can release payload [<a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>, <a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>]. Ultrasound-responsive hydrogels, including colloidal structures such as liposomes, potentially modulate the spatial and temporal release of drugs, rendering them valuable in the fields of cancer treatment and tissue engineering [<a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>, <a href="#CR86" class="usa-link" aria-describedby="CR86">86</a>]. Stimuli-responsive liposomes facilitate targeted drug delivery to specific regions. The formation of stimuli-responsive liposomes depends on the deliberate choice and alteration of lipid components and supplementary elements that confer reactivity to specific stimuli.</p></section></section><section id="Sec14"><h3 class="pmc_sec_title">Thermosensitive system</h3>
<p id="Par24">Phospholipids constitute the structural foundation of stimuli-responsive liposomes. Natural or synthesised phospholipids, including 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), are commonly utilised owing to their well-defined thermotropic phase transition properties. Thermosensitive liposomes typically consist of DPPC, which experiences a phase change at approximately 41 °C, facilitating the release of encapsulated medicines upon localised heating. The inclusion of monostearoyl phosphatidylcholine (MSPC) further improves thermosensitivity and leakage at the phase transition temperature [<a href="#CR89" class="usa-link" aria-describedby="CR89">89</a>].</p></section><section id="Sec15"><h3 class="pmc_sec_title">pH sensitivity</h3>
<p id="Par25">To confer pH sensitivity, lipids with ionizable group, such as 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), are incorporated due to their fusogenic properties under acidic conditions. DOPE is often conjugated with cholesteryl hemisuccinate (CHEMS), forming a stable bilayer at physiological pH that becomes destabilized in acidic environments, such as endosomes or the tumor microenvironment, thereby promoting membrane fusion and facilitating drug release [<a href="#CR83" class="usa-link" aria-describedby="CR83">83</a>].</p></section><section id="Sec16"><h3 class="pmc_sec_title">Redox-responsive systems</h3>
<p id="Par26">Disulfide-containing lipids or polymer-conjugated lipids are utilized in redox-responsive liposomal systems. Disulfide bonds remain stable in the extracellular environment but are cleaved in the reductive intracellular milieu, characterized by elevated glutathione levels, leading to liposomal destabilization and subsequent drug release. Examples are distearoylphosphatidyl-ethanolamine (DSPE)-PEG conjugates altered with disulphide linkers (e.g., DSPE-SS-PEG), which provide responsiveness in tumour cells exhibiting heightened redox potential [<a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>].</p></section><section id="Sec17"><h3 class="pmc_sec_title">Enzyme-responsive liposomes</h3>
<p id="Par27">Enzyme-responsive liposomes are constructed utilising substrates for specific enzymes overexpressed in diseased tissues. For example, matrix metalloproteinase (MMP)-sensitive peptides or phospholipids containing cleavable ester or amide linkages may be included in the liposomal bilayer. Enzymatic cleavage compromises membrane integrity, facilitating cargo release [<a href="#CR91" class="usa-link" aria-describedby="CR91">91</a>].</p></section><section id="Sec18"><h3 class="pmc_sec_title">Polymeric or inorganic additives</h3>
<p id="Par28">In certain instances, polymeric or inorganic additives are integrated to attain responsiveness. For instance, poly(N-isopropylacrylamide) (pNIPAM) can be grafted onto liposomal surfaces to achieve thermo-responsiveness, whereas gold nanoparticles can be included within or affixed to liposomes for photo-triggered release through plasmonic heating [<a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>]. The underlying mechanism of responsiveness generally entails structural destabilisation of the lipid bilayer upon exposure to a stimulus, which increases membrane permeability or causes vesicle disintegration, enabling the regulated and site-specific release of encapsulated substances. These solutions collectively provide a method to enhance treatment efficacy while reducing systemic toxicity.</p>
<p id="Par29">However, the development and application of stimuli-responsive liposomes in biological systems remain challenging [<a href="#CR93" class="usa-link" aria-describedby="CR93">93</a>, <a href="#CR94" class="usa-link" aria-describedby="CR94">94</a>]. Key difficulties include optimizing liposomal formulation for stability and reproducibility, ensuring efficient stimulus-triggered drug release, and maintaining safety and biocompatibility [<a href="#CR95" class="usa-link" aria-describedby="CR95">95</a>]. Despite these obstacles, stimuli-responsive liposomes have intriguing biological uses [<a href="#CR96" class="usa-link" aria-describedby="CR96">96</a>]. They might revolutionise medication delivery, enable personalised therapy, and improve therapeutic efficacy and specificity.</p>
<section id="Sec19"><h4 class="pmc_sec_title">Stealth liposomes</h4>
<p id="Par30">Stealth liposomes represent an advanced subclass of liposomal drug delivery systems engineered to evade detection and clearance by the mononuclear phagocyte system (MPS), thereby prolonging their systemic circulation. This immune evasion is primarily achieved through PEGylation, the covalent attachment of polyethylene glycol (PEG) chains to the liposomal surface. PEG forms a hydrophilic steric shield that minimizes opsonization and phagocytic uptake, significantly extending the circulation half-life of the encapsulated therapeutics [<a href="#CR97" class="usa-link" aria-describedby="CR97">97</a>, <a href="#CR98" class="usa-link" aria-describedby="CR98">98</a>]. Some of the significant examples of stealth liposomes are Doxil/Caelyx (Liposomal doxorubicin) and SPI-077 (Liposomal cisplatin) [<a href="#CR99" class="usa-link" aria-describedby="CR99">99</a>, <a href="#CR100" class="usa-link" aria-describedby="CR100">100</a>].</p>
<p id="Par31">In contrast to conventional liposomes, which are rapidly eliminated from the bloodstream, stealth liposomes are capable of passive accumulation in tumor tissues via the enhanced permeability and retention (EPR) effect. This phenomenon arises from the characteristic leaky vasculature and impaired lymphatic drainage present in many solid tumors [<a href="#CR101" class="usa-link" aria-describedby="CR101">101</a>, <a href="#CR102" class="usa-link" aria-describedby="CR102">102</a>]. Upon reaching the tumor site, stealth liposomes primarily remain within the extracellular matrix rather than entering tumor cells directly. Therefore, for drugs like doxorubicin or cisplatin to achieve therapeutic efficacy, they must first be released from the liposomal carrier into the tumor microenvironment and subsequently diffuse across the cellular membrane into the intracellular space [<a href="#CR103" class="usa-link" aria-describedby="CR103">103</a>]. Stealth liposomes have demonstrated notable versatility in encapsulating both hydrophilic and lipophilic drugs, protecting them from enzymatic degradation and improving pharmacokinetic metrics such as area under the curve (AUC) and maximum plasma concentration (Cmax) [<a href="#CR104" class="usa-link" aria-describedby="CR104">104</a>–<a href="#CR106" class="usa-link" aria-describedby="CR106">106</a>]. A well-established clinical example is PEGylated liposomal doxorubicin (PLD; Doxil<sup>®</sup>/Caelyx<sup>®</sup>), which is approved for the treatment of Kaposi’s sarcoma and recurrent ovarian cancer and is under clinical investigation for other malignancies, including breast cancer and glioblastomas [<a href="#CR107" class="usa-link" aria-describedby="CR107">107</a>].</p>
<p id="Par32">Recent advances have focused on overcoming the limitations of PEGylation, often referred to as the “PEG dilemma”, where the PEG layer extending circulation time can hinder cellular uptake at the target site. To address this, researchers have developed stimuli-responsive PEG-shedding systems that react to tumor-specific cues such as acidic pH or elevated reductive potential, facilitating PEG detachment and enhancing cellular internalization [<a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>, <a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>]. Taken together, these developments solidify stealth liposomes as a highly effective passive targeting platform. Their ability to accumulate at pathological sites through systemic distribution and physicochemical properties, without relying on specific ligand-receptor interactions, distinguishes them from actively targeted nanocarriers.</p></section><section id="Sec20"><h4 class="pmc_sec_title">Active targeting liposomes</h4>
<p id="Par33">Active targeting liposomes are advanced nanocarrier systems designed to achieve site-specific drug delivery by leveraging molecular recognition mechanisms. Unlike stealth liposomes, which rely on the enhanced permeability and retention (EPR) effect for passive accumulation in diseased tissues, active targeting liposomes are functionalized with ligands that bind selectively to overexpressed receptors on target cells. This facilitates receptor-mediated endocytosis and enhances cellular internalization of the therapeutic payload [<a href="#CR110" class="usa-link" aria-describedby="CR110">110</a>, <a href="#CR111" class="usa-link" aria-describedby="CR111">111</a>]. Various modifications can be employed for actively charging the liposomes, including immunoglobulin, carbohydrate, peptide, aptamer, protein, PEG, and small molecules such as folic acid and transferrin [<a href="#CR112" class="usa-link" aria-describedby="CR112">112</a>].</p>
<p id="Par34">Targeting ligands may include monoclonal antibodies (e.g., trastuzumab targeting HER2), peptides (e.g., RGD motifs for integrins), aptamers, or small molecules such as folic acid [<a href="#CR113" class="usa-link" aria-describedby="CR113">113</a>–<a href="#CR116" class="usa-link" aria-describedby="CR116">116</a>]. Following receptor engagement, the liposome is internalized by the target cell, enabling efficient intracellular drug release. This ligand-directed approach reduces systemic toxicity, enhances drug bioavailability at the site of interest, and improves therapeutic outcomes, particularly in tumours with heterogeneous receptor expression profiles [<a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>].</p>
<p id="Par35">Functionalization techniques are broadly categorized into two strategies: post-insertion, where ligands are introduced to preformed liposomes; and one-pot assembly, which involves incorporating ligand-conjugated lipids during liposome formation. Each method offers distinct advantages with respect to ligand density, orientation, and liposomal stability [<a href="#CR118" class="usa-link" aria-describedby="CR118">118</a>–<a href="#CR120" class="usa-link" aria-describedby="CR120">120</a>].</p>
<p id="Par36">Recent developments include dual-targeted liposomes, which employ two different ligands to recognize multiple tumor-specific receptors, thereby enhancing targeting accuracy in complex tumor microenvironments. Moreover, theranostic liposomes, which co-deliver drugs and imaging agents, have been developed to enable simultaneous therapy and real-time monitoring [<a href="#CR121" class="usa-link" aria-describedby="CR121">121</a>]. Active targeting liposomes have also advanced toward clinical applications. One prominent example is MM-302, a HER2-targeted liposomal doxorubicin formulation conjugated with trastuzumab fragments. In a Phase I clinical study, MM-302 demonstrated enhanced tumor-specific uptake and manageable safety in HER2-positive metastatic breast cancer patients [<a href="#CR122" class="usa-link" aria-describedby="CR122">122</a>]. Further development continued in the HERMIONE Phase II trial, although clinical success was constrained by tumor heterogeneity and variability in HER2 expression. Additionally, Du, J., Liu, X., Sun, J. et al. (2024) developed a novel trastuzumab-functionalized liposomal system for co-delivery of pyrotinib, demonstrating improved antitumor activity in HER2-overexpressing breast cancer models. Their preclinical evaluation revealed enhanced receptor-specific uptake and tumor regression, further supporting the viability of targeted liposomal delivery platforms in precision oncology [<a href="#CR123" class="usa-link" aria-describedby="CR123">123</a>].</p>
<p id="Par37">Despite these promising advancements, significant challenges remain. These include immunogenicity associated with certain ligands, restricted tissue penetration due to the tumor’s dense extracellular matrix, and dynamic regulation of receptor expression that can hinder consistent targeting. Moreover, although many active targeting liposomes have shown efficacy in preclinical studies, the number of formulations reaching regulatory approval is still limited. Most approved liposomal therapeutics (e.g., Doxil<sup>®</sup>, Myocet<sup>®</sup>) utilize passive targeting mechanisms [<a href="#CR124" class="usa-link" aria-describedby="CR124">124</a>].</p>
<p id="Par38">In conclusion, active targeting liposomes represent a powerful strategy for precision drug delivery, offering superior specificity and therapeutic efficacy. Continued innovation in ligand engineering, formulation optimization, and tumor microenvironment modulation is essential to enhance their translational success.</p></section><section id="Sec21"><h4 class="pmc_sec_title">Ultra-flexible liposomes</h4>
<p id="Par39">Ultra-flexible liposomes such as transferosomes, ethosomes, and transethosomes possess high elasticity, enabling them to penetrate skin layers easily and deliver drugs to the desired site without any drug loss, enhancing bioavailability and therapeutic efficacy while decreasing their side effects [<a href="#CR125" class="usa-link" aria-describedby="CR125">125</a>]. Ethosomes are vesicular carriers constructed out of high concentrations of ethanol and phospholipids, designed specifically to improve drug delivery through the skin. They have presented significant potential in treating several disorders of the skin including, melanoma, acne, hair loss, and skin whitening [<a href="#CR126" class="usa-link" aria-describedby="CR126">126</a>–<a href="#CR128" class="usa-link" aria-describedby="CR128">128</a>]. These nanocarriers encapsulate a wide range of beneficial pharmaceutical components, making them ideal for administration through the skin [<a href="#CR129" class="usa-link" aria-describedby="CR129">129</a>]. Studies have demonstrated that ethosomal gels had higher transdermal flow and skin deposition than normal gels, proving their usefulness in delivering medicinal medications such as Spironolactone for acne treatment [<a href="#CR130" class="usa-link" aria-describedby="CR130">130</a>]. It has been studied that surfactants with suitable and correct amounts of lipid can destabilize liposome’s membrane which leads to vesicle membrane deformability. This characteristic of the edge activator (surfactant) was used in synthesizing transferosomes making it ultra-flexible and deformable [<a href="#CR131" class="usa-link" aria-describedby="CR131">131</a>]. The integration of Ethosomes and transferosomes results in transethosomes. The essential components of transethosomes are phospholipids, ethanol, and edge activator. Vesicular size, entrapment efficacy, and zeta potential are greatly dependent on the concentration and type of phospholipids [<a href="#CR132" class="usa-link" aria-describedby="CR132">132</a>]. Major advantages of transethosomes are better-bypassing first-pass metabolism, non-invasive drug administration technique making it more patient-friendly, and increased skin permeability, allowing deeper drug penetration. Compared to other ultra-flexible liposomes it is more biocompatible, stable, and biodegradable [<a href="#CR133" class="usa-link" aria-describedby="CR133">133</a>]. Challenges in this approach include achieving cell-specific and controllable delivery [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR134" class="usa-link" aria-describedby="CR134">134</a>].</p></section></section></section><section id="Sec22"><h2 class="pmc_sec_title">Encapsulation</h2>
<p id="Par41">Liposomes are one of the most suitable carriers with minimal toxicity and high accuracy of drug delivery in vitro. They act according to the pH and temperature of the environment and deliver its content. In context to subcutaneous and transdermal delivery, various compounds are being delivered currently. Encapsulation is a process through which a specific drug is enclosed within a vehicle to demonstrate in vivo, biodistribution, stability and pharmacokinetics. Attaining a high encapsulation efficiency is essential for a successful drug delivery. Drug encapsulation is preferred as it has the potential to circumvent some in vivo limitations of therapeutic compounds such as rapid clearance, poor biodistribution, low plasma solubility and poor pharmacokinetics. Despite there being various techniques to encapsulate the drugs and increase encapsulation efficiency, the freeze-thaw cycling and reverse phase evaporation techniques are used extensively [<a href="#CR135" class="usa-link" aria-describedby="CR135">135</a>]. These methods can seamlessly encapsulate hydrophilic and hydrophobic compounds into small liposomes (50–150 nm) [<a href="#CR136" class="usa-link" aria-describedby="CR136">136</a>]. However, while selecting a suitable protocol for encapsulation, various factors are checked, such as drug/lipid ratio, sterility, drug retention, encapsulation efficiency, and drug stability [<a href="#CR137" class="usa-link" aria-describedby="CR137">137</a>].</p>
<p id="Par42">When liposomes are selected, the vesicle size is chosen based on the site of action as, while administering a compound into the lungs, it has been found that injection of MLVs (d = 3 μm) enhances the delivery [<a href="#CR138" class="usa-link" aria-describedby="CR138">138</a>]. Nevertheless, increased partitioning of the bone marrow is seen after administering SUVs [<a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>]. Several studies have shown that due to the interaction with high-density lipoproteins, vesicles that are composed of no more than one phospholipid, become leaky in plasma or serum. Therefore, to overcome this, cholesterol is incorporated into the lipid bilayer which also provides additional improved stability to the liposome while circulating in the blood vessel [<a href="#CR137" class="usa-link" aria-describedby="CR137">137</a>, <a href="#CR140" class="usa-link" aria-describedby="CR140">140</a>]. Techniques extensively utilized for encapsulation in liposomes are active loading and passive loading techniques. Passive loading techniques depend on the ability of the liposomes to encapsulate a certain amount of aqueous solute and solvent during the formation of the vesicle, whereas active loading techniques involve methods for encapsulating amphiphilic compounds as they can rapidly permeate through the lipid bilayer. The lipid composition of liposomes is altered to enhance encapsulation and decrease the rate of release [<a href="#CR137" class="usa-link" aria-describedby="CR137">137</a>]. Figure <a href="#Fig4" class="usa-link">4</a> shows the mechanism of some of the passive loading and active loading methods in liposomes.</p>
<figure class="fig xbox font-sm" id="Fig4"><h3 class="obj_head">Fig. 4.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369165_12951_2025_3660_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/12369165/f648c63d56c6/12951_2025_3660_Fig4_HTML.jpg" loading="lazy" id="d33e1186" height="1015" width="688" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic diagram illustrating major processes involved in the passive and active loading in liposomes</p></figcaption></figure><section id="Sec23"><h3 class="pmc_sec_title">Passive loading in liposome</h3>
<p id="Par44">Passive loading techniques are usually employed to entrap the materials which act completely as aqueous markers as well as materials which are water-soluble bioactive agents. Types of vesicles used such as MLV, SUV or large unilamellar vesicles (LUV) and their encapsulation efficiency varies greatly from 1% for SUVs to 88% for MLVs. This is because SUVs can entrap at lower lipid volume i.e., 0.2–0.8 µl/µmol than compared LUVs and MLVs which show higher lipid entrapment volumes i.e., 1–30 µl/µmol. Due to this varying encapsulation efficiency, not all markers that researchers want to encapsulate act as an ideal aqueous marker [<a href="#CR137" class="usa-link" aria-describedby="CR137">137</a>].</p>
<p id="Par45">Passive loading techniques encompass three distinct methods commonly used for encapsulation such as solvent dispersion method, mechanical dispersion method and detergent removal method.</p></section><section id="Sec24"><h3 class="pmc_sec_title">Solvent dispersion method</h3>
<p id="Par46">Lipids are dispersed in a solvent and then they are gradually mixed into an aqueous phase. Three types of solvent dispersion methods are currently being used, such as ethanol injection, ether injection, and reverse phase evaporation method.</p>
<section id="Sec25"><h4 class="pmc_sec_title">Ethanol injection method</h4>
<p id="Par47">requires a lipids and ethanol solution to be introduced into an excess amount of buffer. This process immediately creates MLVs with varying sizes (30–110 nm). The liposomes formed have modest concentrations, and the elimination of ethanol can be difficult due to their formation of an azeotrope with water [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>].</p></section><section id="Sec26"><h4 class="pmc_sec_title">Ether injection (Solvent vaporization)</h4>
<p id="Par48">entails introducing diethyl ether and lipids solution or ether-methanol into an aqueous solution containing the target molecule for encapsulation. This is done at a temperature range of 55℃ to 65℃ or under reduced pressure conditions. Under vacuum conditions, ethanol is gradually eliminated leading to the encapsulation of the compound in the liposome. However, the size of the liposomes is not controlled, and the liposomes formed are of varying sizes (70–200 nm) [<a href="#CR141" class="usa-link" aria-describedby="CR141">141</a>].</p></section><section id="Sec27"><h4 class="pmc_sec_title">Reverse phase evaporation</h4>
<p id="Par49">is a technique that relies on the formation of inverted micelles. During this procedure, an organic phase solution containing amphiphilic molecules is mixed with a solution containing the compounds to be encapsulated and then subjected to sonication. A viscous or gel-like structure forms because of the gradual release of an organic solvent, and this gel collapses at a critical stage in the process, disrupting certain inverted micelles. This process helps in generating liposomes utilizing the surplus phospholipids from the disrupted micelle to build a bilayer structure within the remaining micelle [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. However, sonication of the solution might result in protein and DNA denaturation.</p>
<p id="Par50">This approach produces MLVs with equilibrium transmembrane solute distribution that retain chemicals for longer and trap 6–38%. Thus, solvent dispersion has been widely employed to encapsulate drugs in LUVs due to its high trapping efficiency of 30–45% and ability to accept a larger compound volume with a high drug/lipid ratio [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. Encapsulating RNA, proteins, and DNA is possible using this approach.</p></section></section><section id="Sec28"><h3 class="pmc_sec_title">Detergent removal method</h3>
<p id="Par51">The detergent removal method basically involves detergent extraction from the solution leading to the formation of liposome. This is achieved by detergent removal of mixed micelles, dialysis, and gel permeation chromatography.</p>
<section id="Sec29"><h4 class="pmc_sec_title">Dialysis</h4>
<p id="Par52">is the process through which the detergent is removed by a device known as LipoPrep (Diachema AG, Switzerland) [<a href="#CR142" class="usa-link" aria-describedby="CR142">142</a>]. Detergents get detached resulting in the combination of micelles with the phospholipid and formation of LUVs. Detergents are employed to solubilize lipids at their critical micelle concentration (CMC) [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>].</p></section><section id="Sec30"><h4 class="pmc_sec_title">Detergent removal of mixed micelle</h4>
<p id="Par53">is the adsorption technique where detergents (alkyl glycosidase, Triton X-100, cholate) are kept in a shaking condition with beads of adsorbers functionalized on micelles. Adsorbers are composed of organic polystyrene materials, such as XAD-2 and Bio-beads SM2. This approach can facilitate removal of detergents with a comparatively lower CMC [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>].</p></section><section id="Sec31"><h4 class="pmc_sec_title">Gel-permeation chromatography</h4>
<p id="Par54">exploits the difference in size between detergents and liposomes. Beads of Sephacryl S200-S1000, Sephadex G-1-00, Sepharose 2B-6B and Sephadex G-50 can be used for size exclusion chromatography. Liposomes are bigger in size; allowing them to pass through the inter-bead spaces [<a href="#CR143" class="usa-link" aria-describedby="CR143">143</a>]. LUVs display variability in drug/lipid ratio and can encapsulate higher volumes (1.5–30 µl/µmol), while their size ranging between 0.1 μm and 10 μm. This method is used to encapsulate SUVs and LUVs, allowing us to adjust liposome size by altering the detergent/lipid ratio and enhancing encapsulation efficiency.</p></section></section><section id="Sec32"><h3 class="pmc_sec_title">Mechanical dispersion method</h3>
<p id="Par55">The mechanical dispersion method is the most used method for encapsulating drugs in the liposomes. It involves physical methods to disrupt lipid bilayers and then encapsulation is carried out. This method involves Freeze-thawed liposomes, sonication, and French pressure cell: extrusion.</p>
<section id="Sec33"><h4 class="pmc_sec_title">Freeze-thawed liposomes</h4>
<p id="Par56">involve quick freezing and gradual thawing of SUVs followed by sonication of the aggregates which disperses them resulting in the formation of LUVs [<a href="#CR144" class="usa-link" aria-describedby="CR144">144</a>]. The inhibition of synthesis can be achieved by increasing the concentration of phospholipid and the ionic strength of the medium. This approach ensures an encapsulation efficiency ranging from 20% − 30% [<a href="#CR145" class="usa-link" aria-describedby="CR145">145</a>]. Though this technique is designed for LUVs, MLVs may encapsulate other chemicals without harming DNA, RNA, or proteins if executed properly with up to 88% entrapping efficiency.</p></section><section id="Sec34"><h4 class="pmc_sec_title">Sonication</h4>
<p id="Par57">results in the conversion of MLVs into SUVs. It is the most used method in which the liposome dispersion is sonicated which leads to the encapsulation of the compounds. Two predominant sonication techniques are being used extensively: bath sonication and probe sonication. In the process of bath sonication, the dispersion is contained within a cylindrical container placed inside a bath sonicator, whereas the probe sonication method utilises the tip of the probe being directly immersed in the dispersion. Bath sonication is preferred as probe sonication might release heavy metals like titanium in the dispersion [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. This method has a low encapsulation efficacy and high frequency can degrade the compounds that are to be encapsulated.</p></section><section id="Sec35"><h4 class="pmc_sec_title">French pressure cell extrusionis</h4>
<p id="Par58">a process in which the MLVs are extruded through a small orifice such as 0.5 μm. The vesicles formed by the French press have better encapsulation efficiency as they seem to remember entrapped compounds for a longer period [<a href="#CR146" class="usa-link" aria-describedby="CR146">146</a>]. The unstable materials need to be handled carefully and the liposomes formed are larger than the ones created by the sonication method. This method requires high temperatures which is difficult to attain as well as only small working volumes can be used such as 50mL maximum.</p></section></section><section id="Sec36"><h3 class="pmc_sec_title">Active loading in liposomes</h3>
<p id="Par59">Unlike passive loading, active loading methods involve procedures in which drug/lipid ratios of the solution are greater than the calculated aqueous trapped volumes. Ion gradient drug loading allows amphiphilic cations like Adriamycin to be encapsulated. This mechanism resembles the way particular probes relocate across lipid bilayers in response to ΔΨ and ΔpH changes [<a href="#CR146" class="usa-link" aria-describedby="CR146">146</a>]. The pH-dependent drug uptake mechanism functions similarly to the ΔpH-dependent transmembrane redistribution of weak bases. Unprotonated ions permeate the lipid-bilayer and accumulate inside the vesicle until [AH<sup>+</sup>]<sub>in</sub>/[AH<sup>+</sup>]<sub>out</sub> = [H<sup>+</sup>]<sub>in</sub>/[H<sup>+</sup>]<sub>out</sub>, where AH + is the compound’s protonate form. Encapsulating drugs across the ion gradient boosts trapping efficiency and reduces drug efflux from vesicles by 30-fold [<a href="#CR147" class="usa-link" aria-describedby="CR147">147</a>].</p>
<p id="Par60">Nicols and Deamer were among the first researchers who demonstrated active loading of amphiphilic amine catecholamines in liposomes [<a href="#CR148" class="usa-link" aria-describedby="CR148">148</a>]. A pH gradient was created by using citrate buffer of 3 units 8.0 outside and 5.0 inside the liposome. To further explore this citrate method Bally et al., studied the effect of proton gradient by replacing the intraliposomal solution to HEPES buffer pH (7.0) from 300 mm citrate buffer (pH 4.0), keeping the internal pH undisturbed. It was observed that biogenic amines such as doxorubicin (anticancer drug) accumulated in the solution [<a href="#CR149" class="usa-link" aria-describedby="CR149">149</a>]. Moreover, it had been seen that a 100% encapsulation efficiency with a high stability was achieved when idarubicin, daunorubicin and doxorubicin were loaded in drug/lipid ratio of 0.3 w/w [<a href="#CR150" class="usa-link" aria-describedby="CR150">150</a>].</p>
<p id="Par61">Gradient of pH can be generated by using ionophore, which is another versatile approach for encapsulation. Deamer et al. were the first to identify that SUVs containing potassium would generate pH gradient of 2 units if nigericin was added to it [<a href="#CR151" class="usa-link" aria-describedby="CR151">151</a>]. To facilitate the absorption of drug, the ionophore is added which couples the outward movement of metal ions and the inward movement of H<sup>+</sup> ions. pH gradient is created which leads to the uptake of weak base molecules. Ionophores offers the opportunity of changing the internal ion which can facilitate different drug transport such as, magnesium or calcium ions. These ions can be used to achieve the required pH gradient as well as for the formation of metal-drug complexes [<a href="#CR152" class="usa-link" aria-describedby="CR152">152</a>]. This is how drug release kinetics can be altered depending on their solubility and the pH inside and outside the membrane.</p>
<p id="Par62">Based on the available information, it is evident that liposomes can encapsulate a diverse range of components. The process of encapsulation and subsequent release is dependent upon the polarity of the compounds involved. It is important to note that not every drug or compound can be effectively encapsulated within liposomes, and each molecule will require a distinct method to ensure successful encapsulation.</p></section><section id="Sec37"><h3 class="pmc_sec_title">Stability</h3>
<p id="Par63">Liposomes can be subjected to degradation due to the formation of self-aggregates, flocculation, the occurrence of coalescence, and precipitation of aqueous liposomes during synthesis and storage [<a href="#CR153" class="usa-link" aria-describedby="CR153">153</a>]. Such instabilities may compromise the integrity of the vesicular structure, resulting in premature drug leakage and uncontrolled release kinetics. Several physicochemical parameters critically influence the membrane fluidity and, consequently, the physical stability of liposomes [<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>, <a href="#CR155" class="usa-link" aria-describedby="CR155">155</a>]. These include temperature, pH, ionic strength, the composition of constituent phospholipids, and the incorporation of stabilizing agents within the lipid bilayer. Additionally, factors such as vesicle size, surface charge, and osmotic pressure contribute to membrane integrity and overall formulation robustness [<a href="#CR156" class="usa-link" aria-describedby="CR156">156</a>].</p>
<p id="Par64">To assess liposomal stability, both long-term and accelerated studies are conducted, employing techniques such as Dynamic Light Scattering (DLS) and advanced microscopy, including cryogenic electron microscopy (cryo-EM), for the evaluation of particle size and distribution. Stability assessments following external stressors, such as centrifugation, heat exposure [<a href="#CR157" class="usa-link" aria-describedby="CR157">157</a>], or surfactant treatment [<a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>], provide further insight into formulation resilience. Computational approaches, including molecular dynamics simulations, have also been utilized to explore the influence of lipid composition and membrane curvature on structural stability over extended periods [<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>, <a href="#CR156" class="usa-link" aria-describedby="CR156">156</a>].</p>
<p id="Par65">Beyond physical parameters, the chemical stability of liposomes is influenced by the susceptibility of lipid functional groups to oxidative and hydrolytic degradation. To mitigate oxidation, raw materials must be free of reactive impurities such as transition metal ions and peroxides [<a href="#CR159" class="usa-link" aria-describedby="CR159">159</a>]. Optimal storage conditions include oxygen-free environments, protection from light, and maintenance at reduced temperatures. Moreover, the incorporation of antioxidants such as butylated hydroxytoluene (BHT) and α-tocopherol has proven effective in preserving phospholipid integrity by inhibiting oxidative processes [<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>, <a href="#CR160" class="usa-link" aria-describedby="CR160">160</a>, <a href="#CR161" class="usa-link" aria-describedby="CR161">161</a>].</p>
<p id="Par66">Post-processing techniques are employed to generate dry and stable liposomes which are highly stable, and the contents are more accessible than the aqueous liposomes. Techniques used include spray drying, freeze-drying, and spray freeze-drying. Figure 5 shows the electron microscopy images of liposomes and the stability of liposomes at different pH during their formation.</p>
<section id="Sec38"><h4 class="pmc_sec_title">Freeze drying process</h4>
<p id="Par67">It is also referred to as lyophilization, which eliminates water from the liposome solution. It involved three primary steps: (1) Liposome freezing with a cryoprotectant, (2) Primary drying and sublimation, and (3) Secondary drying to remove the remnant moisture [<a href="#CR162" class="usa-link" aria-describedby="CR162">162</a>]. This process is mandatory as it prevents the encapsulated compounds from degradation, and it also ensures the stability of the liposomes [<a href="#CR163" class="usa-link" aria-describedby="CR163">163</a>]. Despite the added advantages of the freeze-drying method, there are a few disadvantages associated with it such as membrane integrity may be lost, encapsulated substances might leak out from the vesicle and vesicle size might decrease [<a href="#CR163" class="usa-link" aria-describedby="CR163">163</a>]. Research conducted by Franze et al. reported that during rapid freezing, small, iced crystals can form that can minimise disruption of the bilayer structure. However, large ice crystals are formed, if slow freezing is conducted, damaging the bilayer structure [<a href="#CR164" class="usa-link" aria-describedby="CR164">164</a>]. Despite this drawback, various situations might be created where slow freezing must be required, hence, to overcome this lyoprotectant should be added to the liposome mixture. Lyoprotectants prevent bilayer damage, leakage of encapsulated materials and vesicle aggregation. Proteins, carbohydrates, and alcohols are some of the compounds that act as lyoprotectants [<a href="#CR153" class="usa-link" aria-describedby="CR153">153</a>].</p></section><section id="Sec39"><h4 class="pmc_sec_title">Spray drying process</h4>
<p id="Par68">Spray drying process is used to convert aqueous liposomes into dried and stable form and is preferred over freeze drying because it is comparatively affordable, and particles of defined sizes can be formed [<a href="#CR165" class="usa-link" aria-describedby="CR165">165</a>, <a href="#CR166" class="usa-link" aria-describedby="CR166">166</a>]. Despite this, there are some limitations such as after drying a particle it starts to form aggregate increasing in size of liposomes which eventually leads to leakage of its contents. The formation of aggregates can be checked by utilizing oppositely charged biopolymers such as carbohydrates and proteins as protectants to improve mechanical stability and kinetics.</p></section><section id="Sec40"><h4 class="pmc_sec_title">Spray-freeze drying process</h4>
<p id="Par69">This process is being widely used for the improvement of encapsulation efficiency and stability of liposomes. It amalgamates the benefits of freeze-drying and spray drying, resulting in highly stable products [<a href="#CR164" class="usa-link" aria-describedby="CR164">164</a>]. Three major steps are involved in the process: Atomization, freezing, and freeze drying. An atomizer is used, which converts the feed solution into spherical droplets followed by freezing and freeze-drying using a cryogenic agent. Sublimation of the ice is carried out at low pressure and temperature. The product’s physicochemical characteristics alter based on the equipment type being used [<a href="#CR164" class="usa-link" aria-describedby="CR164">164</a>].</p>
<figure class="fig xbox font-sm" id="Fig5"><h5 class="obj_head">Fig. 5.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369165_12951_2025_3660_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/12369165/83e82693ae35/12951_2025_3660_Fig5_HTML.jpg" loading="lazy" id="d33e1439" height="760" width="669" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>TEM and SEM micrographs of lyophilized liposomes: (<strong>A</strong>) TEM Image was taken at a magnification of 60,000, (<strong>B</strong>) SEM image at a magnification of 43,000 and the callout image represents the magnified image of the liposome. (<strong>C</strong>) Graphs represents the stability of liposomes in different pH. Adapted with permission from [<a href="#CR167" class="usa-link" aria-describedby="CR167">167</a>]</p></figcaption></figure></section></section><section id="Sec41"><h3 class="pmc_sec_title">Targeted drug delivery (TDD)</h3>
<p id="Par71">Targeted drug delivery stands as a meticulous approach, directing medication accurately to afflicted cells or tissues, thereby amplifying their therapeutic impact while mitigating adverse effects on healthy cells or tissues [<a href="#CR168" class="usa-link" aria-describedby="CR168">168</a>, <a href="#CR169" class="usa-link" aria-describedby="CR169">169</a>]. TDD improves drug concentration at the targeted location while minimizing side effects and strengthening treatment efficacy [<a href="#CR170" class="usa-link" aria-describedby="CR170">170</a>]. The swift progress in interdisciplinary technology and the creation of effective nanomedicines, possessing safety profiles and potent targeting abilities, promote their clinical use, contributing invaluable support to medical practitioners and patients [<a href="#CR168" class="usa-link" aria-describedby="CR168">168</a>]. Nanomaterial-based drug delivery systems (NBDDS) utilize nanoparticles for improving drug effectiveness and safety. This approach represents a significant breakthrough, enabling the scientific community with tools to tackle the shortcomings inherent in traditional delivery systems with conventional drug administration [<a href="#CR171" class="usa-link" aria-describedby="CR171">171</a>]. NBDDS utilize rational targeting pathways to enhance stability, bioavailability, solubility, and cell membrane transport, and minimize adverse reactions. TDD using liposomes involves encapsulating drugs within phospholipid bilayer vesicles, allowing for efficient delivery to specific sites in the body [<a href="#CR172" class="usa-link" aria-describedby="CR172">172</a>]. Liposomes can be synthesized through diverse methodologies like mechanical dispersion and solvent dispersion. Moreover, they can be tailor made to modify drug release rates and enhance encapsulation efficiency [<a href="#CR173" class="usa-link" aria-describedby="CR173">173</a>].</p>
<p id="Par72">Factors influencing drug targeting involve the type of targeting, targeting moieties, targeting sites, drug carriers, and ligands. Passive targeted delivery involves the use of carrier systems that prolong residence time and increase bioavailability, leading to higher therapeutic efficacy. This approach does not involve the selective binding of drug molecules to receptors of the targeted sites. Active targeted delivery, on the other hand, utilizes drug molecules that selectively bind to receptors of the targeted sites, allowing for specific delivery to the desired tissue or organ. Active targeting can improve drug distribution and minimize unwanted side effects. It is mostly used to treat cancer, cardiovascular illnesses, neurological ailments, and respiratory diseases [<a href="#CR174" class="usa-link" aria-describedby="CR174">174</a>–<a href="#CR176" class="usa-link" aria-describedby="CR176">176</a>]. Using passive targeting to create nano-carrier structures containing chemotherapeutic drugs can improve Drug delivery and patient survival rates. Nanoparticles can reach the tumour microenvironment and deposit inside it through passive targeting, which utilizes the aberrant vasculature of cancerous cells [<a href="#CR177" class="usa-link" aria-describedby="CR177">177</a>, <a href="#CR178" class="usa-link" aria-describedby="CR178">178</a>]. While TDD systems have demonstrated promising outcomes, scaling up, translating preclinical research into clinical success, and obtaining regulatory approval remain difficulties for commercial success.</p>
<p id="Par73">To effectively treat skin cancer and various other dermatological conditions, TDD is an promising strategy. Nanotechnology has the potential to offer secure and customised delivery of drugs. Nanocarriers have been shown to enhance the delivery of dermatological medicines. The physicochemical characteristics of nanoparticles facilitate the delivery of drugs and enhance skin permeation [<a href="#CR179" class="usa-link" aria-describedby="CR179">179</a>]. Several specialized targeted nanocarriers, such as liposomes, dendrimers, inorganic nanoparticles and inorganic nanoparticles, have been developed for skin cancer treatment [<a href="#CR170" class="usa-link" aria-describedby="CR170">170</a>]. The use of FDA-approved excipients and innovative formulation platforms has been explored to optimize the properties and permeation behaviour of drugs in the skin [<a href="#CR180" class="usa-link" aria-describedby="CR180">180</a>]. TDD in dermatology aims to prolong, localize, and target drug interactions with the diseased skin, leading to improved treatment outcomes and quality of the patient’s life [<a href="#CR181" class="usa-link" aria-describedby="CR181">181</a>]. However, there are still challenges that need to be addressed, such as the optimization of properties, reliable characterization methods, safety evaluation, nanoparticles that might lead to unintended consequences like nano-pollution and cytotoxicity and regulatory aspects related to nanomedicines targeting skin cancer [<a href="#CR176" class="usa-link" aria-describedby="CR176">176</a>, <a href="#CR179" class="usa-link" aria-describedby="CR179">179</a>].</p></section></section><section id="Sec42"><h2 class="pmc_sec_title">Liposome for dermatosis treatment</h2>
<p id="Par74">Dermatosis is a general term for all the skin defects, or any lesions formed on the skin and can be caused throughout the body and not specific to any single part [<a href="#CR182" class="usa-link" aria-describedby="CR182">182</a>]. Dermatotic conditions such as tumors, chronic wounds and psoriasis are triggered due to the perturbation of skin homeostasis because of both internal and external factors. Barrier dysfunction due to unavoidable injuries or allergic responses enhances the release of IL-1α, leading to the increased formation of cytokine proteins [<a href="#CR183" class="usa-link" aria-describedby="CR183">183</a>, <a href="#CR184" class="usa-link" aria-describedby="CR184">184</a>]. This hypothesis suggests that inflammatory cells phenotype specific like the abnormal T cells are trapped within the skin barriers resulting in the release of signalling molecules from the epidermis. A cascade mechanism gets initiated leading to the downstream stimulation of chemokine and intracellular adhesion molecule (ICAM) formation following the generation of IL-lα and TNFα, respectively [<a href="#CR185" class="usa-link" aria-describedby="CR185">185</a>].</p>
<p id="Par75">The continuous distribution in the skin barrier due to genetic factors, injuries, infections, or immune dysregulation is termed inflammatory dermatoses [<a href="#CR186" class="usa-link" aria-describedby="CR186">186</a>–<a href="#CR188" class="usa-link" aria-describedby="CR188">188</a>]. The continuous disruption leads to kelpids and hypertrophic scars which can be viewed as an exuberant wound healing response, explained by a primary barrier abnormality [<a href="#CR189" class="usa-link" aria-describedby="CR189">189</a>]. Hardening refers to the process of repairing a barrier to compensate for any existing damages. This condition exhibits reduced levels of irritation; however, it is characterised by inflammation and epidermal hyperplasia. In summary, this outside-inside theory of skin dermatosis, which encompasses irritating chronic dermatitis, holds significant therapeutic implications [<a href="#CR190" class="usa-link" aria-describedby="CR190">190</a>]. Figure <a href="#Fig6" class="usa-link">6</a> represents various techniques being employed for the transdermal delivery of drugs.</p>
<figure class="fig xbox font-sm" id="Fig6"><h3 class="obj_head">Fig. 6.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369165_12951_2025_3660_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/12369165/da2fde2ef5cc/12951_2025_3660_Fig6_HTML.jpg" loading="lazy" id="d33e1574" height="760" width="669" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>. Diagram illustrating techniques for applying microneedles in the skin to improve delivery of drugs through the skin. <strong>(A) </strong>a-d shows conventional approaches to drug delivery using microneedles. <strong>(A) </strong>e-h introduces hydrogel-making polymeric microneedles (Adapted with permission from [<a href="#CR191" class="usa-link" aria-describedby="CR191">191</a>]). (<strong>B).</strong>i. Depicts drug delivery system utilizing magnetic nanoparticles. ii. A typical magnetic nanoparticle comprises a magnetic nucleus, a shielding layer, an organic connector, and an active compound. <strong>C.</strong> This image illustrates the iontophoresis method. <strong>D.</strong> Illustration shows the electroporation phenomenon. <strong>E.</strong> This illustrates Photothermal therapy. Cells internalize PEGylated nanogels incorporating gold nanoparticles. Both heat and light irradiation are lethal to cancer cells. (<strong>B-E</strong> Adapted with permission from [<a href="#CR192" class="usa-link" aria-describedby="CR192">192</a>])</p></figcaption></figure><section id="Sec43"><h3 class="pmc_sec_title">Application of liposomes in dermatology</h3>
<p id="Par77">Liposomal formulations have shown considerable promise in treating numerous dermatological problems, such as infections, inflammatory disorders, and neoplastic lesions, by boosting medication penetration, improving bioavailability, and minimising systemic side effects. Table 2 summarizes key studies done employing using various liposomal formulations.</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Various liposomal formulations for the treatment of different dermatological diseases</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">S.No.</th>
<th align="left" colspan="1" rowspan="1">Liposomal Formulation</th>
<th align="left" colspan="1" rowspan="1">Dosage</th>
<th align="left" colspan="1" rowspan="1">Disease<br>Targeted</th>
<th align="left" colspan="1" rowspan="1">Observed Outcomes</th>
<th align="left" colspan="1" rowspan="1">Adverse Outcomes if any</th>
<th align="left" colspan="1" rowspan="1">Clinical or Preclinical Studies</th>
<th align="left" colspan="1" rowspan="1">References</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>1.</strong>
</td>
<td align="left" colspan="1" rowspan="1">Azithromycin loaded liposomes</td>
<td align="left" colspan="1" rowspan="1">250 mg twice/day</td>
<td align="left" colspan="1" rowspan="1">Cutaneous Leishmaniasis</td>
<td align="left" colspan="1" rowspan="1">
<p>• Decrease in Lesion size observed.</p>
<p>• Slight improvement: 25% lesion size decrease.</p>
<p>• Mild improvement: 25–75% decrease in lesion size.</p>
<p>• Moderate improvement: 50–75% lesion size decrease.</p>
<p>• Significant improvement: 75% decrease in lesion size.</p>
</td>
<td align="left" colspan="1" rowspan="1">Mild Pruritus in 2 cases</td>
<td align="left" colspan="1" rowspan="1">Pilot Clinical Study: randomized, open label, parallel-group trial</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR193" class="usa-link" aria-describedby="CR193">193</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>2.</strong>
</td>
<td align="left" colspan="1" rowspan="1">Fluconazole and Terbinafine loaded liposomes</td>
<td align="left" colspan="1" rowspan="1">
<p>Fluconazole nanoliposome: 0.5%</p>
<p>Terbinafine nanoliposome: 1%</p>
</td>
<td align="left" colspan="1" rowspan="1">Dermatophytosis</td>
<td align="left" colspan="1" rowspan="1">
<p>• Faster lesion clearance.</p>
<p>• Complete clinical recovery by day 40.</p>
</td>
<td align="left" colspan="1" rowspan="1">No adverse effect</td>
<td align="left" colspan="1" rowspan="1">Pre-clinical study conducted on Guinea Pigs</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR194" class="usa-link" aria-describedby="CR194">194</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>3.</strong>
</td>
<td align="left" colspan="1" rowspan="1">Irutinib and Curcumin loaded liposomes</td>
<td align="left" colspan="1" rowspan="1">
<p>Irutinib: 10 mg/kg</p>
<p>Curcumin: 20 mg/kg</p>
</td>
<td align="left" colspan="1" rowspan="1">Psoriasis</td>
<td align="left" colspan="1" rowspan="1">
<p>• Epidermal hyperplasia and ear thickness were reduced significantly.</p>
<p>• Psoriasis Area and Severity Index (PASI) score were significantly decreased.</p>
<p>• Inflammatory cytokines (TNFα, IL-17, and IL-32) decreased significantly</p>
</td>
<td align="left" colspan="1" rowspan="1">No reported adverse effect</td>
<td align="left" colspan="1" rowspan="1">Preclinical study on BALB/c mice</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR195" class="usa-link" aria-describedby="CR195">195</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>4.</strong>
</td>
<td align="left" colspan="1" rowspan="1">Amphotericin B loaded Liposome</td>
<td align="left" colspan="1" rowspan="1">200 mg, 400 mg, and 800 mg</td>
<td align="left" colspan="1" rowspan="1">Mucocutaneous Candidiasis</td>
<td align="left" colspan="1" rowspan="1">
<p>• All patients exhibited clinical improvement within 2 weeks, in which 3 received 400 mg and 1 received 200 mg daily.</p>
<p>• 3 patients maintained sustained response for 60 months.</p>
<p>• 1 patient experienced relapse at 24th week and was withdrawn.</p>
</td>
<td align="left" colspan="1" rowspan="1">No serious adverse effect observed</td>
<td align="left" colspan="1" rowspan="1">Clinical trial phase 2</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR196" class="usa-link" aria-describedby="CR196">196</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>5.</strong>
</td>
<td align="left" colspan="1" rowspan="1">Amphotericin B loaded liposomes</td>
<td align="left" colspan="1" rowspan="1">0.4% gel applied twice daily for 28 days</td>
<td align="left" colspan="1" rowspan="1">Cutaneous Leishmaniasis</td>
<td align="left" colspan="1" rowspan="1">
<p>• 19 of 22 patients (36 of 39 lesions) were completely cured within 42 days.</p>
<p>• 95% of efficacy achieved.</p>
</td>
<td align="left" colspan="1" rowspan="1">Mild local burning sensation were reported in a small number of patients less than 30%</td>
<td align="left" colspan="1" rowspan="1">Clinical trial phase 2</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR197" class="usa-link" aria-describedby="CR197">197</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>6.</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<em>Vaccinium vitis-idaea</em> extract loaded liposome</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">Atopic Dermatitis</td>
<td align="left" colspan="1" rowspan="1">
<p>• AD = associated signs (erythema, tissue infiltration, and keratinization) were significantly reduced.</p>
<p>• Enhanced collagen fibre formation.</p>
<p>• Inflammatory cytokines (TNF-α, IL-4, IL-13, and MDA) decreased substantially.</p>
</td>
<td align="left" colspan="1" rowspan="1">No recorded abnormality</td>
<td align="left" colspan="1" rowspan="1">Preclinical trial</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR198" class="usa-link" aria-describedby="CR198">198</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>7.</strong>
</td>
<td align="left" colspan="1" rowspan="1">Omiganan loaded liposomes</td>
<td align="left" colspan="1" rowspan="1">2 mg</td>
<td align="left" colspan="1" rowspan="1">Atopic Dermatitis and Psoriasis</td>
<td align="left" colspan="1" rowspan="1">
<p>• Improvement in AD and psoriatic lesions.</p>
<p>• Significant reduction in pro-inflammatory cytokines.</p>
</td>
<td align="left" colspan="1" rowspan="1">No recorded abnormality</td>
<td align="left" colspan="1" rowspan="1">Preclinical trial</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR199" class="usa-link" aria-describedby="CR199">199</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>8.</strong>
</td>
<td align="left" colspan="1" rowspan="1">Chamomile loaded liposomes</td>
<td align="left" colspan="1" rowspan="1">Once daily throughout radiation therapy</td>
<td align="left" colspan="1" rowspan="1">Radiation dermatitis</td>
<td align="left" colspan="1" rowspan="1">
<p>• 76.9% patients experience dry desquamation.</p>
<p>• Lower grades of radiation dermatitis</p>
</td>
<td align="left" colspan="1" rowspan="1">No recorded adverse effect</td>
<td align="left" colspan="1" rowspan="1">Clinical trial phase 2</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR200" class="usa-link" aria-describedby="CR200">200</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec44"><h3 class="pmc_sec_title">Therapeutic applications of liposomes in dermatology</h3>
<section id="Sec45"><h4 class="pmc_sec_title">Antifungal therapy and dermatophytosis</h4>
<p id="Par79">Liposomes have demonstrated considerable potential in enhancing the delivery and efficacy of antifungal agents for the treatment of dermatophytosis. These vesicular systems improve drug solubility, targeting, and retention in the stratum corneum, thereby augmenting therapeutic outcomes. Notably, liposome-based formulations of griseofulvin exhibit improved entrapment efficiency and controlled drug release, rendering them well-suited for sustained antifungal activity [<a href="#CR201" class="usa-link" aria-describedby="CR201">201</a>]. Furthermore, liposomes have been shown to interact with fungal pathogens such as Candida albicans, facilitating increased drug-liposome interaction at the infection site and enhancing antifungal efficacy [<a href="#CR202" class="usa-link" aria-describedby="CR202">202</a>]. Their ability to enhance drug retention in the upper layers of the epidermis further supports their utility in the management of cutaneous mycoses [<a href="#CR202" class="usa-link" aria-describedby="CR202">202</a>, <a href="#CR203" class="usa-link" aria-describedby="CR203">203</a>].</p></section><section id="Sec46"><h4 class="pmc_sec_title">Management of bacterial infections</h4>
<p id="Par80">Liposomes have also been explored for the targeted delivery of antimicrobial agents in the treatment of bacterial dermatoses, particularly those involving biofilm-associated infections [<a href="#CR204" class="usa-link" aria-describedby="CR204">204</a>]. Their inherent properties, including low systemic toxicity, site-specific delivery, and the capacity to penetrate biofilm matrices, enable improved local drug concentration and reduce recurrence rates [<a href="#CR205" class="usa-link" aria-describedby="CR205">205</a>]. For instance, liposomal polyvinylpyrrolidone (PVP)-iodine hydrogel formulations have been investigated for the treatment of impetigo contagiosa and related infective dermatoses, offering extended and controlled drug release profiles that may enhance both therapeutic efficacy and patient compliance [<a href="#CR206" class="usa-link" aria-describedby="CR206">206</a>].</p></section><section id="Sec47"><h4 class="pmc_sec_title">Liposome-based strategies for vitiligo</h4>
<p id="Par81">Recent advancements in liposomal drug delivery have extended to the treatment of vitiligo, with several combination strategies showing promise in enhancing therapeutic response. Liposomes have been employed for the delivery of psoralen, a melanogenesis-inducing agent, and resveratrol, a potent antioxidant that mitigates oxidative stress, both of which are critical to regimentation in vitiligo [<a href="#CR207" class="usa-link" aria-describedby="CR207">207</a>]. Moreover, liposomal formulations have been integrated with ultraviolet (UV) light therapy, demonstrating significant depigmentation effects in clinical studies [<a href="#CR208" class="usa-link" aria-describedby="CR208">208</a>]. Adjunctive approaches involving topical calcineurin inhibitors or corticosteroids in conjunction with phototherapy have yielded improved regimentation outcomes [<a href="#CR209" class="usa-link" aria-describedby="CR209">209</a>, <a href="#CR210" class="usa-link" aria-describedby="CR210">210</a>], while emerging combinations with antioxidants and laser therapies offer additional therapeutic potential, albeit with limited clinical data to date [<a href="#CR211" class="usa-link" aria-describedby="CR211">211</a>].</p></section></section><section id="Sec48"><h3 class="pmc_sec_title">Cosmeceutical application of liposomes</h3>
<section id="Sec49"><h4 class="pmc_sec_title">Anti-ageing and dermal regeneration</h4>
<p id="Par82">In cosmeceutical applications, liposomes have gained significant attention as delivery vehicles in anti-ageing formulations. These nanocarriers facilitate the dermal delivery of biomolecules and enhance their retention within the skin. Liposomal delivery systems have been shown to promote the retention of collagen within artificial membranes and elevate the expression of structural skin proteins such as collagen, keratin, and involucrin, contributing to improved skin elasticity and reduced signs of ageing [<a href="#CR212" class="usa-link" aria-describedby="CR212">212</a>]. Additionally, liposome-encapsulated bee venom has exhibited superior therapeutic efficacy in the management of atopic dermatitis, attributed to the downregulation of pro-inflammatory cytokines and chemokines, as well as a reduction in mast cell infiltration [<a href="#CR212" class="usa-link" aria-describedby="CR212">212</a>].</p></section><section id="Sec50"><h4 class="pmc_sec_title">Applications in hair loss and scalp care</h4>
<p id="Par83">Liposomes are widely incorporated into hair care products, including therapeutic formulations for alopecia. Their structural resemblance to biological membranes—comprising phospholipids and cholesterol, confers enhanced biocompatibility and facilitates efficient transfollicular drug delivery [<a href="#CR213" class="usa-link" aria-describedby="CR213">213</a>, <a href="#CR214" class="usa-link" aria-describedby="CR214">214</a>]. These properties allow for improved localization of active agents at the hair follicle site, potentially enhancing follicular health and promoting hair regrowth through sustained and targeted delivery mechanisms.</p>
<p id="Par84">Collectively, liposome-based delivery systems represent a transformative approach in both therapeutic and cosmeceutical dermatology. By improving the stability, localization, and controlled release of active pharmaceutical ingredients, liposomes enhance the efficacy and safety profiles of topical treatments. These advancements offer promising avenues for the management of complex dermatoses and for the development of next-generation cosmeceutical products. Figure <a href="#Fig7" class="usa-link">7</a> illustrates the transdermal delivery mechanism of liposomes, underscoring their multifunctional role in dermatological applications.</p>
<figure class="fig xbox font-sm" id="Fig7"><h5 class="obj_head">Fig. 7.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369165_12951_2025_3660_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/12369165/0e2df6da52e7/12951_2025_3660_Fig7_HTML.jpg" loading="lazy" id="d33e1937" height="669" width="669" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Applications of transdermal delivery of liposomes. (<strong>A</strong>) Targeted drug delivery of drugs encapsulated liposomes for treating alopecia. (<strong>B</strong>) Administering liposome-containing drugs topically (<strong>C</strong>) Recovery of skin from acne using liposome-based drug delivery. (<strong>D</strong>) Application of liposome-containing drugs on artificial membranes enhances collagen content, resulting in anti-aging effects. (<strong>E</strong>) Liposomes containing antifungal drugs cure for dermatophytosis</p></figcaption></figure></section></section><section id="Sec51"><h3 class="pmc_sec_title">Role of transdermal delivery in dermatosis</h3>
<p id="Par86">Transdermal drug delivery is an alternative approach to hypodermic injection and oral delivery of drugs which offers a wide range of applications. It has numerous benefits, including better patient compliance, bypassing the first pass effect, ensuring controlled rate of drug release, and allows to swiftly halt or terminating the treatment, if required. Transdermal delivery can be used to bypass the first-pass effect, which would otherwise prematurely metabolize the drugs. This approach enhances their bioavailability, efficacy, and targeted delivery. This eliminates the need for intrusive, irritable needles, which generate medical waste, pose a danger of infection, and need to be administered by a medical expert [<a href="#CR215" class="usa-link" aria-describedby="CR215">215</a>]. For the proper delivery of the drug encapsulated in the liposome, it is imperative to take into consideration the properties of both the stratum corneum and the drug, while considering the site of application, body temperature, and the blood flow of the skin. There lies a narrow physiochemical window for the drug to effectively pass the stratum corneum which includes low melting point, low molecular weight of 600 Da, and water/octanol partition coefficient in the range of 1–3 [<a href="#CR216" class="usa-link" aria-describedby="CR216">216</a>].</p>
<p id="Par87">The human skin, accounting for approximately 16% of total body weight, is the largest organ and serves as a primary barrier against environmental insults such as microbial invasion, UV radiation, and chemical or mechanical stress [<a href="#CR217" class="usa-link" aria-describedby="CR217">217</a>, <a href="#CR218" class="usa-link" aria-describedby="CR218">218</a>]. Structurally, it comprises three main layers: the subcutaneous layer (hypodermis), dermis, and epidermis [<a href="#CR219" class="usa-link" aria-describedby="CR219">219</a>, <a href="#CR220" class="usa-link" aria-describedby="CR220">220</a>]. The subcutaneous layer contains fat deposits, while the dermis consists of connective tissue. Above it lies the epidermis, an avascular layer that relies on nutrient diffusion through the dermo-epidermal junction. The outermost layer of the epidermis is the stratum corneum (SC), which consists of 15–20 layers of non-viable, flattened corneocytes embedded in a lipid matrix, and can thicken from 10 to 15 μm to 40 μm under moist conditions [<a href="#CR221" class="usa-link" aria-describedby="CR221">221</a>, <a href="#CR222" class="usa-link" aria-describedby="CR222">222</a>]. This SC layer forms the principal barrier to drug permeation, largely due to its unique lipid composition, predominantly ceramides, cholesterol, fatty acids, and cholesteryl sulfate, arranged in bilayer structures within intercellular spaces [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>, <a href="#CR223" class="usa-link" aria-describedby="CR223">223</a>–<a href="#CR225" class="usa-link" aria-describedby="CR225">225</a>]. These structures regulate water and drug transport and can be disrupted by solvent treatments. Unlike viable epidermal layers, the SC lacks phospholipids [<a href="#CR223" class="usa-link" aria-describedby="CR223">223</a>]. The epidermis also features tight junction proteins that enhance barrier integrity and includes four primary cell types: keratinocytes (forming the water barrier), melanocytes (pigment production), Langerhans cells (immune defense), and Merkel cells (touch receptors) [<a href="#CR226" class="usa-link" aria-describedby="CR226">226</a>, <a href="#CR227" class="usa-link" aria-describedby="CR227">227</a>]. Due to the formidable barrier posed by the SC, only a limited number of drugs are approved for transdermal delivery [<a href="#CR228" class="usa-link" aria-describedby="CR228">228</a>, <a href="#CR229" class="usa-link" aria-describedby="CR229">229</a>].</p>
<p id="Par88">Transdermal delivery allows skin penetration modifying the properties of the stratum corneum using passive or active methods. While the passive technique focuses on drug and vehicle interaction and optimization to affect the stratum corneum structure, the active approach utilizes external energy to facilitate the transportation of drugs through the skin or by physically disrupting the outermost layer of the skin, known as the stratum corneum [<a href="#CR230" class="usa-link" aria-describedby="CR230">230</a>, <a href="#CR231" class="usa-link" aria-describedby="CR231">231</a>].</p></section><section id="Sec52"><h3 class="pmc_sec_title">Active method</h3>
<section id="Sec53"><h4 class="pmc_sec_title">Ultrasound devices</h4>
<p id="Par89">In 1950, Fellinger and Schmidt were the first to deliver the drugs utilizing ultrasound through the skin. Their findings indicate that the combination of hydrocortisone ointment and sonophoresis is effective in treating polyarthritis. Sonophoresis or phonophoresis is the application of ultrasound for drug delivery via the skin [<a href="#CR232" class="usa-link" aria-describedby="CR232">232</a>]. Mechanical energy is propagated longitudinally with the application of ultrasound perturbation at frequencies 20 kHz − 16 MHz with high oscillation of (compression) pressure and low (rarefaction) pressure decreasing the resistance of the skin. By modulating their frequencies, they can raise the skin’s temperature by absorbing sound waves with a frequency higher than what humans can hear [<a href="#CR233" class="usa-link" aria-describedby="CR233">233</a>].</p>
<p id="Par90">Liposomes utilised with ultrasound (sonophoresis) present an effective method for improving transdermal drug administration. Low-frequency ultrasound (20–100 kHz) causes inertial cavitation, causing gas bubbles in the coupling medium to collapse near the stratum corneum, thereby generating microjets and shockwaves that disturb the lipid structure of this barrier [<a href="#CR234" class="usa-link" aria-describedby="CR234">234</a>]. These temporary disturbances generate hydrophilic microchannels, enhancing the penetration of liposomal vesicles and allowing the release of contained pharmaceuticals. Furthermore, steady cavitation and acoustic streaming facilitate passive diffusion and augment local fluid transfer [<a href="#CR235" class="usa-link" aria-describedby="CR235">235</a>]. Ultrasound application to liposome formulations can produce regulated release by cavitation-induced pore development in the lipid bilayer. In a study by Kim et al., the ultrasound-sensitive liposomes exhibited a size distribution of 81.94 nm, with a doxorubicin entrapment effectiveness of 97.1 ± 1.44%. The release of doxorubicin under ultrasound irradiation was 60% with continuous wave and 50% with optimised focused ultrasound settings [<a href="#CR236" class="usa-link" aria-describedby="CR236">236</a>].</p></section><section id="Sec54"><h4 class="pmc_sec_title">Velocity based techniques</h4>
<p id="Par91">Velocity-based transdermal drug delivery methods include jet injection, iontophoresis, and electrophoresis, each utilising distinct physical principles to improve skin penetration. Jet injectors function by expelling high-velocity liquid jets at speeds between 100 and 200 m/s, facilitating needle-free administration of pharmaceuticals through the stratum corneum. These devices are generally propelled by compressed gas or mechanical springs and have been widely employed for the delivery of vaccinations and macromolecules, providing a minimally invasive alternative to traditional needles [<a href="#CR187" class="usa-link" aria-describedby="CR187">187</a>, <a href="#CR237" class="usa-link" aria-describedby="CR237">237</a>]. The notion of jet injection originated in the early 1930 s, first presented by Arnold Sutermesiter.</p>
<p id="Par92">Iontophoresis entails the utilisation of a low electric current to facilitate the transdermal delivery of charged drug-loaded liposomes, hence improving transport across dermal barriers by electrorepulsion and electroosmosis [<a href="#CR238" class="usa-link" aria-describedby="CR238">238</a>–<a href="#CR240" class="usa-link" aria-describedby="CR240">240</a>]. Electrophoresis utilises electric fields to enhance the migration of charged molecules, such as liposomal carriers, by augmenting skin permeability and facilitating active transdermal transport [<a href="#CR241" class="usa-link" aria-describedby="CR241">241</a>–<a href="#CR243" class="usa-link" aria-describedby="CR243">243</a>]. Collectively, these velocity-based methods provide accurate, non-invasive, and efficient drug administration, especially advantageous for macromolecules and formulations exhibiting low passive permeability.</p></section><section id="Sec55"><h4 class="pmc_sec_title">Electroporation</h4>
<p id="Par93">it is a well-established physical technique employed for the Transdermal administration of large molecules. By subjecting cells to high-intensity electric pulses, typically ranging from 50 to 500 volts for a brief duration. This exposure results in the creation of aqueous pores within the lamellar lipid regions of the SC, thereby facilitating the drug diffusion across the skin barrier [<a href="#CR192" class="usa-link" aria-describedby="CR192">192</a>, <a href="#CR244" class="usa-link" aria-describedby="CR244">244</a>]. This technique was discovered by Neuman et al., in 1982 [<a href="#CR245" class="usa-link" aria-describedby="CR245">245</a>]. This method offers immediate action, delivery of macromolecules, and insignificant or minor skin damage. It has been efficient in increasing the TDDs with varying molecular weights including small (fentanyl, orcalcein) to high molecular weight drugs weighing up to 40 kDa. Electroporation, which employs brief, high-voltage pulses, creates transitory holes in the stratum corneum, facilitating enhanced penetration of liposomes. The incorporation of anionic lipids, specifically dimyristoylphosphatidylserine (DMPS), enhances pore stability, yielding a four- to eighteen-fold increase in insulin penetration and producing more robust, linear delivery profiles [<a href="#CR246" class="usa-link" aria-describedby="CR246">246</a>].</p></section><section id="Sec56"><h4 class="pmc_sec_title">Iontophoresis</h4>
<p id="Par94">Transdermal iontophoresis is a potential method for delivering a range of chemicals in a regulated and scheduled manner [<a href="#CR247" class="usa-link" aria-describedby="CR247">247</a>]. This approach has the potential to be widely employed for the administration of hydrophilic medicines. It is a non-invasive technique that enhances dermal and transdermal delivery with the application of continuous low-voltage current [<a href="#CR248" class="usa-link" aria-describedby="CR248">248</a>]. It is known to provide a physiologically acceptable electrical current(0.1-1.0 mA/cm<sup>2</sup>) using an electrode of the same polarity to drive charged permeants across the SC through its potential gradient [<a href="#CR249" class="usa-link" aria-describedby="CR249">249</a>, <a href="#CR250" class="usa-link" aria-describedby="CR250">250</a>]. By the phenomenon of electroosmosis weakly charged molecules or uncharged molecules are transferred but for the transfer of charged molecules, electrophoresis is required. Iontophoresis utilises a mild electric current to enhance the mobility of both charged and uncharged liposomes through the skin, promoting their uptake by skin cells via endocytosis. Research indicates that liposomal formulations delivered using iontophoresis significantly enhance the transdermal transport of encapsulated proteins (such as platelet-rich plasma), propranolol, diclofenac, and peptides in both porcine and human skin, surpassing passive diffusion methods [<a href="#CR251" class="usa-link" aria-describedby="CR251">251</a>–<a href="#CR253" class="usa-link" aria-describedby="CR253">253</a>].</p>
<p id="Par95">By integrating liposomal encapsulation with velocity-driven techniques, researchers can attain higher control over drug release, improved localisation at target areas, and increased bioavailability, rendering this strategy a potent platform for non-invasive and efficient transdermal therapies.</p></section></section><section id="Sec57"><h3 class="pmc_sec_title">Thermal approaches</h3>
<section id="Sec58"><h4 class="pmc_sec_title">Laser thermal ablations</h4>
<p id="Par96">hows potential for enhancing the permeability of SC, which is the outermost layer of the skin, while preserving the integrity of deeper underlying tissues. For treating skin dermatosis including pigmented lesions, laser ablation technique is widely used. The fundamental principle of laser thermal ablation is that laser irradiation causes the skin target to decompose into microscopic particles that travel away from the skin surface at a supersonic speed. As a result, laser ablation may selectively eliminate the SC without causing damage to deeper tissue. This ablation can significantly impair stratum corneum’s barrier function, allowing drugs to pass through the skin more easily [<a href="#CR254" class="usa-link" aria-describedby="CR254">254</a>, <a href="#CR255" class="usa-link" aria-describedby="CR255">255</a>]. The structural integrity of the skin must be evaluated, especially during the high-intensity laser used for big molecular weight drugs.</p>
<p id="Par97">Lee et al. carried out a study to enhance and regulate the penetration of peptides and associated vaccinations into the skin using erbium: yttrium–aluminium–garnet (Er: YAG) laser. Laser therapy and lysozyme antigen immunisation were performed on mouse skin in vivo. Peptide administration increased significantly when the Er: YAG laser partly ablated the SC. Despite a thin and fragmented SC laser, treated skin had 3 to 140 times more peptide than untreated skin. Laser therapy tripled blood serum antibody production without any extra chemicals or boosters [<a href="#CR256" class="usa-link" aria-describedby="CR256">256</a>].</p>
<p id="Par98">Recent studies indicate that laser thermal ablation enhances the transdermal administration of liposomal formulations by promoting deeper skin penetration and enhanced drug release. Fractional CO₂ laser pre-treatment has shown improved absorption of liposome-encapsulated hydrophilic substances, including 5-carboxyfluorescein and ovalbumin, in both pig and murine skin, with a notable increase in permeability linked to the applied laser intensity [<a href="#CR257" class="usa-link" aria-describedby="CR257">257</a>]. The Er: YAG laser selectively ablates sections of the stratum corneum, enhancing the penetration of hydrophilic and lipophilic medicines contained in liposomes, while preserving skin viability [<a href="#CR258" class="usa-link" aria-describedby="CR258">258</a>]. These lasers function by generating microchannels and temporarily breaking lipid bilayers, facilitating the penetration of nanoscale carriers like liposomes into the living epidermal and dermal layers. Furthermore, the localised heat effects of laser exposure can augment the fluidity of stratum corneum lipids and facilitate regulated liposomal fusion and payload release, hence enhancing bioavailability and targeted accumulation of medicines. This method has significant potential for administering macromolecular medications and vaccinations, which are otherwise constrained by the skin’s barrier properties.</p></section><section id="Sec59"><h4 class="pmc_sec_title">Radiofrequency (RF) Thermal Ablation</h4>
<p id="Par99">involves the placement of microelectrode arrays and the use of high frequency alternating current (about 100 kHz) to the specific area [<a href="#CR256" class="usa-link" aria-describedby="CR256">256</a>]. The narrow pathways for drug penetration in the SC are formed when the ions of the cell oscillate near the microelectrode. High frequency alternating current generates thermal energy through ionic vibration, leading to the evaporation of water and the ablution of cells, perhaps causing harm to underlying tissue. Low-cost, disposable devices can be used to transdermally distribute several hydrophilic drugs and macromolecules [<a href="#CR259" class="usa-link" aria-describedby="CR259">259</a>]. Microchannel’s presence is confined to the superficial layers of the skin, where the blood vessels and nerve endings are absent, resulting in a reduction of discomfort. The microchannels are rapidly filled with hydrophilic interstitial fluid within a matter of seconds. The regulation of medicine distribution is influenced by the microchannel number and depth, as well as the microelectrode parameters.</p>
<p id="Par100">RF-induced thermal ablation has demonstrated significant potential in enhancing the transdermal delivery of liposomal drug formulations. By creating uniform and transient microchannels in the stratum corneum, RF facilitates the deeper penetration of liposomes through otherwise impermeable skin barriers. Specifically, studies have shown that RF ablation markedly increases the skin permeation of liposomal encapsulated compounds, including hydrophilic and macromolecular drugs such as insulin and interferon-α, by enabling direct access to the viable epidermis and dermis [<a href="#CR260" class="usa-link" aria-describedby="CR260">260</a>]. The localized heat generated by RF can also temporarily increase lipid fluidity in the stratum corneum, promoting fusion of liposomal bilayers with disrupted skin lipids and enhancing the release of encapsulated drugs [<a href="#CR261" class="usa-link" aria-describedby="CR261">261</a>]. Moreover, RF ablation has been used synergistically with deformable liposomes (transfersomes and ethosomes), further amplifying delivery efficiency by facilitating both mechanical passage through RF-induced microchannels and biochemical fusion with skin lipids [<a href="#CR262" class="usa-link" aria-describedby="CR262">262</a>]. These findings indicate that RF thermal ablation is a promising strategy for the non-invasive, site-specific delivery of liposomal drugs, especially for molecules with poor transdermal permeability under conventional methods.</p></section></section><section id="Sec60"><h3 class="pmc_sec_title">Mechanical approaches</h3>
<section id="Sec61"><h4 class="pmc_sec_title">Microneedle arrays</h4>
<p id="Par101">were created to alleviate the drawbacks of hypodermic needles and to administer drugs that could not diffuse through the skin using passive or externally assisted diffusion [<a href="#CR263" class="usa-link" aria-describedby="CR263">263</a>, <a href="#CR264" class="usa-link" aria-describedby="CR264">264</a>]. MN tests were initially developed to keep the person safe from discomfort caused by hypodermic needles [<a href="#CR265" class="usa-link" aria-describedby="CR265">265</a>]. The Microneedle has the potential to pierce the stratum corneum, generating channels for the drug molecule to quickly diffuse beneath the epidermis. Microneedles (MN) consist of multiple projections typically arranged unilaterally on a supportive base or patch. These projections vary in base width from 50 to 250 μm, heights between 25 and 2000 μm, and diameters of tip from 1 to 25 μm [<a href="#CR238" class="usa-link" aria-describedby="CR238">238</a>, <a href="#CR266" class="usa-link" aria-describedby="CR266">266</a>]. MN was initially conceptualized in the 1970 s by Martin S. Gerste and Virgil A. Place [<a href="#CR267" class="usa-link" aria-describedby="CR267">267</a>]. Figure <a href="#Fig8" class="usa-link">8</a> illustrates various mechanical approaches of transdermal delivery including microneedle arrays.</p>
<figure class="fig xbox font-sm" id="Fig8"><h5 class="obj_head">Fig. 8.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369165_12951_2025_3660_Fig8_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/12369165/025b89d0ddfa/12951_2025_3660_Fig8_HTML.jpg" loading="lazy" id="d33e2234" height="669" width="669" alt="Fig. 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Illustration of four distinct active methods employed in transdermal drug delivery. (1) Positioned in the top left quadrant is the electroporation which involves the application of short high-voltage electrical pulses facilitating permeability for drug absorption. (2) The top right quadrant represents Iontophoresis, which employs the application of low-level electric current to facilitate moles through the skin’s lipid barrier. (3) In the bottom right quadrant is microneedle array, that provides minimally invasive micro-sized needles for the creation for transient channels in the skin. (4) Represented in the bottom right quadrant is the ultrasound devices, which employ mechanical vibrations to disrupt the SC-enhancing drug permeation through the skin</p></figcaption></figure><p id="Par102">To produce transitory aqueous conduits MN was designed, which crossed the skin. As a result, small hydrophilic compounds to macromolecules showed an increase in the flow as well as avoided any nerve exposure when introduced into skin layers [<a href="#CR268" class="usa-link" aria-describedby="CR268">268</a>, <a href="#CR269" class="usa-link" aria-describedby="CR269">269</a>]. MN arrays are prepared from a wide range of materials including metals (Silicon, Palladium, Titanium, etc.), natural polymers (Zein, Chitosan, Dextran, etc.), biodegradable polymers (PVP, PLGA, PLA, etc.), and non-biodegradable polymers (Alginic acid, Polyetherimide, Polyvinyl acetate, etc.) [<a href="#CR270" class="usa-link" aria-describedby="CR270">270</a>]. Aside from painless administration, MN arrays provide numerous advantages, including the absence of bleeding, controlled drug release, minimal pathogen introduction, reduction in transdermal dosage variability of small compounds, and concerns associated with infections [<a href="#CR266" class="usa-link" aria-describedby="CR266">266</a>, <a href="#CR271" class="usa-link" aria-describedby="CR271">271</a>, <a href="#CR272" class="usa-link" aria-describedby="CR272">272</a>].</p>
<p id="Par103">Microneedles have shown significant effectiveness in improving the transdermal administration of liposomal medication compositions, leveraging these benefits. The microchannels created by microneedle insertion provide direct, low-resistance conduits across the stratum corneum, facilitating the penetration of intact liposomes or their contents into deeper skin layers. This is especially advantageous for hydrophilic or high molecular weight pharmaceuticals contained in liposomes, which encounter considerable permeability obstacles. Research indicates that microneedles improve the transdermal delivery and systemic uptake of liposome-encapsulated pharmaceuticals, including insulin, vaccinations, and anticancer medicines [<a href="#CR272" class="usa-link" aria-describedby="CR272">272</a>, <a href="#CR273" class="usa-link" aria-describedby="CR273">273</a>]. Furthermore, the mechanical rupture of the skin by microneedles has been shown to facilitate the fusing of liposomal bilayers with intercellular lipids, hence enhancing the release and diffusion of the active pharmaceutical agent [<a href="#CR274" class="usa-link" aria-describedby="CR274">274</a>]. The integration of MNs with deformable liposomes (e.g., ethosomes, transfersomes) enhances delivery efficacy, since the pliable vesicles can navigate via microchannels and release their contents directly into the dermis [<a href="#CR275" class="usa-link" aria-describedby="CR275">275</a>]. Moreover, MN-mediated administration of liposomal formulations has been shown to diminish drug degradation, enhance bioavailability, and provide regulated or sustained release profiles, establishing it as a highly effective platform for both local and systemic drug delivery [<a href="#CR276" class="usa-link" aria-describedby="CR276">276</a>].</p></section><section id="Sec62"><h4 class="pmc_sec_title">Tape stripping</h4>
<p id="Par104">is an invasive technique used for the removal of the SC by the repeated applications of adhesive tapes. It is critical to flatten the adhesive tape with the force similar to the roller while applying it to avoid the influence of recesses and creases on tape peeling [<a href="#CR277" class="usa-link" aria-describedby="CR277">277</a>]. The amount of SC removed depends on factors including anatomical site, pH and transepidermal water loss [<a href="#CR278" class="usa-link" aria-describedby="CR278">278</a>]. The pace of removal of the adhesive tape is indirectly proportional to the quantity of skin removed from the patch, which is directly proportional to the adherence of the SC to the patch [<a href="#CR279" class="usa-link" aria-describedby="CR279">279</a>]. While tape stripping is a simple and robust procedure, several aspects should be addressed before implementing this technique.</p>
<p id="Par105">The mechanical extraction of stratum corneum layers via successive applications of adhesive tapes facilitates liposome penetration into deeper epidermal strata, thus enhancing the bioavailability and therapeutic effectiveness of the encapsulated pharmaceuticals. Tape stripping has been utilised as a pre-treatment to enhance medication penetration and as an analytical technique to evaluate the depth and uniformity of drug permeation into the skin. Research has shown that the absorption of liposome-encapsulated hydrophilic compounds, such as 5-aminolevulinic acid, markedly increases following tape removal, which facilitates vesicle migration into the living epidermis [<a href="#CR280" class="usa-link" aria-describedby="CR280">280</a>]. This approach demonstrates synergy with deformable liposomes or transfersomes, which can further navigate through the intercellular spaces of the partially removed stratum corneum, hence improving their delivery efficiency [<a href="#CR281" class="usa-link" aria-describedby="CR281">281</a>]. Notwithstanding its invasiveness, tape stripping is regarded as a reproducible and regulated technique for temporarily diminishing the skin barrier, rendering it a significant instrument for investigating and enhancing liposomal transdermal drug delivery systems.</p></section></section><section id="Sec63"><h3 class="pmc_sec_title">Passive method</h3>
<section id="Sec64"><h4 class="pmc_sec_title">Chemical enhancer</h4>
<p id="Par107">application is a widely used passive method for transdermal delivery without long-term damage to the skin. It promotes the movement of drugs into the barrier domain of the stratum corneum, leading to improved drug absorption. Enhancer has the potential to modify the properties of the formulation to promote the delivery of drugs [<a href="#CR282" class="usa-link" aria-describedby="CR282">282</a>]. Species interaction at the cellular level, dispersion or intercellular lipids extraction, increased fluidity of stratum corneum lipid bilayers, higher drug thermodynamic activity, and greater SC hydration are all mechanisms that support drug administration using chemical enhancers [<a href="#CR283" class="usa-link" aria-describedby="CR283">283</a>].</p>
<p id="Par108">Various substances have been examined as enhancers, with regularly researched examples including alcohols (such as ethanol), fatty acids, polyalcohols, pyrrolidone, amines, amides, dimethyl sulfoxide, sulfoxides, esters, water, terpenes, surfactants, and others [<a href="#CR284" class="usa-link" aria-describedby="CR284">284</a>]. The chemical enhancers must be non-allergenic or non-toxic, showing compatibility with both drugs and excipients. These are usually unidirectional with rapid working activity with a predetermined duration [<a href="#CR285" class="usa-link" aria-describedby="CR285">285</a>]. When utilised in conjunction with liposomes, chemical enhancers such as ethanol, oleic acid, terpenes, and surfactants interact synergistically to augment the permeability of both the skin and the liposomal vesicles. Ethanol fluidizes the stratum corneum lipid bilayers and improves the deformability of liposomes, facilitating their passage through the intercellular matrix of the stratum corneum to reach viable epidermal layers [<a href="#CR258" class="usa-link" aria-describedby="CR258">258</a>]. Terpenes like limonene and menthol are recognised for their ability to alter the lipid organisation of the stratum corneum, generating microvoids that facilitate the passage of liposomes [<a href="#CR286" class="usa-link" aria-describedby="CR286">286</a>]. Surfactants such as sodium lauryl sulphate can solubilise intercellular lipids, diminishing the barrier resistance of the stratum corneum and enhancing the penetration of vesicular carriers [<a href="#CR287" class="usa-link" aria-describedby="CR287">287</a>]. This amalgamation of mechanisms not only improves the bioavailability of liposome-encapsulated pharmaceuticals but also facilitates the administration of larger or more hydrophilic compounds that would typically encounter difficulties in permeating the epidermal barrier. Research indicates that liposomes altered with ethanol (ethosomes) or utilised with chemical enhancers demonstrate markedly increased transdermal drug flow relative to traditional liposomes [<a href="#CR288" class="usa-link" aria-describedby="CR288">288</a>]. Chemical enhancers work as effective adjuncts in liposomal delivery systems, offering a controlled and efficient method to surmount the skin’s robust barrier without inflicting long-term damage.</p></section><section id="Sec65"><h4 class="pmc_sec_title">Vesicular and nanocarriers</h4>
<p id="Par109">The drug-carrying vesicles in transdermal delivery including liposomes and nanoparticles are one of the most promising methods which ease skin penetration as it improves fluidizing the skin lipids, the drug portioning into the skin, and drug solubilization into the formulations [<a href="#CR289" class="usa-link" aria-describedby="CR289">289</a>, <a href="#CR290" class="usa-link" aria-describedby="CR290">290</a>]. Ultra-flexible liposomes such as ethosomes are employed to increase penetration for poorly soluble drugs’ delivery [<a href="#CR291" class="usa-link" aria-describedby="CR291">291</a>]. Polymeric nanoparticles are chosen for TDDS because they easily toss chemical and physical properties, minimising drug reduction and boosting SC penetration. Self-assembling nanocarriers made of biocompatible, biodegradable, and amphiphilic copolymers, these polymeric vesicles can be natural or synthetic [<a href="#CR292" class="usa-link" aria-describedby="CR292">292</a>, <a href="#CR293" class="usa-link" aria-describedby="CR293">293</a>].</p>
<p id="Par110">Vesicular and nanocarrier-based approaches, especially those employing liposomes, have shown significant promise in augmenting transdermal drug delivery by boosting drug stability, penetration, and release kinetics. Liposomes, consisting of phospholipid bilayers, function as biocompatible carriers capable of encapsulating both hydrophilic and lipophilic medicines. Their flexible form facilitates merging with stratum corneum lipids, enhancing penetration into deeper skin layers [<a href="#CR294" class="usa-link" aria-describedby="CR294">294</a>]. Progress in vesicular formulations, including ultra-deformable liposomes (transfersomes and ethosomes), has enhanced skin permeability by allowing the vesicles to go across intercellular routes in the stratum corneum under osmotic gradients or ethanol-induced lipid fluidisation [<a href="#CR258" class="usa-link" aria-describedby="CR258">258</a>, <a href="#CR281" class="usa-link" aria-describedby="CR281">281</a>]. Ethosomes specifically possess elevated ethanol concentrations that augment stratum corneum lipid fluidity and vesicle pliability, thus enhancing the transdermal transit of poorly water-soluble pharmaceuticals [<a href="#CR295" class="usa-link" aria-describedby="CR295">295</a>]. Polymeric nanoparticles, like those composed of PLGA or chitosan, provide regulated drug release and safeguard against enzymatic degradation, while improving skin penetration due to their adjustable size, surface charge, and hydrophobicity [<a href="#CR296" class="usa-link" aria-describedby="CR296">296</a>]. Moreover, self-assembling nanocarriers, constructed from amphiphilic copolymers, can replicate natural membrane architectures and facilitate drug delivery through diffusion or endocytosis, all while ensuring minimal cytotoxicity and elevated biocompatibility [<a href="#CR297" class="usa-link" aria-describedby="CR297">297</a>]. These vesicular and nanocarrier systems collectively augment the capacity of liposomes to penetrate the epidermal barrier, providing potential platforms for safe and effective transdermal medication delivery.</p></section><section id="Sec66"><h4 class="pmc_sec_title">Nano-emulsion</h4>
<p id="Par111">The use of nanoemulsions to enhance drug efficacy is well established, with current research largely focused on the development of semisolid dosage forms based on nanoemulsion technology [<a href="#CR298" class="usa-link" aria-describedby="CR298">298</a>]. Nanoemulsions serve as effective carrier systems for delivering various substances through intact skin, which functions as a natural barrier. Their advantages stem from the nanoscale droplet size, offering high solubilization capacity, thermodynamic and kinetic stability—surpassing that of conventional dosage forms. Structurally, nanoemulsions are composed of two immiscible liquids, forming an isotropic yet heterogeneous system wherein pharmaceutical agents are encapsulated within nanodroplets [<a href="#CR299" class="usa-link" aria-describedby="CR299">299</a>, <a href="#CR300" class="usa-link" aria-describedby="CR300">300</a>].</p>
<p id="Par112">Sithole et al. developed nano-emulgels and nano-emulsions as an alternative to oral administration that facilitated the transdermal distribution of statins. An oil-in-water (o/w) nanostructure was developed, consisting of 2% (w/w) statin and 8% apricot kernel oil as the oil phase. The nanoemulsions were found to have a size ranging from 14.23 to 169.83 nm, whereas the size of the nano-emulgels ranged from 149.83 to 267.53 nm. Entrapment efficiency varied from 90.77 to 99.55%, confirming statin inclusion. Membrane release procedures showed that nano-emulsions released statins more than nano-emulgels, as seen by greater flux values. Ex vivo (skin diffusion) experiments indicated that nano-emulsions had relatively lower median values than nano-emulgels [<a href="#CR301" class="usa-link" aria-describedby="CR301">301</a>].</p>
<p id="Par113">Incorporating liposomes into nanoemulsion systems provides the twin benefits of vesicular encapsulation and droplet-mediated increased permeability of the stratum corneum. The lipid composition of nanoemulsions disturbs the intercellular lipid structure of the skin, facilitating enhanced drug diffusion and deeper tissue penetration [<a href="#CR302" class="usa-link" aria-describedby="CR302">302</a>]. Moreover, nanoemulsions improve the fluidity and flexibility of liposomal membranes, hence enhancing fusion with skin layers and aiding the administration of both hydrophilic and lipophilic pharmaceuticals [<a href="#CR303" class="usa-link" aria-describedby="CR303">303</a>]. Moravedeh et al. conducted a study revealing that curcumin-loaded liposomal nanoemulsions exhibited superior percutaneous absorption and sustained release compared to plain liposomes or curcumin solution, hence confirming the synergistic effect of liposomes and nanoemulsions in transdermal applications [<a href="#CR304" class="usa-link" aria-describedby="CR304">304</a>]. The elevated kinetic stability and thermodynamic equilibrium of nanoemulsions diminish phase separation and enhance shelf life, rendering them appropriate for integration into semisolid formulations such as creams or gels for effective transdermal delivery [<a href="#CR305" class="usa-link" aria-describedby="CR305">305</a>]. Nanoemulsions boost the skin permeability of liposomal carriers and provide controlled and targeted distribution, hence improving therapeutic efficacy.</p></section></section><section id="Sec67"><h3 class="pmc_sec_title">Liposome as a delivery vehicle</h3>
<p id="Par114">Liposomes due to their biphasic structure, can encapsulate both hydrophobic and hydrophilic pharmaceutical compounds. Liposomes, which are noted for their great versatility and interchangeability, are regarded as potential vehicles that can be employed in modified-release formulations, for targeting organs, or as protectors of compounds that are sensitive to pH, light, or aqueous medium [<a href="#CR306" class="usa-link" aria-describedby="CR306">306</a>]. Among the different types of liposomes, namely SUVs, LUVs, and MLVs, depending on the quantity and dimensions of bilayers, LUVs have the ideal build and constitution for transdermal delivery owing to their high capacity for loading drugs, efficient penetration across the SC, and inherent stability. Phospholipid bilayers in the liquid crystalline state are preferred for transdermal drug administration, and liposomal formulations depending on composition may be divided into two major groups: innovative liposomes such as flexible/deformable/elastic liposomes and standard liposomes [<a href="#CR307" class="usa-link" aria-describedby="CR307">307</a>]. The general mechanism of liposomal drug delivery follows the implantation of drug molecules within the aqueous core of the liposome, using the lipid bilayer, ensuring its protection from the body’s aqueous environment. The membrane deteriorates with time and the drug contents are released at the site of release [<a href="#CR308" class="usa-link" aria-describedby="CR308">308</a>]. Figure <a href="#Fig9" class="usa-link">9</a> illustrates possible mechanism of liposomal drug delivery for skin diseases such as Atopic dermatitis and psoriasis. Figure <a href="#Fig10" class="usa-link">10</a> shows the experimental results of drug delivery on mice for the treatment of Atopic dermatitis and psoriasis by Kwon et al. and Jain et al. [<a href="#CR309" class="usa-link" aria-describedby="CR309">309</a>, <a href="#CR310" class="usa-link" aria-describedby="CR310">310</a>].</p>
<figure class="fig xbox font-sm" id="Fig9"><h4 class="obj_head">Fig. 9.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369165_12951_2025_3660_Fig9_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/12369165/1a29a4d8d176/12951_2025_3660_Fig9_HTML.jpg" loading="lazy" id="d33e2457" height="1015" width="728" alt="Fig. 9"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig9/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>(A)</strong> Layers of the skin; <strong>(B)</strong> Possible mechanism of Liposome entry into the skin for Atopic Dermatitis treatment (Left) and Psoriasis (Right)</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig10"><h4 class="obj_head">Fig. 10.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369165_12951_2025_3660_Fig10_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/12369165/56023ab167c2/12951_2025_3660_Fig10_HTML.jpg" loading="lazy" id="d33e2532" height="1042" width="797" alt="Fig. 10"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig10/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>(i)</strong> Dorsal skin morphology of mice with DNCB-induced atopic dermatitis (AD), treated with various formulations of <em>H. cordata</em> extract (PBS, cubosomes, liposomes), compared to untreated controls and healthy skin (magnifications: 60× and 200×). <strong>(ii)</strong> Serum IgE and IL-4 levels in corresponding groups, indicating immunomodulatory effects of the treatments (<em>p</em> &lt; 0.05, *<em>p</em> &lt; 0.01, **<em>p</em> &lt; 0.001). Adapted with permission from [<a href="#CR309" class="usa-link" aria-describedby="CR309">309</a>]. <strong>(iii)</strong> Skin compliance and histological changes in IMQ-induced psoriatic mice treated with thymoquinone (TMQ) solution and lipospheres, showing dose-dependent improvement in epidermal thickness and morphology. Adapted with permission from [<a href="#CR310" class="usa-link" aria-describedby="CR310">310</a>]</p></figcaption></figure><p id="Par115">In 1992, Cvec et al. initially proposed the concept of ultra-deformable or flexible liposomes as an alternative to the limits posed by conventional liposomes. These are biodegradable and biocompatible containing natural phospholipids. They exhibit better encapsulation efficiencies, reaching up to 90% for lipophilic pharmaceutical compounds (PCs). Additionally, they enable the encapsulation of hydrophilic PCs with molecules of varying molecular weights [<a href="#CR281" class="usa-link" aria-describedby="CR281">281</a>, <a href="#CR311" class="usa-link" aria-describedby="CR311">311</a>]. The ultra-deformable liposomes boost the active pharmaceutical penetration via SC using two methods. In the first process, liposomes function as vesicles that permeate the skin primarily due to their deformability and amphiphilic nature [<a href="#CR312" class="usa-link" aria-describedby="CR312">312</a>]. Their inherent flexibility allows them to withstand mechanical stress and facilitates their penetration into deeper layers of the skin, including the viable epidermis. Additionally, these liposomes act as permeation enhancers by interacting with and disrupting the organized lipid matrix of the SC, particularly by altering the structure of the intracellular lipid lamellae. This disruption promotes enhanced diffusion of the encapsulated drug across the skin barrier [<a href="#CR313" class="usa-link" aria-describedby="CR313">313</a>, <a href="#CR314" class="usa-link" aria-describedby="CR314">314</a>]. In the second mechanism, liposomes function as reservoirs that release the active drug in a regulated manner at or near the skin’s surface. The drug subsequently diffuses across the stratum corneum following its concentration gradient. This technique depends on the slow release and passive diffusion of the drug molecule, perhaps augmented by the liposomal formulation and its interaction with skin lipids [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>].</p>
<p id="Par116">Pharmaceutical compounds (PCs) that are not associated with a vehicle or attached to the surface have the potential to penetrate the skin. When the PCs are attached to vesicles, the penetration occurs as the vesicle dissolute in the skin and joins the SC, resulting in the formation of structures with the lipid lamella, increasing the pharmaceutical compound’s penetration [<a href="#CR315" class="usa-link" aria-describedby="CR315">315</a>]. Liposomes as a delivery vehicle, adsorb to the stratum corneum’s surface and release PCs directly on the skin via adsorption or they can fuse with the SC’s lipid matrix facilitating the diffusion of PCs within the skin [<a href="#CR316" class="usa-link" aria-describedby="CR316">316</a>]. There’s improved sedimentation stability for stratum corneum liposomes as compared to hydroalcoholic solutions, and alcoholic-oil emulsions [<a href="#CR317" class="usa-link" aria-describedby="CR317">317</a>].</p>
<p id="Par117">Phospholipid monomers can gather at electroporated sites, forming liquid microdomains within the skin, thus reversing damage induced by electroporation [<a href="#CR318" class="usa-link" aria-describedby="CR318">318</a>]. Also, integrating hydrophilic drugs into charged liposomes can significantly enhance their encapsulation efficiency, which is typically low.</p>
<p id="Par118">In a study published by Rangsimawong, the effect of sonophoresis at a frequency of 20 kHz on the transdermal administration of sodium fluorescein (NaFI)using lipid-based nanocarriers including niosomes (NI), liposomes (LI), and solid lipid nanoparticles (SLN). Sonophoresis reduces the skin penetration of NaFI-loaded SLN by a factor of 6.32 and NI by a factor of 1.79, while enhancing the penetration of NaFI-loaded liposomes by a factor of 5.36. These results could be because of sonication which could lead to break the vesicle, lamella, and the solid cores of the nanocarrier. However, when the liposome lamellae degraded, the residual phospholipids diffused into the SC to actively repair the skin via adsorption while simultaneously enhancing drug penetration [<a href="#CR319" class="usa-link" aria-describedby="CR319">319</a>].</p>
<p id="Par119">Once the drug has been dissolved in the vehicle of choice, diffusion of the drug occurs from the vehicle or reservoir to the skin surface. Once the drug is present on the skin surface, it can diffuse through the epidermis through two routes, either transepidermal(transcellular or intercellular) or transappendageal(sweat ducts, hair follicles, and pilosebaceous glands) [<a href="#CR311" class="usa-link" aria-describedby="CR311">311</a>]. For intercellular delivery, once the drug of interest penetrates the SC. It permeates the lipid domains before diffusing through both the lipid bilayers and the aqueous region [<a href="#CR320" class="usa-link" aria-describedby="CR320">320</a>]. In the transcellular or intracellular pathway, the permeation occurs through the corneocyte clusters within the imprecations that generate openings containing water [<a href="#CR321" class="usa-link" aria-describedby="CR321">321</a>]. This pathway is thus considered relatively hydrophilic, as it offers lower resistance to the permeation of hydrophilic compounds through the aqueous domains of corneocytes. The transappendageal delivery follows the penetration through a diffusional shunt provided by the hair follicles or the pilosebaceous unit [<a href="#CR290" class="usa-link" aria-describedby="CR290">290</a>, <a href="#CR322" class="usa-link" aria-describedby="CR322">322</a>]. It is followed by the partitioning into the sebum followed by the diffusion through the lipids. From here, the drug molecule for all three delivery pathways is partitioned into the viable epidermis where it diffuses through the cellular mass of the epidermis and diffuses through the upper dermis [<a href="#CR323" class="usa-link" aria-describedby="CR323">323</a>]. It finally gets uptake by the capillaries or the deeper tissue entering the systemic circulation.</p>
<p id="Par120">In research conducted by Walunj et al., the improvement of cyclosporine-loaded cationic liposomes was done to address the unfavourable physicochemical properties of Cyclosporine, a drug for immunosuppression. The positive charge because of Dioleoyl-3-trimethylammonium propane (DOTAP), on the surface of the liposome, improved its affinity for the anionic skin membrane resulting in enhanced efficiency in a psoriatic plaque model induced by imiquimod (IMQ) [<a href="#CR324" class="usa-link" aria-describedby="CR324">324</a>]. Yu et al., further expanded the research to enhance transdermal absorption, by incorporating cell-penetrating peptides (CPP) into the liposomes. The paracellular routes across the epithelium open because of the CPPs’ interaction with the C-terminus of the Na<sup>+</sup>/K<sup>+</sup>-ATPase beta-subunit (ATP1B1). Curcumin-CPP (Cur-CPP) liposomes had better skin penetration and cutaneous retention than Curcumin liposomes without CPPs. Cur-CPP liposomes significantly ameliorate apparent symptoms including erythema and silver scales, as well as epidermal thickness, in an IMQ-induced psoriasis mouse model [<a href="#CR325" class="usa-link" aria-describedby="CR325">325</a>].</p>
<section id="Sec68"><h4 class="pmc_sec_title">Atopic dermatitis (AD)</h4>
<p id="Par122">is a persistent and relapsing chronic skin inflammation that causes itching, xerosis, edema, peeling, and erythema. The exact cause of this condition is unidentified however immunological dysregulation, and allergic-like reactions are thought to have a role. Elevated levels of interleukins (ILs), immunoglobulin E, and certain blood cells (such as mast cells, type 2 helper T cells, and eosinophils) are perceived in the plasma [<a href="#CR326" class="usa-link" aria-describedby="CR326">326</a>, <a href="#CR327" class="usa-link" aria-describedby="CR327">327</a>]. Omiganan, a synthetic cationic peptide of 12 amino acids, is used to treat atopic dermatitis because it kills both gram-positive and gram-negative bacteria, and fungus. In mice with atopic dermatitis (AD) and psoriasis, gel and lotion were compared to Omiganan liposomal gel. In addition to 72% encapsulation.</p>
<p id="Par123">efficiency, liposome formulation demonstrated 7.2% loading efficacy, 120 nm vesicle size, and − 16.2mV zeta potential. Compared to lotion and gel formulations, Omiganan liposomal gel dramatically lowered pro-inflammatory cytokine levels and enhanced AD and psoriatic lesions [<a href="#CR199" class="usa-link" aria-describedby="CR199">199</a>]. Kwon et al. investigated enhancing the efficacy of the water-soluble extract of Houttuynia cordata against AD by utilising lipid nanocarriers. The extract was incorporated into liposome and cubosomal solutions using a thin film hydration technique. The study revealed that cubosomes, compared to liposomes, enhanced the penetration of HCWSE into the skin and prevented further development of atopic dermatitis in hairless mice. Suspensions containing HCWSE decreased the synthesis of IgE and IL-4 while increasing the expression of IgE [<a href="#CR309" class="usa-link" aria-describedby="CR309">309</a>].</p></section><section id="Sec69"><h4 class="pmc_sec_title">Psoriasis</h4>
<p id="Par124">is an autoimmune condition caused by genetic and environmental causes. It is characterised by silver-white scales, inflammatory cells in the epidermis, keratinocyte hyperproliferation, and lesions [<a href="#CR328" class="usa-link" aria-describedby="CR328">328</a>]. In an experiment conducted by Yu et al., curcumin modified with peptides (CRC-TD-Lip) was loaded into liposomes, and its effect was tested by transdermal delivery on the psoriatic area. Results showed increased uptake and inhibitory effect of CRC-TD-Lip on HaCaT cells. The modified curcumin resulted in better anti-psoriasis efficiency [<a href="#CR325" class="usa-link" aria-describedby="CR325">325</a>]. Thymoquinone (TMQ) has strong anti-psoriatic efficacy, but its hydrophobicity, low water solubility, and light and pH sensitivity limit its transport to the target site. Jain et al. created lipospheres with particle sizes less than 70 nm using TmQ encapsulation. Cell line studies revealed a decrease in the levels of IL-1β, IL-6, nitric oxide, TNF-α, and IL-2while in vivo research revealed better constitution and histopathological features with lower TNF-α and IL-17 in psoriatic skin and lipospheres, allowing for deeper skin penetration and target site delivery. Figure <a href="#Fig10" class="usa-link">10</a> represents the experimental results of drug delivery on mice for the treatment psoriasis by Jain et al. [<a href="#CR310" class="usa-link" aria-describedby="CR310">310</a>]. This study shows skin compliance study of the psoriatic mice skin treated with normal skin, Thymoquinone (TMQ) solution, and TMQ liposphere. TMQ lipospheres shown a greater decrease in the thickness and regularity of the epidermis, as compared to the TMQ solution. Both the solution and lipospheres treated groups showed improvement that varied depending on the dose [<a href="#CR310" class="usa-link" aria-describedby="CR310">310</a>].</p></section><section id="Sec70"><h4 class="pmc_sec_title">Vitiligo</h4>
<p id="Par126">is a disorder characterised by developing white skin spots acquired with an unknown cause [<a href="#CR329" class="usa-link" aria-describedby="CR329">329</a>]. Psoralen (PSR) in conjunction with ultraviolet A (PUVA) treats vitiligo, a depigmenting skin condition, by promoting both tyrosinase activity and melanin production in melanocytes. Resveratrol (RSV) functions as a sirtuin activator and a possible antioxidant, decreasing oxidative stress that leads to inflammation in vitiligo. Resveratrol coupled with psoralen was useful in treating vitiligo. Figure <a href="#Fig11" class="usa-link">11</a><strong> G</strong>,<strong> H</strong>,<strong>I</strong> shows a study by Doppalapudi et al. on the uptake of cells to ascertain the ability of UDL to penetrate, as well as the impact of PSR and RSV formulations on melanin and tyrosinase [<a href="#CR208" class="usa-link" aria-describedby="CR208">208</a>].</p>
<figure class="fig xbox font-sm" id="Fig11"><h5 class="obj_head">Fig. 11.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369165_12951_2025_3660_Fig11_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c025/12369165/1862afb27ceb/12951_2025_3660_Fig11_HTML.jpg" loading="lazy" id="d33e2662" height="599" width="669" alt="Fig. 11"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig11/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Targeted liposomal formulations (DCS12-AmB-LLs and DCS78-AmB-LLs) exhibit enhanced binding to exopolysaccharide matrices of C. albicans, <strong>A</strong>. fumigatus, and <strong>C</strong>. neoformans compared to non-targeted AmB-LLs; (<strong>A</strong>, <strong>C</strong>, <strong>E</strong>) exhibit fluorescent imaging while (<strong>B</strong>, <strong>D</strong>, <strong>F</strong>) show flow cytometry analysis. Adapted with permission from [<a href="#CR338" class="usa-link" aria-describedby="CR338">338</a>]. <strong>G.</strong> Cellular uptake of ultra-deformable liposomes (UDL) evaluated in B16F10 cells, indicating enhanced cellular internalization. Scale bar: 1000 μm. <strong>H.</strong> Effect of Psoralen (PSR) and Resveratrol (RSV) UDL formulations on melanin synthesis in B16F10 cells. Fontana-Masson silver staining visualized melanin as black deposits (yellow arrows) across four groups: (i) Control, (ii) PSR-UDL, (iii) RSV-UDL, and (iv) PSR + RSV-UDL. Combined PSR + RSV-UDL treatment significantly enhanced melanin deposition and tyrosinase activity, with PSR contributing predominantly. Scale bar: 1000 μm. <strong>I.</strong> A. Quantification of relative melanin content in treated B16F10 cells. <strong>B</strong>. Tyrosinase activity assay in cells across treatment groups. <strong>C</strong>. Cell-free tyrosinase assay assessing direct enzymatic inhibition by formulations. Results are expressed as mean ± SD (<em>n</em> = 3). Statistical significance: <em>p</em> &lt; 0.05, <em>p</em> &lt; 0.01, <em>p</em> &lt; 0.001, <em>p</em> &lt; 0.0001 vs. control. G, H, and I Adapted with permission from [<a href="#CR208" class="usa-link" aria-describedby="CR208">208</a>]</p></figcaption></figure></section><section id="Sec71"><h4 class="pmc_sec_title">Acne</h4>
<p id="Par127">is a prevalent skin issue that affects individuals globally, without being limited by ethnicity or genetics and is most frequently observed among teenagers and young adults. The blockage of keratinocytes, sebum in the sebaceous gland, and hair follicles causes this inflammatory skin illness as it restricts the sebum from reaching the skin’s surface [<a href="#CR330" class="usa-link" aria-describedby="CR330">330</a>]. It frequently results in developing pimples or zits on the skin’s surface, leading to redness, swelling, discomfort, and heat [<a href="#CR331" class="usa-link" aria-describedby="CR331">331</a>]. Madan et al., designed an approach to enable the efficient formulation of cationic liposomes for the preparation of curcumin, azithromycin, and lauric acid liposomal gels. The stability was assessed over 60 days. TNF-α and IL-1β regulate inflammatory markers responsible for acne-induced inflammation. All the liposomal formulations and the combined application of curcumin and lauric acid liposomal gels effectively reduced IL-1β release caused by P. acnes and suppressed the release of TNF-α. Therefore, when curcumin and lauric acid liposomal gels are combined for therapy, there is a notable decrease in IL-1β and TNF-α levels by around 1.9 and 2.5 times, indicating its effectiveness in treating acne [<a href="#CR332" class="usa-link" aria-describedby="CR332">332</a>].</p>
<p id="Par128">Quercetin is proven to be therapeutic on cutaneous eczema, a kind of skin disease characterised by inflammation. However, quercetin has low solubility in organic solvents because of its structural features thus leading to low availability and limiting clinical applications. The preparation of quercetin-containing liposomes for gel (QU-LG) formulation proves to be efficient against eczema as it significantly reduces dermatopathological symptoms. The sodium carboxymethylcellulose (CMC-Na) present in the QU-LG can improve the flexibility of the liposome bilayer reducing the barrier function of the SC, creating channels for the drug molecule to enter for exerting its antioxidant and anti-inflammatory activities [<a href="#CR333" class="usa-link" aria-describedby="CR333">333</a>]. Ascorbic acid, widely used in cosmetic formulations, is delivered to the skin with negatively charged liposomes favouring better skin retention [<a href="#CR334" class="usa-link" aria-describedby="CR334">334</a>]. Resveratrol (3,3,3’-triydroxy-trans-stilbene), a phenol derived from the root of knotweed (Polygonium cuspidatum), found in Japan and China [<a href="#CR335" class="usa-link" aria-describedby="CR335">335</a>]. It is effective for treating venereal diseases purulent skin infections and mycoses. It also has wound healing and anti-cancerous activities (melanoma) [<a href="#CR336" class="usa-link" aria-describedby="CR336">336</a>]. To increase its bioactivity and bioavailability resveratrol is encapsulated inside liposomes which acts as an ideal solution for its activity as resveratrol is less soluble in water. Furthermore, recent findings presented by Kwon et al. suggested that co-encapsulation of resveratrol with 4-n-butyl resorcinol (4nBR) in liposomes helped in melasma treatment [<a href="#CR337" class="usa-link" aria-describedby="CR337">337</a>]. Additionally, Fig. <a href="#Fig11" class="usa-link">11</a> illustrates the study conducted by Ambati et. al., which involved the use of DCS12 and DCS78 coated liposomes on fungal exopolysaccharide matrices which are known to cause skin infections. The study focused on three different fungus species and aimed to examine the binding and quantification process. This study showed that the liposomes DCS12-Amphoterecin B-Loaded Liposome (DCS12-AmB-LLs) and DCS78-Amphoterecin B-Loaded Liposome (DCS78-AmB-LLs), targeted to DC-SIGN, exhibit a higher level of binding efficiency to the exopolysaccharide matrices of three highly dangerous fungal pathogens compared to AmB-LLs. of UDL.</p></section></section></section><section id="Sec72"><h2 class="pmc_sec_title">Challenges and limitations</h2>
<p id="Par130">Liposomes and lipid-based vesicles employed for encapsulating and administrating pharmaceuticals have significant potential in drug delivery, specifically in dermatological applications. The challenges associated with liposomal drug administration discuss a range of factors, including stability and the short half-life of liposomal drugs, concerns about their size and penetration, encapsulation effectiveness, skin barrier integrity, and the crucial component of patient compliance. Clinical evidence from studies shedding light on these limitations and problems reveals the complexities of optimizing liposome-based drug delivery to treat skin disorders [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>].</p>
<section id="Sec73"><h3 class="pmc_sec_title">Limited half-life and stability</h3>
<p id="Par131">Liposomes for their limited half-life and susceptibility to degradation and fusion present significant challenges in drug delivery. Over time, liposomes can undergo degradation due to exposure to light, temperature fluctuations, and the existence of enzymes within living structures [<a href="#CR98" class="usa-link" aria-describedby="CR98">98</a>]. Liposomes can fuse with other cellular structures, such as cell membranes. This fusion can occur during storage, transport, or within the bloodstream, leading to the merging of their contents. Furthermore, liposomes can degrade, destabilising their lipid bilayer structure, which results in the premature release of the encapsulated drug. This sudden release can lead to suboptimal drug concentrations at the intended target site in the body, diminishing the drug’s therapeutic effect [<a href="#CR339" class="usa-link" aria-describedby="CR339">339</a>]. Encapsulated drugs within liposomes have been found to degrade or lose their activity before exerting their intended medicinal effects [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. This can be especially problematic in applications where maintaining drug potency and precise delivery timing is crucial, such as cancer therapy or treating infectious diseases. Despite these challenges, liposomes remain a valuable tool in drug delivery, and ongoing research seeks to maximize their potential while minimizing their burdens [<a href="#CR340" class="usa-link" aria-describedby="CR340">340</a>].</p></section><section id="Sec74"><h3 class="pmc_sec_title">Size and penetration</h3>
<p id="Par132">Liposomes come in various sizes, and selecting the proper size is crucial for efficient skin penetration. The size of liposomes and their impact on skin penetration and stability present complex challenges that must be addressed for optimal drug release and penetration. Smaller liposomes, typically in the nanometre range, tend to penetrate the skin more effectively due to their ability to navigate its various barriers. However, there’s a trade-off with stability – smaller liposomes are more susceptible to aggregation, fusion, and cargo leakage, which may reduce their efficacy [<a href="#CR341" class="usa-link" aria-describedby="CR341">341</a>]. On the other hand, giant liposomes are generally more stable but may not penetrate the skin as efficiently. Researchers and formulators face the challenge of tailoring liposome size to suit specific dermatological applications, considering the skin’s anatomy and the therapeutic agent’s properties [<a href="#CR341" class="usa-link" aria-describedby="CR341">341</a>]. Smaller liposomes are preferred for deep penetration, while more giant liposomes might be more appropriate for superficial treatments. Additionally, finding ways to enhance the stability of smaller liposomes, perhaps through surface modifications or the inclusion of stabilizing agents, is an ongoing area of research. However, liposome size is not the only factor affecting skin penetration and efficacy. The lipid composition, charge, and surface properties of liposomes also play a significant role. Therefore, it is essential to consider these factors in conjunction with size to develop liposomal formulations that maximize drug delivery and therapeutic outcomes in dermatology [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>].</p></section><section id="Sec75"><h3 class="pmc_sec_title">Encapsulation efficiency</h3>
<p id="Par133">Encapsulation efficiency is another critical factor in liposome-based drug delivery systems, and its limitations pose challenges in pharmaceutical development. Liposomes encapsulate drugs in lipid bilayers or aqueous cores, depending on their characteristics. However, drug release kinetics and therapeutic results vary because not all drugs can be encapsulated successfully. One of the primary factors affecting encapsulation efficiency is the nature of the drug itself. Liposomes are tailored to encapsulate hydrophobic or hydrophilic drugs, but the structural compatibility between the drug and the liposome is crucial [<a href="#CR342" class="usa-link" aria-describedby="CR342">342</a>]. Drugs that do not readily integrate into the liposomal structure may result in lower encapsulation rates, leading to unpredictable drug release kinetics. Clinical studies have highlighted these variations in encapsulation efficiency, underscoring the need for careful formulation and optimization in liposome-based drug delivery. In cases where encapsulation efficiency is low, patients may not receive the intended dose of the drug, leading to suboptimal treatment efficacy [<a href="#CR343" class="usa-link" aria-describedby="CR343">343</a>].</p>
<p id="Par134">Conversely, high encapsulation efficiency can result in drug overdosing, potentially leading to adverse side effects. Techniques such as modifying liposome composition, optimizing drug-loading methods, and designing drug-specific liposomes are being explored to enhance encapsulation [<a href="#CR344" class="usa-link" aria-describedby="CR344">344</a>]. Ongoing research efforts are focused on enhancing encapsulation efficiency’s reliability and consistency to ensure better patient therapeutic outcomes.</p></section><section id="Sec76"><h3 class="pmc_sec_title">Skin barrier integrity</h3>
<p id="Par135">Skin barrier integrity plays a crucial role in the effectiveness of liposome-based drug delivery systems, and challenges associated with compromised skin barriers in patients with dermatological diseases can significantly impact successful drug delivery. One primary challenge when dealing with compromised skin barriers is the decreased ability of the skin to function as a protective barrier, which is seen in patients with dermatological diseases such as psoriasis, eczema, or burns [<a href="#CR345" class="usa-link" aria-describedby="CR345">345</a>]. Disruptions in the stratum corneum often characterize this compromised barrier, the outermost layer of the epidermis responsible for maintaining skin integrity. These disruptions can be due to inflammation, excessive dryness, or other pathological processes associated with skin diseases. Liposome-based drug delivery systems rely on the intactness of the skin barrier to effectively transport drugs to the target site within the skin or to allow systemic absorption. When the skin barrier is compromised, liposomes may not adhere to the skin surface as efficiently, and drug release from liposomes may not occur as expected [<a href="#CR346" class="usa-link" aria-describedby="CR346">346</a>]. This can lead to a decrease in the effectiveness of drugs and an unexpected treatment outcome.</p></section><section id="Sec77"><h3 class="pmc_sec_title">Regulatory hurdles</h3>
<p id="Par136">Liposomes, although recognised for their promise to improve transdermal drug delivery, encounter numerous hurdles and restrictions that impede their wider clinical and commercial use. A notable obstacle is regulatory challenges, since the intricacy of liposomal formulations creates ambiguities in characterisation, quality assurance, and long-term stability, so rendering regulatory approval processes more rigorous. Regulatory bodies like the FDA and EMA necessitate thorough physicochemical characterisation, stability information, and proof of therapeutic equivalency, which can be challenging for these heterogeneous systems [<a href="#CR124" class="usa-link" aria-describedby="CR124">124</a>].</p></section><section id="Sec78"><h3 class="pmc_sec_title">Reproducibility and scalability of liposomes</h3>
<p id="Par137">A significant restriction pertains to the reproducibility and scalability of liposome synthesis. The shift from laboratory-scale to industrial-scale production frequently results in variability in vesicle size, lamellarity, encapsulation efficiency, and batch consistency, largely due to the sensitivity of liposome characteristics to process parameters like hydration rate, extrusion pressure, and lipid composition. Advanced methods such as microfluidization and high-pressure homogenisation enhance outcomes but necessitate intricate equipment and stringent quality assurance standards, hence elevating manufacturing complexity [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>].</p></section><section id="Sec79"><h3 class="pmc_sec_title">Cost-effectiveness</h3>
<p id="Par138">Cost-effectiveness continues to be a key issue, as the raw materials (such as high-purity phospholipids and cholesterol), sterile manufacturing facilities, and specialised machinery considerably increase production costs relative to traditional formulations. Moreover, the necessity for cold chain storage and restricted shelf life exacerbate logistical challenges, imposing limitations in resource-constrained environments and affecting market feasibility [<a href="#CR347" class="usa-link" aria-describedby="CR347">347</a>].</p></section><section id="Sec80"><h3 class="pmc_sec_title">Patient adherence</h3>
<p id="Par139">Ultimately, patient adherence may be influenced by the physical properties of the formulation. Certain liposomal transdermal systems may possess oily textures or necessitate certain application methods, potentially diminishing user convenience. Furthermore, if regular application or occlusion is necessary to sustain therapeutic levels, patient adherence may diminish, especially in chronic treatment contexts [<a href="#CR348" class="usa-link" aria-describedby="CR348">348</a>].</p></section></section><section id="Sec81"><h2 class="pmc_sec_title">Future perspective</h2>
<p id="Par140">The future of transdermal drug delivery of liposomes for skin dermatosis holds immense promise and can revolutionise the course of medication and management of various dermatological conditions. To fully utilise the potential of liposomes in treating skin dermatosis, it is imperative to focus on several key aspects. Dermatosis encompasses many disorders, including eczema, psoriasis, acne, and various inflammatory skin diseases.</p>
<p id="Par141">First and foremost, research and development efforts must be directed towards tailoring liposomes for specific skin conditions to maximise therapeutic outcomes by customising their lipid composition, size, charge, and surface modification. Advanced liposome vesicles, known for their elasticity, flexibility, and deformability, carry various therapeutic agents. The ability to release therapeutic compounds variably from these carriers makes them promise for future delivery systems [<a href="#CR349" class="usa-link" aria-describedby="CR349">349</a>]. Further investigation should prioritise the advancement of liposomal delivery vehicles, emphasising overcoming their limitations and directing efforts towards achieving targeted and precise actions. Additionally, innovation in liposomal technology should extend to incorporating cutting-edge active ingredients. Developing scalable and cost-effective manufacturing techniques is essential to make liposome-based dermatological products accessible to a wider population. This can be achieved through advancements in microfluidics, lyophilisation, and automation, allowing for the mass production of liposomes with consistent quality.</p>
<p id="Par142">Developing user-friendly formulations that are easy to apply, non-greasy, and aesthetically pleasing can significantly enhance patient adherence to drug treatment regimens [<a href="#CR350" class="usa-link" aria-describedby="CR350">350</a>]. Ensuring liposomal products do not cause discomfort or inconvenience will improve patient outcomes and overall satisfaction. To address skin dermatosis, future liposomal transdermal delivery should incorporate artificial intelligence and data-driven methodologies. AI can assess extensive datasets including skin conditions, treatment response, and genetic characteristics to identify optimal liposomal compositions [<a href="#CR351" class="usa-link" aria-describedby="CR351">351</a>]. Modified liposomes, such as transfersomes, niosomes, ethosomes, and invasomes, have been developed to further enhance drug delivery across the skin [<a href="#CR352" class="usa-link" aria-describedby="CR352">352</a>]. However, further research and clinical trials are needed to completely explore the potential of liposomes in the treatment of dermatophytosis and other dermatological conditions [<a href="#CR353" class="usa-link" aria-describedby="CR353">353</a>].</p>
<p id="Par143">Traditional treatments for dermatosis often rely on corticosteroids, which can have detrimental side effects [<a href="#CR354" class="usa-link" aria-describedby="CR354">354</a>]. Liposomes provide an opportunity to deliver alternative compounds, such as natural antioxidants, antimicrobial peptides, and anti-inflammatory agents. It can also encapsulate gene therapy vectors, opening the potential for personalized treatments. Integrating novel and safe therapeutic agents within liposomes is crucial for future exploration, offering patients more effective and side-effect-free treatment options. With the increased use of hyaluronic acid (HA) in the pharmaceutical industry, there can be new ways to explore the potential methods to integrate HA into nanoparticles and liposomal transdermal systems. This can be beneficial for treating anti-inflammatory illness, as HA improves both permeability and biocompatibility [<a href="#CR355" class="usa-link" aria-describedby="CR355">355</a>]. Ruxolitinib, the first topical JAK inhibitor cream has been approved by the FDA for treating mild to moderate apoptotic dermatosis [<a href="#CR356" class="usa-link" aria-describedby="CR356">356</a>].</p>
<p id="Par144">One of the biggest variations in the different results in publications is because of the varied physiochemical features of liposomes including size, the charge, the composition and the drugs used for the studies. The different additives added to the liposomes for efficient drug delivery including ethanol, penetration enhancers and edge activators also modify the characteristics of the lipid bilayer [<a href="#CR357" class="usa-link" aria-describedby="CR357">357</a>]. Eventually, regulatory bodies and healthcare stakeholders must work together to guarantee the safety and effectiveness of liposomal formulations, while also establishing a structure for their authorization and extensive utilisation. These investigations should include assessments of skin permeability, drug release kinetics, and compatibility [<a href="#CR358" class="usa-link" aria-describedby="CR358">358</a>]. Long-term testing is necessary to establish the effectiveness of liposome-based therapies in comparison to conventional therapy. The provision of regulatory assistance promotes innovation within the liposomal area and supports the successful implementation of liposomal research in pragmatic clinical settings.</p></section><section id="Sec82"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par145">Transdermal drug delivery through liposomal formulation has seen many advancements with the emergence of nanotechnology. Moreover, the synergy between liposomal technology and emerging techniques such as immunotherapy and gene therapy holds great potential for recolonizing dermatological treatment strategies. Liposomes provide a flexible method for delivering drugs by enclosing hydrophilic and lipophilic molecules. This approach reduces toxicity, improves drug distribution throughout the body, and prolonged therapeutic benefits. The advancement of flexible and deformable liposomes broadens the range of drug distribution, accommodating various physiological situations with enhanced tolerance. In the future, it is necessary to do further study to improve nanotechnology-based methods in clinical dermatology. Liposomes are a potential tool that may be used to enhance the effectiveness and safety of dermatological treatments.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We acknowledge infrastructure support available through DBT-BUILDER program (BT/INF/22/SP42155/2021) at KIIT UNIVERSITY, BHUBANESWAR, INDIA.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Anmol Choudhury: Writing – review &amp; editing, Writing – original draft, Methodology, Investigation, Formal analysis, Data curation, Conceptualization, Apoorv Kirti: Writing – review &amp; editing, Writing – original draft, Methodology, Investigation, Formal analysis, Data curation, Conceptualization, Sudakshya S Lenka: Writing – original draft, Validation, Resources, Methodology, Conceptualization, Writing – review &amp; editing, Shaikh Sheeran Naser: Writing – review &amp; editing, Writing – original draft, Visualization, Validation, Adrija Sinha: Writing – review &amp; editing, Writing – original draft, Visualization, Validation, Supervision, Software, Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Resources. Aishee Ghosh: Writing – review &amp; editing, Writing – original draft, Visualization, Validation, Supervision, Software, Conceptualization, Data curation, Formal analysis. Suresh K Verma: Writing – review &amp; editing, Writing – original draft, Visualization, Validation, Supervision, Software, Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Resources.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>Open access funding provided by Uppsala University.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par146">Not Applicable.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par147">All authors read and agreed to submit the manuscript.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par148">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Nagendra Kumar Kaushik, Email: kaushik.nagendra@kw.ac.kr.</p>
<p>Aishee Ghosh, Email: aishee.ghosh@physics.uu.se.</p>
<p>Suresh K. Verma, Email: sureshverma22@gmail.com</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Trucillo P, Campardelli R, Reverchon E. Liposomes: from Bangham to supercritical fluids. Processes. 2020;8:1022.</cite> [<a href="https://scholar.google.com/scholar_lookup?Trucillo%20P,%20Campardelli%20R,%20Reverchon%20E.%20Liposomes:%20from%20Bangham%20to%20supercritical%20fluids.%20Processes.%202020;8:1022." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomed. 2015;975.</cite> [<a href="https://doi.org/10.2147/IJN.S68861" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4324542/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25678787/" class="usa-link">PubMed</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Guimarães D, Cavaco-Paulo A, Nogueira E. Design of liposomes as drug delivery system for therapeutic applications. Int J Pharm. 2021;601: 120571.
</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2021.120571" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33812967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guimar%C3%A3es%20D,%20Cavaco-Paulo%20A,%20Nogueira%20E.%20Design%20of%20liposomes%20as%20drug%20delivery%20system%20for%20therapeutic%20applications.%20Int%20J%20Pharm.%202021;601:%20120571." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Umbarkar M, Thakare S, Surushe T, Giri A, Chopade V. Formulation and evaluation of liposome by thin film hydration method. J Drug Deliv Ther. 2021;11:72–6.</cite> [<a href="https://scholar.google.com/scholar_lookup?Umbarkar%20M,%20Thakare%20S,%20Surushe%20T,%20Giri%20A,%20Chopade%20V.%20Formulation%20and%20evaluation%20of%20liposome%20by%20thin%20film%20hydration%20method.%20J%20Drug%20Deliv%20Ther.%202021;11:72%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Mahajan VK, Handa S. Diagnosis of skin diseases. Atlas dermatology, dermatopathol venereol. Cham: Springer International Publishing; 2020. pp. 1–61.</cite> [<a href="https://scholar.google.com/scholar_lookup?Mahajan%20VK,%20Handa%20S.%20Diagnosis%20of%20skin%20diseases.%20Atlas%20dermatology,%20dermatopathol%20venereol.%20Cham:%20Springer%20International%20Publishing;%202020.%20pp.%201%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Shoaib S, Kaur G, Yusuf K, Yusuf N. Herbal medicines and skin disorders. Herb Med. Elsevier; 2022. pp. 307–28.</cite>
</li>
<li id="CR7">
<span class="label">7.</span><cite>Pierre MBR, Dos Santos Miranda Costa I. Liposomal systems as drug delivery vehicles for dermal and transdermal applications. Arch Dermatol Res. 2011;303: 607.
</cite> [<a href="https://doi.org/10.1007/s00403-011-1166-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21805180/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pierre%20MBR,%20Dos%20Santos%20Miranda%20Costa%20I.%20Liposomal%20systems%20as%20drug%20delivery%20vehicles%20for%20dermal%20and%20transdermal%20applications.%20Arch%20Dermatol%20Res.%202011;303:%20607." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Foldvari M, Gesztes A, Mezei M. Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. J Microencapsul. 1990;7:479–89.
</cite> [<a href="https://doi.org/10.3109/02652049009040470" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2266473/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Foldvari%20M,%20Gesztes%20A,%20Mezei%20M.%20Dermal%20drug%20delivery%20by%20liposome%20encapsulation:%20clinical%20and%20electron%20microscopic%20studies.%20J%20Microencapsul.%201990;7:479%E2%80%9389." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Zhu L, Liu Y, Gong Z, Zhu B, Zhang C, Zhang H et al. Noncoding RNAs in Atopic Dermatitis: Insight Into Inflammation and Immune Regulation. Dermatol Ther. 2025;2025.</cite>
</li>
<li id="CR10">
<span class="label">10.</span><cite>Hafeez A, Afzal Usmani S. Perspective chapter: Nose-to-Brain drug delivery through Liposomes - Recent applications. Liposomes - Recent Adv New Perspect Appl. IntechOpen; 2023.</cite>
</li>
<li id="CR11">
<span class="label">11.</span><cite>Lee MS, Bui HD, Kim SJ, Lee JB, Yoo HS. Liposome-assisted penetration and antiaging effects of collagen in a &lt;scp&gt;3D skin model. J Cosmet Dermatol. 2024;23:236–43.
</cite> [<a href="https://doi.org/10.1111/jocd.15912" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37415450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20MS,%20Bui%20HD,%20Kim%20SJ,%20Lee%20JB,%20Yoo%20HS.%20Liposome-assisted%20penetration%20and%20antiaging%20effects%20of%20collagen%20in%20a%20&lt;scp&gt;3D%20skin%20model.%20J%20Cosmet%20Dermatol.%202024;23:236%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Bahadur S, Sharma M. Liposome based drug delivery for the management of Psoriasis - a comprehensive review. Curr Pharm Biotechnol. 2023;24:1383–96.
</cite> [<a href="https://doi.org/10.2174/1389201024666221213144228" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36518042/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bahadur%20S,%20Sharma%20M.%20Liposome%20based%20drug%20delivery%20for%20the%20management%20of%20Psoriasis%20-%20a%20comprehensive%20review.%20Curr%20Pharm%20Biotechnol.%202023;24:1383%E2%80%9396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Shu M, Fan Z, Huang B, Wang C. Retrospective analysis of clinical features of pembrolizumab induced psoriasis. Invest New Drugs. 2025. 10.1007/s10637-025-01536-5.
</cite> [<a href="https://doi.org/10.1007/s10637-025-01536-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40304864/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shu%20M,%20Fan%20Z,%20Huang%20B,%20Wang%20C.%20Retrospective%20analysis%20of%20clinical%20features%20of%20pembrolizumab%20induced%20psoriasis.%20Invest%20New%20Drugs.%202025.%2010.1007/s10637-025-01536-5." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Raina N, Rani R, Thakur VK, Gupta M. New insights in topical drug delivery for skin disorders: from a nanotechnological perspective. ACS Omega. 2023;8:19145–67.
</cite> [<a href="https://doi.org/10.1021/acsomega.2c08016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10249123/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37305231/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Raina%20N,%20Rani%20R,%20Thakur%20VK,%20Gupta%20M.%20New%20insights%20in%20topical%20drug%20delivery%20for%20skin%20disorders:%20from%20a%20nanotechnological%20perspective.%20ACS%20Omega.%202023;8:19145%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Patnaik S, Purohit D, Biswasroy P, Diab WM, Dubey A. Recent advances for Commedonal acne treatment by employing lipid nanocarriers topically. Int J Health Sci (Qassim). 2022;180–205.</cite>
</li>
<li id="CR16">
<span class="label">16.</span><cite>Miere F, Fritea L, Cavalu S, Vicaș SI. Formulation, characterization, and advantages of using liposomes in multiple therapies. Pharmacophore. 2020;11:1–12.</cite> [<a href="https://scholar.google.com/scholar_lookup?Miere%20F,%20Fritea%20L,%20Cavalu%20S,%20Vica%C8%99%20SI.%20Formulation,%20characterization,%20and%20advantages%20of%20using%20liposomes%20in%20multiple%20therapies.%20Pharmacophore.%202020;11:1%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Ghosh A, Gupta A, Jena S, Kirti A, Choudhury A, Saha U, et al. Advances in posterity of visualization in paradigm of nano-level ultra-structures for nano–bio interaction studies. View. 2024. 10.1002/VIW.20240042.</cite> [<a href="https://scholar.google.com/scholar_lookup?Ghosh%20A,%20Gupta%20A,%20Jena%20S,%20Kirti%20A,%20Choudhury%20A,%20Saha%20U,%20et%20al.%20Advances%20in%20posterity%20of%20visualization%20in%20paradigm%20of%20nano-level%20ultra-structures%20for%20nano%E2%80%93bio%20interaction%20studies.%20View.%202024.%2010.1002/VIW.20240042." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 2013;8:102. 10.1186/1556-276X-8-102.</cite> [<a href="https://doi.org/10.1186/1556-276X-8-102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3599573/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23432972/" class="usa-link">PubMed</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Li J, Wang X, Zhang T, Wang C, Huang Z, Luo X, et al. A review on phospholipids and their main applications in drug delivery systems. Asian J Pharm Sci. 2015;10:81–98.</cite> [<a href="https://scholar.google.com/scholar_lookup?Li%20J,%20Wang%20X,%20Zhang%20T,%20Wang%20C,%20Huang%20Z,%20Luo%20X,%20et%20al.%20A%20review%20on%20phospholipids%20and%20their%20main%20applications%20in%20drug%20delivery%20systems.%20Asian%20J%20Pharm%20Sci.%202015;10:81%E2%80%9398." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Sinha A, Simnani FZ, Singh D, Nandi A, Choudhury A, Patel P, et al. The translational paradigm of nanobiomaterials: biological chemistry to modern applications. Mater Today Bio. 2022. 10.1016/j.mtbio.2022.100463.
</cite> [<a href="https://doi.org/10.1016/j.mtbio.2022.100463" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9615318/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36310541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sinha%20A,%20Simnani%20FZ,%20Singh%20D,%20Nandi%20A,%20Choudhury%20A,%20Patel%20P,%20et%20al.%20The%20translational%20paradigm%20of%20nanobiomaterials:%20biological%20chemistry%20to%20modern%20applications.%20Mater%20Today%20Bio.%202022.%2010.1016/j.mtbio.2022.100463." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Naser SS, Gupta A, Choudhury A, Yadav A, Sinha A, Kirti A, et al. Biophysical translational paradigm of polymeric nanoparticle: embarked advancement to brain tumor therapy. Biomed Pharmacother. 2024. 10.1016/j.biopha.2024.117372.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2024.117372" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39208668/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Naser%20SS,%20Gupta%20A,%20Choudhury%20A,%20Yadav%20A,%20Sinha%20A,%20Kirti%20A,%20et%20al.%20Biophysical%20translational%20paradigm%20of%20polymeric%20nanoparticle:%20embarked%20advancement%20to%20brain%20tumor%20therapy.%20Biomed%20Pharmacother.%202024.%2010.1016/j.biopha.2024.117372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Luiz MT, Dutra JAP, Tofani LB, de Araújo JTC, Di Filippo LD, Marchetti JM, et al. Targeted liposomes: a nonviral gene delivery system for cancer therapy. Pharmaceutics. 2022;14:821.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics14040821" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9030342/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35456655/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Luiz%20MT,%20Dutra%20JAP,%20Tofani%20LB,%20de%20Ara%C3%BAjo%20JTC,%20Di%20Filippo%20LD,%20Marchetti%20JM,%20et%20al.%20Targeted%20liposomes:%20a%20nonviral%20gene%20delivery%20system%20for%20cancer%20therapy.%20Pharmaceutics.%202022;14:821." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Neves LF, Duan J, Voelker A, Khanal A, McNally L, Steinbach-Rankins J, et al. Preparation and optimisation of anionic liposomes for delivery of small peptides and cDNA to human corneal epithelial cells. J Microencapsul. 2016;33:391–9.
</cite> [<a href="https://doi.org/10.1080/02652048.2016.1202343" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5033054/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27530524/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Neves%20LF,%20Duan%20J,%20Voelker%20A,%20Khanal%20A,%20McNally%20L,%20Steinbach-Rankins%20J,%20et%20al.%20Preparation%20and%20optimisation%20of%20anionic%20liposomes%20for%20delivery%20of%20small%20peptides%20and%20cDNA%20to%20human%20corneal%20epithelial%20cells.%20J%20Microencapsul.%202016;33:391%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Tang F, Hughes JA. Synthesis of a single-tailed cationic lipid and investigation of its transfection. J Control Release. 1999;62:345–58.
</cite> [<a href="https://doi.org/10.1016/s0168-3659(99)00158-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10528072/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tang%20F,%20Hughes%20JA.%20Synthesis%20of%20a%20single-tailed%20cationic%20lipid%20and%20investigation%20of%20its%20transfection.%20J%20Control%20Release.%201999;62:345%E2%80%9358." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Musumeci T, Bonaccorso A, De Gaetano F, Larsen KL, Pignatello R, Mazzaglia A, et al. A physico-chemical study on amphiphilic cyclodextrin/liposomes nanoassemblies with drug carrier potential. J Liposome Res. 2020;30:407–16.
</cite> [<a href="https://doi.org/10.1080/08982104.2019.1682603" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31726887/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Musumeci%20T,%20Bonaccorso%20A,%20De%20Gaetano%20F,%20Larsen%20KL,%20Pignatello%20R,%20Mazzaglia%20A,%20et%20al.%20A%20physico-chemical%20study%20on%20amphiphilic%20cyclodextrin/liposomes%20nanoassemblies%20with%20drug%20carrier%20potential.%20J%20Liposome%20Res.%202020;30:407%E2%80%9316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Zhang G, Sun J. Lipid in chips: a brief review of liposomes formation by microfluidics. Int J Nanomed. 2021;16:7391–416.</cite> [<a href="https://doi.org/10.2147/IJN.S331639" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8575451/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34764647/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20G,%20Sun%20J.%20Lipid%20in%20chips:%20a%20brief%20review%20of%20liposomes%20formation%20by%20microfluidics.%20Int%20J%20Nanomed.%202021;16:7391%E2%80%93416." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Khan I, Elhissi A, Shah M, Alhnan MA, Ahmed W. Liposome-based carrier systems and devices used for pulmonary drug delivery. Biomater Med Tribol. Elsevier; 2013. pp. 395–443.</cite>
</li>
<li id="CR28">
<span class="label">28.</span><cite>Maja L, Željko K, Mateja P. Sustainable technologies for liposome Preparation. J Supercrit Fluids. 2020;165:104984.</cite> [<a href="https://scholar.google.com/scholar_lookup?Maja%20L,%20%C5%BDeljko%20K,%20Mateja%20P.%20Sustainable%20technologies%20for%20liposome%20Preparation.%20J%20Supercrit%20Fluids.%202020;165:104984." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Zhang H. Thin-Film Hydration Followed by Extrusion Method for Liposome Preparation. 2017. pp. 17–22.</cite> [<a href="https://doi.org/10.1007/978-1-4939-6591-5_2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27837527/" class="usa-link">PubMed</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Naser SS, Singh D, Preetam S, Kishore S, Kumar L, Nandi A, et al. Posterity of nanoscience as lipid nanosystems for Alzheimer’s disease regression. Mater Today Bio. 2023. 10.1016/j.mtbio.2023.100701.
</cite> [<a href="https://doi.org/10.1016/j.mtbio.2023.100701" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10320624/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37415846/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Naser%20SS,%20Singh%20D,%20Preetam%20S,%20Kishore%20S,%20Kumar%20L,%20Nandi%20A,%20et%20al.%20Posterity%20of%20nanoscience%20as%20lipid%20nanosystems%20for%20Alzheimer%E2%80%99s%20disease%20regression.%20Mater%20Today%20Bio.%202023.%2010.1016/j.mtbio.2023.100701." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Çağdaş M, Sezer AD, Bucak S. Liposomes as Potential Drug Carrier Systems for Drug Delivery. Appl Nanotechnol Drug Deliv. InTech; 2014.</cite>
</li>
<li id="CR32">
<span class="label">32.</span><cite>Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022;8:e09394.
</cite> [<a href="https://doi.org/10.1016/j.heliyon.2022.e09394" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9118483/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35600452/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nsairat%20H,%20Khater%20D,%20Sayed%20U,%20Odeh%20F,%20Al%20Bawab%20A,%20Alshaer%20W.%20Liposomes:%20structure,%20composition,%20types,%20and%20clinical%20applications.%20Heliyon.%202022;8:e09394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Panda PK, Verma SK, Suar M. Nanoparticle-biological interactions: the renaissance of bionomics in the myriad nanomedical technologies. Nanomedicine. 2021;16:2249–54.
</cite> [<a href="https://doi.org/10.2217/nnm-2021-0174" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34544260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Panda%20PK,%20Verma%20SK,%20Suar%20M.%20Nanoparticle-biological%20interactions:%20the%20renaissance%20of%20bionomics%20in%20the%20myriad%20nanomedical%20technologies.%20Nanomedicine.%202021;16:2249%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Casares D, Escribá PV, Rosselló CA. Membrane lipid composition: effect on membrane and organelle structure, function and compartmentalization and therapeutic avenues. Int J Mol Sci. 2019;20:2167.
</cite> [<a href="https://doi.org/10.3390/ijms20092167" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6540057/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31052427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Casares%20D,%20Escrib%C3%A1%20PV,%20Rossell%C3%B3%20CA.%20Membrane%20lipid%20composition:%20effect%20on%20membrane%20and%20organelle%20structure,%20function%20and%20compartmentalization%20and%20therapeutic%20avenues.%20Int%20J%20Mol%20Sci.%202019;20:2167." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Šturm L, Poklar Ulrih N. Basic methods for preparation of liposomes and studying their interactions with different compounds, with the emphasis on polyphenols. Int J Mol Sci. 2021;22: 6547.
</cite> [<a href="https://doi.org/10.3390/ijms22126547" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8234105/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34207189/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?%C5%A0turm%20L,%20Poklar%20Ulrih%20N.%20Basic%20methods%20for%20preparation%20of%20liposomes%20and%20studying%20their%20interactions%20with%20different%20compounds,%20with%20the%20emphasis%20on%20polyphenols.%20Int%20J%20Mol%20Sci.%202021;22:%206547." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Pidgeon C, McNeely S, Schmidt T, Johnson JE. Multilayered vesicles prepared by reverse-phase evaporation: liposome structure and optimum solute entrapment. Biochemistry. 1987;26:17–29.
</cite> [<a href="https://doi.org/10.1021/bi00375a004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3828297/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pidgeon%20C,%20McNeely%20S,%20Schmidt%20T,%20Johnson%20JE.%20Multilayered%20vesicles%20prepared%20by%20reverse-phase%20evaporation:%20liposome%20structure%20and%20optimum%20solute%20entrapment.%20Biochemistry.%201987;26:17%E2%80%9329." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Szoka F, Papahadjopoulos D. Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu Rev Biophys Bioeng. 1980;9:467–508.
</cite> [<a href="https://doi.org/10.1146/annurev.bb.09.060180.002343" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6994593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Szoka%20F,%20Papahadjopoulos%20D.%20Comparative%20properties%20and%20methods%20of%20preparation%20of%20lipid%20vesicles%20(liposomes).%20Annu%20Rev%20Biophys%20Bioeng.%201980;9:467%E2%80%93508." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Batzri S, Korn ED. Single bilayer liposomes prepared without sonication. Biochimica et Biophysica Acta (BBA). 1973;298:1015–9.
</cite> [<a href="https://doi.org/10.1016/0005-2736(73)90408-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/4738145/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Batzri%20S,%20Korn%20ED.%20Single%20bilayer%20liposomes%20prepared%20without%20sonication.%20Biochimica%20et%20Biophysica%20Acta%20(BBA).%201973;298:1015%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Szoka F, Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci U S A. 1978;75:4194–8.
</cite> [<a href="https://doi.org/10.1073/pnas.75.9.4194" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC336078/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/279908/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Szoka%20F,%20Papahadjopoulos%20D.%20Procedure%20for%20preparation%20of%20liposomes%20with%20large%20internal%20aqueous%20space%20and%20high%20capture%20by%20reverse-phase%20evaporation.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%201978;75:4194%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Lombardo D, Kiselev MA. Methods of liposomes preparation: formation and control factors of versatile nanocarriers for biomedical and nanomedicine application. Pharmaceutics. 2022;14:543.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics14030543" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8955843/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35335920/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lombardo%20D,%20Kiselev%20MA.%20Methods%20of%20liposomes%20preparation:%20formation%20and%20control%20factors%20of%20versatile%20nanocarriers%20for%20biomedical%20and%20nanomedicine%20application.%20Pharmaceutics.%202022;14:543." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Shen H-H, Lithgow T, Martin L. Reconstitution of membrane proteins into model membranes: seeking better ways to retain protein activities. Int J Mol Sci. 2013;14:1589–607.
</cite> [<a href="https://doi.org/10.3390/ijms14011589" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3565336/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23344058/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shen%20H-H,%20Lithgow%20T,%20Martin%20L.%20Reconstitution%20of%20membrane%20proteins%20into%20model%20membranes:%20seeking%20better%20ways%20to%20retain%20protein%20activities.%20Int%20J%20Mol%20Sci.%202013;14:1589%E2%80%93607." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Schwendener RA, Asanger M, Weder HG. N-alkyl-glucosides as detergents for the preparation of highly homogeneous bilayer liposomes of variable sizes (60–240 Nm φ) applying defined rates of detergent removal by dialysis. Biochem Biophys Res Commun. 1981;100:1055–62.
</cite> [<a href="https://doi.org/10.1016/0006-291x(81)91930-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7271790/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schwendener%20RA,%20Asanger%20M,%20Weder%20HG.%20N-alkyl-glucosides%20as%20detergents%20for%20the%20preparation%20of%20highly%20homogeneous%20bilayer%20liposomes%20of%20variable%20sizes%20(60%E2%80%93240%20Nm%20%CF%86)%20applying%20defined%20rates%20of%20detergent%20removal%20by%20dialysis.%20Biochem%20Biophys%20Res%20Commun.%201981;100:1055%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Milsmann MHW, Schwendener RA, Weder H-G. The preparation of large single bilayer liposomes by a fast and controlled dialysis. Biochimica et Biophysica Acta (BBA). 1978;512:147–55.
</cite> [<a href="https://doi.org/10.1016/0005-2736(78)90225-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/698210/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Milsmann%20MHW,%20Schwendener%20RA,%20Weder%20H-G.%20The%20preparation%20of%20large%20single%20bilayer%20liposomes%20by%20a%20fast%20and%20controlled%20dialysis.%20Biochimica%20et%20Biophysica%20Acta%20(BBA).%201978;512:147%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Ollivon M, Lesieur S, Grabielle-Madelmont C, Paternostre M. Vesicle reconstitution from lipid–detergent mixed micelles. Biochim Biophys Acta - Biomembr. 2000;1508:34–50.</cite> [<a href="https://doi.org/10.1016/s0304-4157(00)00006-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11090817/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ollivon%20M,%20Lesieur%20S,%20Grabielle-Madelmont%20C,%20Paternostre%20M.%20Vesicle%20reconstitution%20from%20lipid%E2%80%93detergent%20mixed%20micelles.%20Biochim%20Biophys%20Acta%20-%20Biomembr.%202000;1508:34%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Andra VVSNL, Pammi SVN, Bhatraju LVKP, Ruddaraju LK. A comprehensive review on novel liposomal methodologies, commercial formulations, clinical trials and patents. Bionanoscience. 2022;12:274–91.
</cite> [<a href="https://doi.org/10.1007/s12668-022-00941-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8790012/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35096502/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Andra%20VVSNL,%20Pammi%20SVN,%20Bhatraju%20LVKP,%20Ruddaraju%20LK.%20A%20comprehensive%20review%20on%20novel%20liposomal%20methodologies,%20commercial%20formulations,%20clinical%20trials%20and%20patents.%20Bionanoscience.%202022;12:274%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Mozafari MR. Liposomes: an overview of manufacturing techniques. Cell Mol Biol Lett. 2005;10:711–9.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/16341279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mozafari%20MR.%20Liposomes:%20an%20overview%20of%20manufacturing%20techniques.%20Cell%20Mol%20Biol%20Lett.%202005;10:711%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Jahadi M, Khosravi-Darani K, Ehsani MR, Mozafari MR, Saboury AA, Pourhosseini PS. The encapsulation of flavourzyme in nanoliposome by heating method. J Food Sci Technol. 2015;52:2063–72.
</cite> [<a href="https://doi.org/10.1007/s13197-013-1243-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4375226/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25829586/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jahadi%20M,%20Khosravi-Darani%20K,%20Ehsani%20MR,%20Mozafari%20MR,%20Saboury%20AA,%20Pourhosseini%20PS.%20The%20encapsulation%20of%20flavourzyme%20in%20nanoliposome%20by%20heating%20method.%20J%20Food%20Sci%20Technol.%202015;52:2063%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Hauser H. Mechanism of spontaneous vesiculation. Proc Natl Acad Sci U S A. 1989;86:5351–5.
</cite> [<a href="https://doi.org/10.1073/pnas.86.14.5351" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC297620/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2748590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hauser%20H.%20Mechanism%20of%20spontaneous%20vesiculation.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%201989;86:5351%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Varona S, Martín Á, Cocero MJ. Liposomal incorporation of Lavandin essential oil by a thin-film hydration method and by particles from gas-saturated solutions. Ind Eng Chem Res. 2011;50:2088–97.</cite> [<a href="https://scholar.google.com/scholar_lookup?Varona%20S,%20Mart%C3%ADn%20%C3%81,%20Cocero%20MJ.%20Liposomal%20incorporation%20of%20Lavandin%20essential%20oil%20by%20a%20thin-film%20hydration%20method%20and%20by%20particles%20from%20gas-saturated%20solutions.%20Ind%20Eng%20Chem%20Res.%202011;50:2088%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Charcosset C, Juban A, Valour J-P, Urbaniak S, Fessi H. Preparation of liposomes at large scale using the ethanol injection method: effect of scale-up and injection devices. Chem Eng Res Des. 2015;94:508–15.</cite> [<a href="https://scholar.google.com/scholar_lookup?Charcosset%20C,%20Juban%20A,%20Valour%20J-P,%20Urbaniak%20S,%20Fessi%20H.%20Preparation%20of%20liposomes%20at%20large%20scale%20using%20the%20ethanol%20injection%20method:%20effect%20of%20scale-up%20and%20injection%20devices.%20Chem%20Eng%20Res%20Des.%202015;94:508%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Pham HL, Shaw PN, Davies NM. Preparation of immuno-stimulating complexes (ISCOMs) by ether injection. Int J Pharm. 2006;310:196–202.
</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2005.11.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16413713/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pham%20HL,%20Shaw%20PN,%20Davies%20NM.%20Preparation%20of%20immuno-stimulating%20complexes%20(ISCOMs)%20by%20ether%20injection.%20Int%20J%20Pharm.%202006;310:196%E2%80%93202." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Deamer D, Bangham AD. Large volume liposomes by an ether vaporization method. Biochimica et Biophysica Acta (BBA). 1976;443:629–34.
</cite> [<a href="https://doi.org/10.1016/0005-2736(76)90483-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/963074/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deamer%20D,%20Bangham%20AD.%20Large%20volume%20liposomes%20by%20an%20ether%20vaporization%20method.%20Biochimica%20et%20Biophysica%20Acta%20(BBA).%201976;443:629%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Grijalvo S, Mayr J, Eritja R, Díaz DD. Biodegradable liposome-encapsulated hydrogels for biomedical applications: a marriage of convenience. Biomater Sci. 2016;4:555–74.
</cite> [<a href="https://doi.org/10.1039/c5bm00481k" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26818789/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Grijalvo%20S,%20Mayr%20J,%20Eritja%20R,%20D%C3%ADaz%20DD.%20Biodegradable%20liposome-encapsulated%20hydrogels%20for%20biomedical%20applications:%20a%20marriage%20of%20convenience.%20Biomater%20Sci.%202016;4:555%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Mouritsen OG. Lipids, curvature, and nano-medicine. Eur J Lipid Sci Technol. 2011;113:1174–87.
</cite> [<a href="https://doi.org/10.1002/ejlt.201100050" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3229985/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22164124/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mouritsen%20OG.%20Lipids,%20curvature,%20and%20nano-medicine.%20Eur%20J%20Lipid%20Sci%20Technol.%202011;113:1174%E2%80%9387." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Nkanga CI, Krause RWM. Encapsulation of isoniazid-conjugated phthalocyanine-in-cyclodextrin-in-liposomes using heating method. Sci Rep. 2019;9:11485.
</cite> [<a href="https://doi.org/10.1038/s41598-019-47991-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6685989/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31391517/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nkanga%20CI,%20Krause%20RWM.%20Encapsulation%20of%20isoniazid-conjugated%20phthalocyanine-in-cyclodextrin-in-liposomes%20using%20heating%20method.%20Sci%20Rep.%202019;9:11485." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Brunner J, Skrabal P, Hausser H. Single bilayer vesicles prepared without sonication physico-chemical properties. Biochimica et Biophysica Acta (BBA). 1976;455:322–31.
</cite> [<a href="https://doi.org/10.1016/0005-2736(76)90308-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1033769/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brunner%20J,%20Skrabal%20P,%20Hausser%20H.%20Single%20bilayer%20vesicles%20prepared%20without%20sonication%20physico-chemical%20properties.%20Biochimica%20et%20Biophysica%20Acta%20(BBA).%201976;455:322%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Wang T, Deng Y, Geng Y, Gao Z, Zou J, Wang Z. Preparation of submicron unilamellar liposomes by freeze-drying double emulsions. Biochimica et Biophysica Acta (BBA). 2006;1758:222–31.
</cite> [<a href="https://doi.org/10.1016/j.bbamem.2006.01.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16563340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20T,%20Deng%20Y,%20Geng%20Y,%20Gao%20Z,%20Zou%20J,%20Wang%20Z.%20Preparation%20of%20submicron%20unilamellar%20liposomes%20by%20freeze-drying%20double%20emulsions.%20Biochimica%20et%20Biophysica%20Acta%20(BBA).%202006;1758:222%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Wang T, Wang N, Wang T, Sun W, Li T. Preparation of submicron liposomes exhibiting efficient entrapment of drugs by freeze-drying water-in-oil emulsions. Chem Phys Lipids. 2011;164:151–7.
</cite> [<a href="https://doi.org/10.1016/j.chemphyslip.2010.12.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21185814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20T,%20Wang%20N,%20Wang%20T,%20Sun%20W,%20Li%20T.%20Preparation%20of%20submicron%20liposomes%20exhibiting%20efficient%20entrapment%20of%20drugs%20by%20freeze-drying%20water-in-oil%20emulsions.%20Chem%20Phys%20Lipids.%202011;164:151%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Otake K, Imura T, Sakai H, Abe M. Development of a new preparation method of liposomes using supercritical carbon dioxide. Langmuir. 2001;17:3898–901.</cite> [<a href="https://scholar.google.com/scholar_lookup?Otake%20K,%20Imura%20T,%20Sakai%20H,%20Abe%20M.%20Development%20of%20a%20new%20preparation%20method%20of%20liposomes%20using%20supercritical%20carbon%20dioxide.%20Langmuir.%202001;17:3898%E2%80%93901." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Baykal-Caglar E, Hassan-Zadeh E, Saremi B, Huang J. Preparation of giant unilamellar vesicles from damp lipid film for better lipid compositional uniformity. Biochimica et Biophysica Acta (BBA). 2012;1818:2598–604.
</cite> [<a href="https://doi.org/10.1016/j.bbamem.2012.05.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22652256/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Baykal-Caglar%20E,%20Hassan-Zadeh%20E,%20Saremi%20B,%20Huang%20J.%20Preparation%20of%20giant%20unilamellar%20vesicles%20from%20damp%20lipid%20film%20for%20better%20lipid%20compositional%20uniformity.%20Biochimica%20et%20Biophysica%20Acta%20(BBA).%202012;1818:2598%E2%80%93604." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Herold C, Chwastek G, Schwille P, Petrov EP. Efficient electroformation of supergiant unilamellar vesicles containing cationic lipids on ITO-coated electrodes. Langmuir. 2012;28:5518–21.
</cite> [<a href="https://doi.org/10.1021/la3005807" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22424289/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Herold%20C,%20Chwastek%20G,%20Schwille%20P,%20Petrov%20EP.%20Efficient%20electroformation%20of%20supergiant%20unilamellar%20vesicles%20containing%20cationic%20lipids%20on%20ITO-coated%20electrodes.%20Langmuir.%202012;28:5518%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Okumura Y, Sugiyama T. Electroformation of giant vesicles on a polymer mesh. Membranes. 2011;1:184–94.
</cite> [<a href="https://doi.org/10.3390/membranes1030184" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4021901/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24957731/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Okumura%20Y,%20Sugiyama%20T.%20Electroformation%20of%20giant%20vesicles%20on%20a%20polymer%20mesh.%20Membranes.%202011;1:184%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Pott T, Bouvrais H, Méléard P. Giant unilamellar vesicle formation under physiologically relevant conditions. Chem Phys Lipids. 2008;154:115–9.
</cite> [<a href="https://doi.org/10.1016/j.chemphyslip.2008.03.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18405664/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pott%20T,%20Bouvrais%20H,%20M%C3%A9l%C3%A9ard%20P.%20Giant%20unilamellar%20vesicle%20formation%20under%20physiologically%20relevant%20conditions.%20Chem%20Phys%20Lipids.%202008;154:115%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Patil YP, Ahluwalia AK, Jadhav S. Isolation of giant unilamellar vesicles from electroformed vesicle suspensions and their extrusion through nano-pores. Chem Phys Lipids. 2013;167–168:1–8.
</cite> [<a href="https://doi.org/10.1016/j.chemphyslip.2013.01.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23328131/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Patil%20YP,%20Ahluwalia%20AK,%20Jadhav%20S.%20Isolation%20of%20giant%20unilamellar%20vesicles%20from%20electroformed%20vesicle%20suspensions%20and%20their%20extrusion%20through%20nano-pores.%20Chem%20Phys%20Lipids.%202013;167%E2%80%93168:1%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Tejera-Garcia R, Ranjan S, Zamotin V, Sood R, Kinnunen PKJ. Making unilamellar liposomes using focused ultrasound. Langmuir. 2011;27:10088–97.
</cite> [<a href="https://doi.org/10.1021/la201708x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21740027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tejera-Garcia%20R,%20Ranjan%20S,%20Zamotin%20V,%20Sood%20R,%20Kinnunen%20PKJ.%20Making%20unilamellar%20liposomes%20using%20focused%20ultrasound.%20Langmuir.%202011;27:10088%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Yamaguchi T, Nomura M, Matsuoka T, Koda S. Effects of frequency and power of ultrasound on the size reduction of liposome. Chem Phys Lipids. 2009;160:58–62.
</cite> [<a href="https://doi.org/10.1016/j.chemphyslip.2009.04.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19397902/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yamaguchi%20T,%20Nomura%20M,%20Matsuoka%20T,%20Koda%20S.%20Effects%20of%20frequency%20and%20power%20of%20ultrasound%20on%20the%20size%20reduction%20of%20liposome.%20Chem%20Phys%20Lipids.%202009;160:58%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Chandrawati R, Caruso F. Biomimetic liposome- and polymersome-based multicompartmentalized assemblies. Langmuir. 2012;28:13798–807.
</cite> [<a href="https://doi.org/10.1021/la301958v" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22831559/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chandrawati%20R,%20Caruso%20F.%20Biomimetic%20liposome-%20and%20polymersome-based%20multicompartmentalized%20assemblies.%20Langmuir.%202012;28:13798%E2%80%93807." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Budin I, Devaraj NK. Membrane assembly driven by a biomimetic coupling reaction. J Am Chem Soc. 2012;134:751–3.
</cite> [<a href="https://doi.org/10.1021/ja2076873" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3262119/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22239722/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Budin%20I,%20Devaraj%20NK.%20Membrane%20assembly%20driven%20by%20a%20biomimetic%20coupling%20reaction.%20J%20Am%20Chem%20Soc.%202012;134:751%E2%80%933." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Yu D-G, Branford-White C, Williams GR, Bligh SWA, White K, Zhu L-M, et al. Self-assembled liposomes from amphiphilic electrospun nanofibers. Soft Matter. 2011;7:8239.</cite> [<a href="https://scholar.google.com/scholar_lookup?Yu%20D-G,%20Branford-White%20C,%20Williams%20GR,%20Bligh%20SWA,%20White%20K,%20Zhu%20L-M,%20et%20al.%20Self-assembled%20liposomes%20from%20amphiphilic%20electrospun%20nanofibers.%20Soft%20Matter.%202011;7:8239." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Zhang J, Wang K, Mao, Fan X, Jiang, Chen, et al. Application of liposomes in drug development – focus on gastroenterological targets. Int J Nanomedicine. 2013;1325.</cite> [<a href="https://doi.org/10.2147/IJN.S42153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3623572/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23630417/" class="usa-link">PubMed</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Bulbake U, Doppalapudi S, Kommineni N, Khan W. Liposomal formulations in clinical use: an updated review. Pharmaceutics. 2017;9:12.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics9020012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5489929/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28346375/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bulbake%20U,%20Doppalapudi%20S,%20Kommineni%20N,%20Khan%20W.%20Liposomal%20formulations%20in%20clinical%20use:%20an%20updated%20review.%20Pharmaceutics.%202017;9:12." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Retraction. Liposomes: structure, biomedical applications, and stability parameters with emphasis on cholesterol. Front Bioeng Biotechnol. 2023;11.</cite> [<a href="https://doi.org/10.3389/fbioe.2023.1285118" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10507466/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37731758/" class="usa-link">PubMed</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Nsairat H, Ibrahim AA, Jaber AM, Abdelghany S, Atwan R, Shalan N, et al. Liposome bilayer stability: emphasis on cholesterol and its alternatives. J Liposome Res. 2024;34:178–202.
</cite> [<a href="https://doi.org/10.1080/08982104.2023.2226216" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37378553/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nsairat%20H,%20Ibrahim%20AA,%20Jaber%20AM,%20Abdelghany%20S,%20Atwan%20R,%20Shalan%20N,%20et%20al.%20Liposome%20bilayer%20stability:%20emphasis%20on%20cholesterol%20and%20its%20alternatives.%20J%20Liposome%20Res.%202024;34:178%E2%80%93202." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>Chen X, Wu J, Lin X, Wu X, Yu X, Wang B, et al. Tacrolimus loaded cationic liposomes for dry eye treatment. Front Pharmacol. 2022. 10.3389/fphar.2022.838168.
</cite> [<a href="https://doi.org/10.3389/fphar.2022.838168" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8855213/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35185587/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20X,%20Wu%20J,%20Lin%20X,%20Wu%20X,%20Yu%20X,%20Wang%20B,%20et%20al.%20Tacrolimus%20loaded%20cationic%20liposomes%20for%20dry%20eye%20treatment.%20Front%20Pharmacol.%202022.%2010.3389/fphar.2022.838168." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR75">
<span class="label">75.</span><cite>Ewert KK, Scodeller P, Simón-Gracia L, Steffes VM, Wonder EA, Teesalu T, et al. Cationic liposomes as vectors for nucleic acid and hydrophobic drug therapeutics. Pharmaceutics. 2021;13:1365.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics13091365" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8465808/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34575441/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ewert%20KK,%20Scodeller%20P,%20Sim%C3%B3n-Gracia%20L,%20Steffes%20VM,%20Wonder%20EA,%20Teesalu%20T,%20et%20al.%20Cationic%20liposomes%20as%20vectors%20for%20nucleic%20acid%20and%20hydrophobic%20drug%20therapeutics.%20Pharmaceutics.%202021;13:1365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR76">
<span class="label">76.</span><cite>Kirti A, Simnani FZ, Jena S, Lenka SS, Kalalpitiya C, Naser SS, et al. Nanoparticle-mediated metronomic chemotherapy in cancer: a paradigm of precision and persistence. Cancer Lett. 2024;594:216990. 10.1016/j.canlet.2024.216990.
</cite> [<a href="https://doi.org/10.1016/j.canlet.2024.216990" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38801886/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kirti%20A,%20Simnani%20FZ,%20Jena%20S,%20Lenka%20SS,%20Kalalpitiya%20C,%20Naser%20SS,%20et%20al.%20Nanoparticle-mediated%20metronomic%20chemotherapy%20in%20cancer:%20a%20paradigm%20of%20precision%20and%20persistence.%20Cancer%20Lett.%202024;594:216990.%2010.1016/j.canlet.2024.216990." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR77">
<span class="label">77.</span><cite>Luo D, Geng J, Li N, Carter KA, Shao S, Atilla-Gokcumen GE, et al. Vessel-targeted chemophototherapy with cationic porphyrin-phospholipid liposomes. Mol Cancer Ther. 2017;16:2452–61.
</cite> [<a href="https://doi.org/10.1158/1535-7163.MCT-17-0276" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5669815/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28729400/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Luo%20D,%20Geng%20J,%20Li%20N,%20Carter%20KA,%20Shao%20S,%20Atilla-Gokcumen%20GE,%20et%20al.%20Vessel-targeted%20chemophototherapy%20with%20cationic%20porphyrin-phospholipid%20liposomes.%20Mol%20Cancer%20Ther.%202017;16:2452%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR78">
<span class="label">78.</span><cite>Liu C, Zhang L, Zhu W, Guo R, Sun H, Chen X, et al. Barriers and strategies of cationic liposomes for cancer gene therapy. Mol Ther. 2020;18:751–64.</cite> [<a href="https://doi.org/10.1016/j.omtm.2020.07.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7452052/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32913882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20C,%20Zhang%20L,%20Zhu%20W,%20Guo%20R,%20Sun%20H,%20Chen%20X,%20et%20al.%20Barriers%20and%20strategies%20of%20cationic%20liposomes%20for%20cancer%20gene%20therapy.%20Mol%20Ther.%202020;18:751%E2%80%9364." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR79">
<span class="label">79.</span><cite>Huang Y, Yue N, Fan A. Cationic liposome-triggered luminol chemiluminescence reaction and its applications. Analyst. 2020;145(13):4551–9.
</cite> [<a href="https://doi.org/10.1039/d0an00632g" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32421110/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20Y,%20Yue%20N,%20Fan%20A.%20Cationic%20liposome-triggered%20luminol%20chemiluminescence%20reaction%20and%20its%20applications.%20Analyst.%202020;145(13):4551%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR80">
<span class="label">80.</span><cite>Han X, Lu Y, Xu Z, Chu Y, Ma X, Wu H, et al. Anionic liposomes prepared without organic solvents for effective siRNA delivery. IET Nanobiotechnol. 2023;17:269–80.
</cite> [<a href="https://doi.org/10.1049/nbt2.12117" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10190622/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36786285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Han%20X,%20Lu%20Y,%20Xu%20Z,%20Chu%20Y,%20Ma%20X,%20Wu%20H,%20et%20al.%20Anionic%20liposomes%20prepared%20without%20organic%20solvents%20for%20effective%20siRNA%20delivery.%20IET%20Nanobiotechnol.%202023;17:269%E2%80%9380." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR81">
<span class="label">81.</span><cite>Efimova AA, Sorokina SA, Trosheva KS, Yaroslavov AA, Shifrina ZB. Complexes of cationic pyridylphenylene dendrimers with anionic liposomes: the role of dendrimer composition in membrane structural changes. Int J Mol Sci. 2023;24: 2225.
</cite> [<a href="https://doi.org/10.3390/ijms24032225" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9917332/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36768548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Efimova%20AA,%20Sorokina%20SA,%20Trosheva%20KS,%20Yaroslavov%20AA,%20Shifrina%20ZB.%20Complexes%20of%20cationic%20pyridylphenylene%20dendrimers%20with%20anionic%20liposomes:%20the%20role%20of%20dendrimer%20composition%20in%20membrane%20structural%20changes.%20Int%20J%20Mol%20Sci.%202023;24:%202225." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR82">
<span class="label">82.</span><cite>Cazzolla A, Mondala JRM, Wanigasekara J, Carroll J, Daly N, Tiwari B, et al. Synthesis of cationic liposome nanoparticles using a thin film dispersed hydration and extrusion method. PLoS ONE. 2024;19:1–11.</cite> [<a href="https://doi.org/10.1371/journal.pone.0300467" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11003666/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38593146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cazzolla%20A,%20Mondala%20JRM,%20Wanigasekara%20J,%20Carroll%20J,%20Daly%20N,%20Tiwari%20B,%20et%20al.%20Synthesis%20of%20cationic%20liposome%20nanoparticles%20using%20a%20thin%20film%20dispersed%20hydration%20and%20extrusion%20method.%20PLoS%20ONE.%202024;19:1%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR83">
<span class="label">83.</span><cite>Alrbyawi H, Poudel I, Annaji M, Boddu SHS, Arnold RD, Tiwari AK, et al. pH-sensitive liposomes for enhanced cellular uptake and cytotoxicity of Daunorubicin in melanoma (B16-BL6) cell lines. Pharmaceutics. 2022;14:1128.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics14061128" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9228428/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35745701/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alrbyawi%20H,%20Poudel%20I,%20Annaji%20M,%20Boddu%20SHS,%20Arnold%20RD,%20Tiwari%20AK,%20et%20al.%20pH-sensitive%20liposomes%20for%20enhanced%20cellular%20uptake%20and%20cytotoxicity%20of%20Daunorubicin%20in%20melanoma%20(B16-BL6)%20cell%20lines.%20Pharmaceutics.%202022;14:1128." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR84">
<span class="label">84.</span><cite>Ta T, Porter TM. Thermosensitive liposomes for localized delivery and triggered release of chemotherapy. J Control Release. 2013;169:112–25.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2013.03.036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5127786/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23583706/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ta%20T,%20Porter%20TM.%20Thermosensitive%20liposomes%20for%20localized%20delivery%20and%20triggered%20release%20of%20chemotherapy.%20J%20Control%20Release.%202013;169:112%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR85">
<span class="label">85.</span><cite>Selianitis D, Sentoukas T, Skandalis A, Balafouti A, Pippa N, Pispas S. Stimulus-responsive liposomes as smart nanocarriers for drug delivery applications. Nov Platforms Drug Deliv Appl. Elsevier; 2023. pp. 177–215.</cite>
</li>
<li id="CR86">
<span class="label">86.</span><cite>Yeingst TJ, Arrizabalaga JH, Hayes DJ. Ultrasound-induced drug release from stimuli-responsive hydrogels. Gels. 2022;8:554.
</cite> [<a href="https://doi.org/10.3390/gels8090554" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9498906/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36135267/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yeingst%20TJ,%20Arrizabalaga%20JH,%20Hayes%20DJ.%20Ultrasound-induced%20drug%20release%20from%20stimuli-responsive%20hydrogels.%20Gels.%202022;8:554." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR87">
<span class="label">87.</span><cite>Lou J, Schuster JA, Barrera FN, Best MD. ATP-responsive liposomes via screening of lipid switches designed to undergo conformational changes upon binding phosphorylated metabolites. J Am Chem Soc. 2022;144:3746–56.
</cite> [<a href="https://doi.org/10.1021/jacs.2c00191" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35171601/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lou%20J,%20Schuster%20JA,%20Barrera%20FN,%20Best%20MD.%20ATP-responsive%20liposomes%20via%20screening%20of%20lipid%20switches%20designed%20to%20undergo%20conformational%20changes%20upon%20binding%20phosphorylated%20metabolites.%20J%20Am%20Chem%20Soc.%202022;144:3746%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR88">
<span class="label">88.</span><cite>Alrbyawi H, Poudel I, Annaji M, Arnold RD, Tiwari AK, Babu RJ. Recent advancements of stimuli-responsive targeted liposomal formulations for cancer drug delivery. Pharm Nanotechnol. 2022;10:3–23.
</cite> [<a href="https://doi.org/10.2174/2211738510666220214102626" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35156590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alrbyawi%20H,%20Poudel%20I,%20Annaji%20M,%20Arnold%20RD,%20Tiwari%20AK,%20Babu%20RJ.%20Recent%20advancements%20of%20stimuli-responsive%20targeted%20liposomal%20formulations%20for%20cancer%20drug%20delivery.%20Pharm%20Nanotechnol.%202022;10:3%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR89">
<span class="label">89.</span><cite>Needham D, Dewhirst MW. The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv Drug Deliv Rev. 2001;53:285–305.
</cite> [<a href="https://doi.org/10.1016/s0169-409x(01)00233-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11744173/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Needham%20D,%20Dewhirst%20MW.%20The%20development%20and%20testing%20of%20a%20new%20temperature-sensitive%20drug%20delivery%20system%20for%20the%20treatment%20of%20solid%20tumors.%20Adv%20Drug%20Deliv%20Rev.%202001;53:285%E2%80%93305." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR90">
<span class="label">90.</span><cite>Rao NV, Ko H, Lee J, Park JH. Recent progress and advances in stimuli-responsive polymers for cancer therapy. Front Bioeng Biotechnol. 2018;6:110.
</cite> [<a href="https://doi.org/10.3389/fbioe.2018.00110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6104418/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30159310/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rao%20NV,%20Ko%20H,%20Lee%20J,%20Park%20JH.%20Recent%20progress%20and%20advances%20in%20stimuli-responsive%20polymers%20for%20cancer%20therapy.%20Front%20Bioeng%20Biotechnol.%202018;6:110." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR91">
<span class="label">91.</span><cite>Andresen TL, Thompson DH, Kaasgaard T. Enzyme-triggered nanomedicine: drug release strategies in cancer therapy (invited review). Mol Membr Biol. 2010;27:353–63.
</cite> [<a href="https://doi.org/10.3109/09687688.2010.515950" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6889806/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20939771/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Andresen%20TL,%20Thompson%20DH,%20Kaasgaard%20T.%20Enzyme-triggered%20nanomedicine:%20drug%20release%20strategies%20in%20cancer%20therapy%20(invited%20review).%20Mol%20Membr%20Biol.%202010;27:353%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR92">
<span class="label">92.</span><cite>Zhang J, Lin Y, Lin Z, Wei Q, Qian J, Ruan R et al. Stimuli-Responsive nanoparticles for controlled drug delivery in synergistic cancer immunotherapy. Adv Sci. 2022;9.</cite> [<a href="https://doi.org/10.1002/advs.202103444" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8844476/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34927373/" class="usa-link">PubMed</a>]</li>
<li id="CR93">
<span class="label">93.</span><cite>Verma SK, Jha E, Kiran KJ, Bhat S, Suar M, Mohanty PS. Synthesis and characterization of novel polymer-hybrid silver nanoparticles and its biomedical study. Mater Today Proc. 2016;3:1949–57.</cite> [<a href="https://scholar.google.com/scholar_lookup?Verma%20SK,%20Jha%20E,%20Kiran%20KJ,%20Bhat%20S,%20Suar%20M,%20Mohanty%20PS.%20Synthesis%20and%20characterization%20of%20novel%20polymer-hybrid%20silver%20nanoparticles%20and%20its%20biomedical%20study.%20Mater%20Today%20Proc.%202016;3:1949%E2%80%9357." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR94">
<span class="label">94.</span><cite>Jha E, Patel P, Kumari P, Verma KK, Panda PK, Mohanty PS, et al. In vivo molecular biocompatibility of <em>Calotropis Gigentea</em> contrived smart poly(N-isopropylacrylamide)-co-sulphonic-Silver microgel hybrid with embryonic <em>Danio rerio</em> inferred via intrinsic atomic physiological impacts. J Environ Chem Eng. 2023;11(6):111183. 10.1016/j.jece.2023.111183.</cite> [<a href="https://scholar.google.com/scholar_lookup?Jha%20E,%20Patel%20P,%20Kumari%20P,%20Verma%20KK,%20Panda%20PK,%20Mohanty%20PS,%20et%20al.%20In%20vivo%20molecular%20biocompatibility%20of%20Calotropis%20Gigentea%20contrived%20smart%20poly(N-isopropylacrylamide)-co-sulphonic-Silver%20microgel%20hybrid%20with%20embryonic%20Danio%20rerio%20inferred%20via%20intrinsic%20atomic%20physiological%20impacts.%20J%20Environ%20Chem%20Eng.%202023;11(6):111183.%2010.1016/j.jece.2023.111183." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR95">
<span class="label">95.</span><cite>Rahman A, Bin Imran A. Stimuli-responsive and Self-healing multicomponent hydrogels for biomedical applications. multicomponent hydrogels. The Royal Society of Chemistry; 2023. pp. 578–603.</cite>
</li>
<li id="CR96">
<span class="label">96.</span><cite>Nazarzadeh Zare E, Makvandi P, editors. Stimuli-Responsive materials for biomedical applications. Washington, DC: American Chemical Society; 2023.</cite> [<a href="https://scholar.google.com/scholar_lookup?Nazarzadeh%20Zare%20E,%20Makvandi%20P,%20editors.%20Stimuli-Responsive%20materials%20for%20biomedical%20applications.%20Washington,%20DC:%20American%20Chemical%20Society;%202023." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR97">
<span class="label">97.</span><cite>Chaves MA, Esposto BS, Martelli-Tosi M, Pinho SC. Liposomes. Bioact deliv syst lipophilic nutraceuticals. The Royal Society of Chemistry; 2023. pp. 267–300.</cite>
</li>
<li id="CR98">
<span class="label">98.</span><cite>Liu P, Chen G, Zhang J. A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives. Molecules. 2022;27(4):1372. 10.3390/molecules27041372.
</cite> [<a href="https://doi.org/10.3390/molecules27041372" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8879473/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35209162/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20P,%20Chen%20G,%20Zhang%20J.%20A%20review%20of%20liposomes%20as%20a%20drug%20delivery%20system:%20current%20status%20of%20approved%20products,%20regulatory%20environments,%20and%20future%20perspectives.%20Molecules.%202022;27(4):1372.%2010.3390/molecules27041372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR99">
<span class="label">99.</span><cite>Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed. 2006;1:297–315.</cite> [<a href="/articles/PMC2426795/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17717971/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Immordino%20ML,%20Dosio%20F,%20Cattel%20L.%20Stealth%20liposomes:%20review%20of%20the%20basic%20science,%20rationale,%20and%20clinical%20applications,%20existing%20and%20potential.%20Int%20J%20Nanomed.%202006;1:297%E2%80%93315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR100">
<span class="label">100.</span><cite>Rosenthal DI, Yom SS, Liu L, Machtay M, Algazy K, Weber RS, et al. A phase I study of SPI-077 (stealth<sup>®</sup> liposomal cisplatin) concurrent with radiation therapy for locally advanced head and neck cancer. Invest New Drugs. 2002;20:343–9.
</cite> [<a href="https://doi.org/10.1023/a:1016201732368" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12201498/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rosenthal%20DI,%20Yom%20SS,%20Liu%20L,%20Machtay%20M,%20Algazy%20K,%20Weber%20RS,%20et%20al.%20A%20phase%20I%20study%20of%20SPI-077%20(stealth%C2%AE%20liposomal%20cisplatin)%20concurrent%20with%20radiation%20therapy%20for%20locally%20advanced%20head%20and%20neck%20cancer.%20Invest%20New%20Drugs.%202002;20:343%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR101">
<span class="label">101.</span><cite>Ejigah V, Owoseni O, Bataille-Backer P, Ogundipe OD, Fisusi FA, Adesina SK. Approaches to improve macromolecule and nanoparticle accumulation in the tumor microenvironment by the enhanced permeability and retention effect. Polym (Basel). 2022;14:2601.</cite> [<a href="https://doi.org/10.3390/polym14132601" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9268820/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35808648/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ejigah%20V,%20Owoseni%20O,%20Bataille-Backer%20P,%20Ogundipe%20OD,%20Fisusi%20FA,%20Adesina%20SK.%20Approaches%20to%20improve%20macromolecule%20and%20nanoparticle%20accumulation%20in%20the%20tumor%20microenvironment%20by%20the%20enhanced%20permeability%20and%20retention%20effect.%20Polym%20(Basel).%202022;14:2601." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR102">
<span class="label">102.</span><cite>Izci M, Maksoudian C, Manshian BB, Soenen SJ. The use of alternative strategies for enhanced nanoparticle delivery to solid tumors. Chem Rev. 2021;121:1746–803.
</cite> [<a href="https://doi.org/10.1021/acs.chemrev.0c00779" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7883342/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33445874/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Izci%20M,%20Maksoudian%20C,%20Manshian%20BB,%20Soenen%20SJ.%20The%20use%20of%20alternative%20strategies%20for%20enhanced%20nanoparticle%20delivery%20to%20solid%20tumors.%20Chem%20Rev.%202021;121:1746%E2%80%93803." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR103">
<span class="label">103.</span><cite>Harrington KJ, Rowlinson-Busza G, Syrigos KN, Uster PS, Abra RM, Stewart JSW. Biodistribution and pharmacokinetics of <sup>111</sup>In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies. Br J Cancer. 2000;83:232–8.
</cite> [<a href="https://doi.org/10.1054/bjoc.1999.1232" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2363473/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10901376/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Harrington%20KJ,%20Rowlinson-Busza%20G,%20Syrigos%20KN,%20Uster%20PS,%20Abra%20RM,%20Stewart%20JSW.%20Biodistribution%20and%20pharmacokinetics%20of%20111In-DTPA-labelled%20pegylated%20liposomes%20in%20a%20human%20tumour%20xenograft%20model:%20implications%20for%20novel%20targeting%20strategies.%20Br%20J%20Cancer.%202000;83:232%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR104">
<span class="label">104.</span><cite>Ocaña-Arakachi K, Martínez-Herculano J, Jurado R, Llaguno-Munive M, Garcia-Lopez P. Pharmacokinetics and anti-tumor efficacy of pegylated liposomes co-loaded with cisplatin and mifepristone. Pharmaceuticals. 2023;16:1337.
</cite> [<a href="https://doi.org/10.3390/ph16101337" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10609730/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37895808/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Oca%C3%B1a-Arakachi%20K,%20Mart%C3%ADnez-Herculano%20J,%20Jurado%20R,%20Llaguno-Munive%20M,%20Garcia-Lopez%20P.%20Pharmacokinetics%20and%20anti-tumor%20efficacy%20of%20pegylated%20liposomes%20co-loaded%20with%20cisplatin%20and%20mifepristone.%20Pharmaceuticals.%202023;16:1337." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR105">
<span class="label">105.</span><cite>Agarwal K. Liposome assisted drug Delivery-An updated review. Indian J Pharm Sci. 2022;84.</cite>
</li>
<li id="CR106">
<span class="label">106.</span><cite>Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics of pegylated liposomal doxorubicin. Clin Pharmacokinet. 2003;42:419–36.
</cite> [<a href="https://doi.org/10.2165/00003088-200342050-00002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12739982/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gabizon%20A,%20Shmeeda%20H,%20Barenholz%20Y.%20Pharmacokinetics%20of%20pegylated%20liposomal%20doxorubicin.%20Clin%20Pharmacokinet.%202003;42:419%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR107">
<span class="label">107.</span><cite>Hussein MA, Anderson KC. Role of liposomal anthracyclines in the treatment of multiple myeloma. Semin Oncol. 2004;31:147–60.
</cite> [<a href="https://doi.org/10.1053/j.seminoncol.2004.08.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15717741/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hussein%20MA,%20Anderson%20KC.%20Role%20of%20liposomal%20anthracyclines%20in%20the%20treatment%20of%20multiple%20myeloma.%20Semin%20Oncol.%202004;31:147%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR108">
<span class="label">108.</span><cite>Zalipsky S, Qazen M, Walker JA, Mullah N, Quinn YP, Huang SK. New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine. Bioconjug Chem. 1999;10:703–7.
</cite> [<a href="https://doi.org/10.1021/bc990031n" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10502334/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zalipsky%20S,%20Qazen%20M,%20Walker%20JA,%20Mullah%20N,%20Quinn%20YP,%20Huang%20SK.%20New%20detachable%20poly(ethylene%20glycol)%20conjugates:%20cysteine-cleavable%20lipopolymers%20regenerating%20natural%20phospholipid,%20diacyl%20phosphatidylethanolamine.%20Bioconjug%20Chem.%201999;10:703%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR109">
<span class="label">109.</span><cite>Zamboni WC, Gervais AC, Egorin MJ, Schellens JHM, Zuhowski EG, Pluim D, et al. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma. Cancer Chemother Pharmacol. 2004;53:329–36.
</cite> [<a href="https://doi.org/10.1007/s00280-003-0719-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14673619/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zamboni%20WC,%20Gervais%20AC,%20Egorin%20MJ,%20Schellens%20JHM,%20Zuhowski%20EG,%20Pluim%20D,%20et%20al.%20Systemic%20and%20tumor%20disposition%20of%20platinum%20after%20administration%20of%20cisplatin%20or%20STEALTH%20liposomal-cisplatin%20formulations%20(SPI-077%20and%20SPI-077%20B103)%20in%20a%20preclinical%20tumor%20model%20of%20melanoma.%20Cancer%20Chemother%20Pharmacol.%202004;53:329%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR110">
<span class="label">110.</span><cite>Xu S, Olenyuk BZ, Okamoto CT, Hamm-Alvarez SF. Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances. Adv Drug Deliv Rev. 2013;65:121–38.
</cite> [<a href="https://doi.org/10.1016/j.addr.2012.09.041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3565049/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23026636/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20S,%20Olenyuk%20BZ,%20Okamoto%20CT,%20Hamm-Alvarez%20SF.%20Targeting%20receptor-mediated%20endocytotic%20pathways%20with%20nanoparticles:%20rationale%20and%20advances.%20Adv%20Drug%20Deliv%20Rev.%202013;65:121%E2%80%9338." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR111">
<span class="label">111.</span><cite>Nag OK, Delehanty JB. Active cellular and subcellular targeting of nanoparticles for drug delivery. Pharmaceutics. 2019;11:543.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics11100543" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6836276/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31635367/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nag%20OK,%20Delehanty%20JB.%20Active%20cellular%20and%20subcellular%20targeting%20of%20nanoparticles%20for%20drug%20delivery.%20Pharmaceutics.%202019;11:543." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR112">
<span class="label">112.</span><cite>Khan AA, Allemailem KS, Almatroodi SA, Almatroudi A, Rahmani AH. Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications. 3 Biotech. 2020;10: 163.
</cite> [<a href="https://doi.org/10.1007/s13205-020-2144-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7062946/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32206497/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Khan%20AA,%20Allemailem%20KS,%20Almatroodi%20SA,%20Almatroudi%20A,%20Rahmani%20AH.%20Recent%20strategies%20towards%20the%20surface%20modification%20of%20liposomes:%20an%20innovative%20approach%20for%20different%20clinical%20applications.%203%20Biotech.%202020;10:%20163." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR113">
<span class="label">113.</span><cite>Nieto C, Vega MA. Martín Del Valle EM. Trastuzumab: more than a guide in HER2-Positive cancer nanomedicine. Nanomaterials. 2020;10:1674.
</cite> [<a href="https://doi.org/10.3390/nano10091674" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7557948/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32859026/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nieto%20C,%20Vega%20MA.%20Mart%C3%ADn%20Del%20Valle%20EM.%20Trastuzumab:%20more%20than%20a%20guide%20in%20HER2-Positive%20cancer%20nanomedicine.%20Nanomaterials.%202020;10:1674." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR114">
<span class="label">114.</span><cite>Naik H, Sonju JJ, Singh S, Chatzistamou I, Shrestha L, Gauthier T, et al. Lipidated peptidomimetic ligand-functionalized HER2 targeted liposome as nano-carrier designed for doxorubicin delivery in cancer therapy. Pharmaceuticals. 2021;14:221.
</cite> [<a href="https://doi.org/10.3390/ph14030221" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8002094/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33800723/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Naik%20H,%20Sonju%20JJ,%20Singh%20S,%20Chatzistamou%20I,%20Shrestha%20L,%20Gauthier%20T,%20et%20al.%20Lipidated%20peptidomimetic%20ligand-functionalized%20HER2%20targeted%20liposome%20as%20nano-carrier%20designed%20for%20doxorubicin%20delivery%20in%20cancer%20therapy.%20Pharmaceuticals.%202021;14:221." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR115">
<span class="label">115.</span><cite>Nguyen V, Du Min H-K, Kim C-S, Han J, Park J-O, Choi E. Folate receptor-targeted liposomal nanocomplex for effective synergistic photothermal-chemotherapy of breast cancer in vivo. Colloids Surf B Biointerfaces. 2019;173:539–48.
</cite> [<a href="https://doi.org/10.1016/j.colsurfb.2018.10.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30343218/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nguyen%20V,%20Du%20Min%20H-K,%20Kim%20C-S,%20Han%20J,%20Park%20J-O,%20Choi%20E.%20Folate%20receptor-targeted%20liposomal%20nanocomplex%20for%20effective%20synergistic%20photothermal-chemotherapy%20of%20breast%20cancer%20in%20vivo.%20Colloids%20Surf%20B%20Biointerfaces.%202019;173:539%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR116">
<span class="label">116.</span><cite>Lin C, Zhang X, Chen H, Bian Z, Zhang G, Riaz MK, et al. Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide. Drug Deliv. 2018;25:256–66.
</cite> [<a href="https://doi.org/10.1080/10717544.2018.1425777" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6058720/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29334814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin%20C,%20Zhang%20X,%20Chen%20H,%20Bian%20Z,%20Zhang%20G,%20Riaz%20MK,%20et%20al.%20Dual-ligand%20modified%20liposomes%20provide%20effective%20local%20targeted%20delivery%20of%20lung-cancer%20drug%20by%20antibody%20and%20tumor%20lineage-homing%20cell-penetrating%20peptide.%20Drug%20Deliv.%202018;25:256%E2%80%9366." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR117">
<span class="label">117.</span><cite>Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release. 2010;148:135–46.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2010.08.027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20797419/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Danhier%20F,%20Feron%20O,%20Pr%C3%A9at%20V.%20To%20exploit%20the%20tumor%20microenvironment:%20passive%20and%20active%20tumor%20targeting%20of%20nanocarriers%20for%20anti-cancer%20drug%20delivery.%20J%20Control%20Release.%202010;148:135%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR118">
<span class="label">118.</span><cite>Eloy JO, Petrilli R, Trevizan LNF, Chorilli M. Immunoliposomes. A review on functionalization strategies and targets for drug delivery. Colloids Surf B Biointerfaces. 2017;159:454–67.
</cite> [<a href="https://doi.org/10.1016/j.colsurfb.2017.07.085" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28837895/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Eloy%20JO,%20Petrilli%20R,%20Trevizan%20LNF,%20Chorilli%20M.%20Immunoliposomes.%20A%20review%20on%20functionalization%20strategies%20and%20targets%20for%20drug%20delivery.%20Colloids%20Surf%20B%20Biointerfaces.%202017;159:454%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR119">
<span class="label">119.</span><cite>Nsairat H, Mahmoud IS, Odeh F, Abuarqoub D, Al-Azzawi H, Zaza R, et al. Grafting of anti-nucleolin aptamer into preformed and remotely loaded liposomes through aptamer-cholesterol post-insertion. RSC Adv. 2020;10:36219–29.
</cite> [<a href="https://doi.org/10.1039/d0ra07325c" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9056972/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35517091/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nsairat%20H,%20Mahmoud%20IS,%20Odeh%20F,%20Abuarqoub%20D,%20Al-Azzawi%20H,%20Zaza%20R,%20et%20al.%20Grafting%20of%20anti-nucleolin%20aptamer%20into%20preformed%20and%20remotely%20loaded%20liposomes%20through%20aptamer-cholesterol%20post-insertion.%20RSC%20Adv.%202020;10:36219%E2%80%9329." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR120">
<span class="label">120.</span><cite>De Leo V, Milano F, Agostiano A, Catucci L. Recent advancements in polymer/liposome assembly for drug delivery: from surface modifications to hybrid vesicles. Polymers. 2021;13(7): 13:1027.
</cite> [<a href="https://doi.org/10.3390/polym13071027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8037206/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33810273/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?De%20Leo%20V,%20Milano%20F,%20Agostiano%20A,%20Catucci%20L.%20Recent%20advancements%20in%20polymer/liposome%20assembly%20for%20drug%20delivery:%20from%20surface%20modifications%20to%20hybrid%20vesicles.%20Polymers.%202021;13(7):%2013:1027." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR121">
<span class="label">121.</span><cite>Cressey D. Europe sets out to reform its clinical trial rules. Nat Rev Drug Discov. 2012;11:660–1.
</cite> [<a href="https://doi.org/10.1038/nrd3843" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22935791/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cressey%20D.%20Europe%20sets%20out%20to%20reform%20its%20clinical%20trial%20rules.%20Nat%20Rev%20Drug%20Discov.%202012;11:660%E2%80%931." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR122">
<span class="label">122.</span><cite>Espelin CW, Leonard SC, Geretti E, Wickham TJ, Hendriks BS. Dual HER2 targeting with trastuzumab and liposomal-encapsulated doxorubicin (MM-302) demonstrates synergistic antitumor activity in breast and gastric cancer. Cancer Res. 2016;76:1517–27.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-15-1518" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26759238/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Espelin%20CW,%20Leonard%20SC,%20Geretti%20E,%20Wickham%20TJ,%20Hendriks%20BS.%20Dual%20HER2%20targeting%20with%20trastuzumab%20and%20liposomal-encapsulated%20doxorubicin%20(MM-302)%20demonstrates%20synergistic%20antitumor%20activity%20in%20breast%20and%20gastric%20cancer.%20Cancer%20Res.%202016;76:1517%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR123">
<span class="label">123.</span><cite>Du J, Liu X, Sun J, Wu Q, Hu Y, Shi H, et al. Trastuzumab-functionalized bionic pyrotinib liposomes for targeted therapy of HER2-positive breast cancer. Breast Cancer Res. 2024;26:99.
</cite> [<a href="https://doi.org/10.1186/s13058-024-01853-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11167944/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38867302/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Du%20J,%20Liu%20X,%20Sun%20J,%20Wu%20Q,%20Hu%20Y,%20Shi%20H,%20et%20al.%20Trastuzumab-functionalized%20bionic%20pyrotinib%20liposomes%20for%20targeted%20therapy%20of%20HER2-positive%20breast%20cancer.%20Breast%20Cancer%20Res.%202024;26:99." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR124">
<span class="label">124.</span><cite>Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S. Advances and challenges of liposome assisted drug delivery. Front Pharmacol. 2015;6:286.
</cite> [<a href="https://doi.org/10.3389/fphar.2015.00286" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4664963/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26648870/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sercombe%20L,%20Veerati%20T,%20Moheimani%20F,%20Wu%20SY,%20Sood%20AK,%20Hua%20S.%20Advances%20and%20challenges%20of%20liposome%20assisted%20drug%20delivery.%20Front%20Pharmacol.%202015;6:286." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR125">
<span class="label">125.</span><cite>Yan A, Chen X, He J, Ge Y, Liu Q, Men D, et al. Phosphorothioated DNA engineered liposomes as a general platform for stimuli-responsive cell‐specific intracellular delivery and genome editing. Angew Chem. 2023;135(25):e202303973. 10.1002/ange.202303973.</cite> [<a href="https://doi.org/10.1002/anie.202303973" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37100742/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yan%20A,%20Chen%20X,%20He%20J,%20Ge%20Y,%20Liu%20Q,%20Men%20D,%20et%20al.%20Phosphorothioated%20DNA%20engineered%20liposomes%20as%20a%20general%20platform%20for%20stimuli-responsive%20cell%E2%80%90specific%20intracellular%20delivery%20and%20genome%20editing.%20Angew%20Chem.%202023;135(25):e202303973.%2010.1002/ange.202303973." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR126">
<span class="label">126.</span><cite>Grossi LN, Braz WR, da Silva NP, Cazarim ELCC, Palmieri MGS, Tavares GD, et al. Ethosomes as delivery system for treatment of melanoma: a mini-review. Oncologie. 2023;25:455–9.</cite> [<a href="https://scholar.google.com/scholar_lookup?Grossi%20LN,%20Braz%20WR,%20da%20Silva%20NP,%20Cazarim%20ELCC,%20Palmieri%20MGS,%20Tavares%20GD,%20et%20al.%20Ethosomes%20as%20delivery%20system%20for%20treatment%20of%20melanoma:%20a%20mini-review.%20Oncologie.%202023;25:455%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR127">
<span class="label">127.</span><cite>Abu-Huwaij R, Zidan AN. Unlocking the potential of cosmetic dermal delivery with ethosomes: a comprehensive review. J Cosmet Dermatol. 2024;23:17–26.
</cite> [<a href="https://doi.org/10.1111/jocd.15895" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37393573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Abu-Huwaij%20R,%20Zidan%20AN.%20Unlocking%20the%20potential%20of%20cosmetic%20dermal%20delivery%20with%20ethosomes:%20a%20comprehensive%20review.%20J%20Cosmet%20Dermatol.%202024;23:17%E2%80%9326." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR128">
<span class="label">128.</span><cite>Devaki J, Pavuluri S, Suma N, Ethosomes. A vesicular carrier as a novel tool for transdermal drug delivery system. J Drug Deliv Ther. 2023;13:159–64.</cite> [<a href="https://scholar.google.com/scholar_lookup?Devaki%20J,%20Pavuluri%20S,%20Suma%20N,%20Ethosomes.%20A%20vesicular%20carrier%20as%20a%20novel%20tool%20for%20transdermal%20drug%20delivery%20system.%20J%20Drug%20Deliv%20Ther.%202023;13:159%E2%80%9364." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR129">
<span class="label">129.</span><cite>Verma S, Singh A, Jakhmola V. Ethosomes loaded with spiranolactone for acne treatment through topical gel formulation. Res J Pharm Technol. 2023;1219–24.</cite>
</li>
<li id="CR130">
<span class="label">130.</span><cite>Khanam S, Sheel S, Biswas P, Karmakar V. Ethosome as a potential transdermal drug delivery system. Journal of Pharmaceutical and Biological Sciences. 2023;10:72–8.</cite> [<a href="https://scholar.google.com/scholar_lookup?Khanam%20S,%20Sheel%20S,%20Biswas%20P,%20Karmakar%20V.%20Ethosome%20as%20a%20potential%20transdermal%20drug%20delivery%20system.%20Journal%20of%20Pharmaceutical%20and%20Biological%20Sciences.%202023;10:72%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR131">
<span class="label">131.</span><cite>Pola KK, Kumar Rada S. An overview on ultra-deformable vesicular drug delivery systems in transdermal drug delivery. Int J Appl Pharm 2023;28–34.</cite>
</li>
<li id="CR132">
<span class="label">132.</span><cite>Raj A, Dua K, Nair RS, Sarath Chandran C, Alex AT. Transethosome: an ultra-deformable ethanolic vesicle for enhanced transdermal drug delivery. Chem Phys Lipids. 2023;255: 105315.
</cite> [<a href="https://doi.org/10.1016/j.chemphyslip.2023.105315" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37356610/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Raj%20A,%20Dua%20K,%20Nair%20RS,%20Sarath%20Chandran%20C,%20Alex%20AT.%20Transethosome:%20an%20ultra-deformable%20ethanolic%20vesicle%20for%20enhanced%20transdermal%20drug%20delivery.%20Chem%20Phys%20Lipids.%202023;255:%20105315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR133">
<span class="label">133.</span><cite>Nayak BS, Mohanty B, Mishra B, Roy H, Nandi S. Transethosomes. Cutting edge approach for drug permeation enhancement in transdermal drug delivery system. Chem Biol Drug Des. 2023;102:653–67.
</cite> [<a href="https://doi.org/10.1111/cbdd.14254" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37062593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nayak%20BS,%20Mohanty%20B,%20Mishra%20B,%20Roy%20H,%20Nandi%20S.%20Transethosomes.%20Cutting%20edge%20approach%20for%20drug%20permeation%20enhancement%20in%20transdermal%20drug%20delivery%20system.%20Chem%20Biol%20Drug%20Des.%202023;102:653%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR134">
<span class="label">134.</span><cite>Zafar A, Asim-ur-Rehman, Ahmed N. Nanovesicles for target specific drug delivery. Appl Nanovesicular Drug Deliv. Elsevier; 2022. pp. 149–65.</cite>
</li>
<li id="CR135">
<span class="label">135.</span><cite>Xu X, Costa A, Burgess DJ. Protein encapsulation in unilamellar liposomes: high encapsulation efficiency and a novel technique to assess lipid-protein interaction. Pharm Res. 2012;29:1919–31.
</cite> [<a href="https://doi.org/10.1007/s11095-012-0720-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22403024/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20X,%20Costa%20A,%20Burgess%20DJ.%20Protein%20encapsulation%20in%20unilamellar%20liposomes:%20high%20encapsulation%20efficiency%20and%20a%20novel%20technique%20to%20assess%20lipid-protein%20interaction.%20Pharm%20Res.%202012;29:1919%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR136">
<span class="label">136.</span><cite>Large DE, Abdelmessih RG, Fink EA, Auguste DT. Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv Drug Deliv Rev. 2021;176: 113851.
</cite> [<a href="https://doi.org/10.1016/j.addr.2021.113851" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34224787/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Large%20DE,%20Abdelmessih%20RG,%20Fink%20EA,%20Auguste%20DT.%20Liposome%20composition%20in%20drug%20delivery%20design,%20synthesis,%20characterization,%20and%20clinical%20application.%20Adv%20Drug%20Deliv%20Rev.%202021;176:%20113851." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR137">
<span class="label">137.</span><cite>Mayer LD, Bally MB, Hope MJ, Cullis PR. Techniques for encapsulating bioactive agents into liposomes. Chem Phys Lipids. 1986;40:333–45.
</cite> [<a href="https://doi.org/10.1016/0009-3084(86)90077-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3742676/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mayer%20LD,%20Bally%20MB,%20Hope%20MJ,%20Cullis%20PR.%20Techniques%20for%20encapsulating%20bioactive%20agents%20into%20liposomes.%20Chem%20Phys%20Lipids.%201986;40:333%E2%80%9345." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR138">
<span class="label">138.</span><cite>Illum L, Thomas NW, Davis SS. Effect of a selected suppression of the reticuloendothelial system on the distribution of model carrier particles. J Pharm Sci. 1986;75:16–22.
</cite> [<a href="https://doi.org/10.1002/jps.2600750105" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2420964/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Illum%20L,%20Thomas%20NW,%20Davis%20SS.%20Effect%20of%20a%20selected%20suppression%20of%20the%20reticuloendothelial%20system%20on%20the%20distribution%20of%20model%20carrier%20particles.%20J%20Pharm%20Sci.%201986;75:16%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR139">
<span class="label">139.</span><cite>Senior J, Delgado C, Fisher D, Tilcock C, Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta - Biomembr. 1991;1062:77–82.</cite> [<a href="https://doi.org/10.1016/0005-2736(91)90337-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1998713/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Senior%20J,%20Delgado%20C,%20Fisher%20D,%20Tilcock%20C,%20Gregoriadis%20G.%20Influence%20of%20surface%20hydrophilicity%20of%20liposomes%20on%20their%20interaction%20with%20plasma%20protein%20and%20clearance%20from%20the%20circulation:%20studies%20with%20poly(ethylene%20glycol)-coated%20vesicles.%20Biochim%20Biophys%20Acta%20-%20Biomembr.%201991;1062:77%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR140">
<span class="label">140.</span><cite>Finkelstein MC, Kuhn SH, Schieren H, Weissmann G, Hoffstein S. Liposome uptake by human leukocytes. Biochim Biophys Acta-Gen Subj. 1981;673:286–302.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/7225420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Finkelstein%20MC,%20Kuhn%20SH,%20Schieren%20H,%20Weissmann%20G,%20Hoffstein%20S.%20Liposome%20uptake%20by%20human%20leukocytes.%20Biochim%20Biophys%20Acta-Gen%20Subj.%201981;673:286%E2%80%93302." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR141">
<span class="label">141.</span><cite>Schieren H, Rudolph S, Finkelstein M, Coleman P, Weissmann G. Comparison of large unilamellar vesicles prepared by a petroleum ether vaporization method with multilamellar vesicles. Biochim Biophys Acta - Gen Subj. 1978;542:137–53.</cite> [<a href="https://doi.org/10.1016/0304-4165(78)90240-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/208648/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schieren%20H,%20Rudolph%20S,%20Finkelstein%20M,%20Coleman%20P,%20Weissmann%20G.%20Comparison%20of%20large%20unilamellar%20vesicles%20prepared%20by%20a%20petroleum%20ether%20vaporization%20method%20with%20multilamellar%20vesicles.%20Biochim%20Biophys%20Acta%20-%20Gen%20Subj.%201978;542:137%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR142">
<span class="label">142.</span><cite>Daemen T, Hofstede G, Ten Kate MT, Bakker-Woudenberg IAJM, Scherphof GL. Liposomal doxorubicin‐induced toxicity: depletion and impairment of phagocytic activity of liver macrophages. Int J Cancer. 1995;61:716–21.
</cite> [<a href="https://doi.org/10.1002/ijc.2910610520" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7768646/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Daemen%20T,%20Hofstede%20G,%20Ten%20Kate%20MT,%20Bakker-Woudenberg%20IAJM,%20Scherphof%20GL.%20Liposomal%20doxorubicin%E2%80%90induced%20toxicity:%20depletion%20and%20impairment%20of%20phagocytic%20activity%20of%20liver%20macrophages.%20Int%20J%20Cancer.%201995;61:716%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR143">
<span class="label">143.</span><cite>Hu H, Ding J, Zhang S, Li Y, Bai L, Yuan N. Photodeposition of Ag2S on TiO2 nanorod arrays for quantum dot-sensitized solar cells. Nanoscale Res Lett. 2013;8:10.
</cite> [<a href="https://doi.org/10.1186/1556-276X-8-10" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3552843/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23286551/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20H,%20Ding%20J,%20Zhang%20S,%20Li%20Y,%20Bai%20L,%20Yuan%20N.%20Photodeposition%20of%20Ag2S%20on%20TiO2%20nanorod%20arrays%20for%20quantum%20dot-sensitized%20solar%20cells.%20Nanoscale%20Res%20Lett.%202013;8:10." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR144">
<span class="label">144.</span><cite>Llu L, Yonetani T. Preparation and characterization of liposome-encapsulated haemoglobin by a freeze-thaw method. J Microencapsul. 1994;11:409–21.
</cite> [<a href="https://doi.org/10.3109/02652049409034258" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7931940/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Llu%20L,%20Yonetani%20T.%20Preparation%20and%20characterization%20of%20liposome-encapsulated%20haemoglobin%20by%20a%20freeze-thaw%20method.%20J%20Microencapsul.%201994;11:409%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR145">
<span class="label">145.</span><cite>Pick U. Liposomes with a large trapping capacity prepared by freezing and thawing of sonicated phospholipid mixtures. Arch Biochem Biophys. 1981;212:186–94.
</cite> [<a href="https://doi.org/10.1016/0003-9861(81)90358-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7197900/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pick%20U.%20Liposomes%20with%20a%20large%20trapping%20capacity%20prepared%20by%20freezing%20and%20thawing%20of%20sonicated%20phospholipid%20mixtures.%20Arch%20Biochem%20Biophys.%201981;212:186%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR146">
<span class="label">146.</span><cite>Song H, Geng H, Ruan J, Wang K, Bao C, Wang J, et al. Development of polysorbate 80/phospholipid mixed micellar formation for docetaxel and assessment of its in vivo distribution in animal models. Nanoscale Res Lett. 2011;6:354.
</cite> [<a href="https://doi.org/10.1186/1556-276X-6-354" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3211444/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21711889/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Song%20H,%20Geng%20H,%20Ruan%20J,%20Wang%20K,%20Bao%20C,%20Wang%20J,%20et%20al.%20Development%20of%20polysorbate%2080/phospholipid%20mixed%20micellar%20formation%20for%20docetaxel%20and%20assessment%20of%20its%20in%20vivo%20distribution%20in%20animal%20models.%20Nanoscale%20Res%20Lett.%202011;6:354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR147">
<span class="label">147.</span><cite>Hazel JR, Williams EE, Livermore R, Mozingo N. Thermal adaptation in biological membranes: functional significance of changes in phospholipid molecular species composition. Lipids. 1991;26:277–82.
</cite> [<a href="https://doi.org/10.1007/BF02537137" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1865763/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hazel%20JR,%20Williams%20EE,%20Livermore%20R,%20Mozingo%20N.%20Thermal%20adaptation%20in%20biological%20membranes:%20functional%20significance%20of%20changes%20in%20phospholipid%20molecular%20species%20composition.%20Lipids.%201991;26:277%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR148">
<span class="label">148.</span><cite>Bally MB, Mayer LD, Loughrey H, Redelmeier T, Madden TD, Wong K, et al. Dopamine accumulation in large unilamellar vesicle systems induced by transmembrane ion gradients. Chem Phys Lipids. 1988;47:97–107.
</cite> [<a href="https://doi.org/10.1016/0009-3084(88)90078-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2457454/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bally%20MB,%20Mayer%20LD,%20Loughrey%20H,%20Redelmeier%20T,%20Madden%20TD,%20Wong%20K,%20et%20al.%20Dopamine%20accumulation%20in%20large%20unilamellar%20vesicle%20systems%20induced%20by%20transmembrane%20ion%20gradients.%20Chem%20Phys%20Lipids.%201988;47:97%E2%80%93107." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR149">
<span class="label">149.</span><cite>Mayer LD, Bally MB, Hope MJ, Cullis PR. Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. Biochimica et Biophysica Acta (BBA). 1985;816:294–302.
</cite> [<a href="https://doi.org/10.1016/0005-2736(85)90497-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3839135/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mayer%20LD,%20Bally%20MB,%20Hope%20MJ,%20Cullis%20PR.%20Uptake%20of%20antineoplastic%20agents%20into%20large%20unilamellar%20vesicles%20in%20response%20to%20a%20membrane%20potential.%20Biochimica%20et%20Biophysica%20Acta%20(BBA).%201985;816:294%E2%80%93302." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR150">
<span class="label">150.</span><cite>Gallois L, Fiallo M, Garnier-Suillerot A. Comparison of the interaction of doxorubicin, daunorubicin, Idarubicin and Idarubicinol with large unilamellar vesicles. Biochimica et Biophysica Acta (BBA). 1998;1370:31–40.
</cite> [<a href="https://doi.org/10.1016/s0005-2736(97)00241-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9518541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gallois%20L,%20Fiallo%20M,%20Garnier-Suillerot%20A.%20Comparison%20of%20the%20interaction%20of%20doxorubicin,%20daunorubicin,%20Idarubicin%20and%20Idarubicinol%20with%20large%20unilamellar%20vesicles.%20Biochimica%20et%20Biophysica%20Acta%20(BBA).%201998;1370:31%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR151">
<span class="label">151.</span><cite>Deamer DW, Prince RC, Crofts AR. The response of fluorescent amines to pH gradients across liposome membranes. Biochimica et Biophysica Acta (BBA). 1972;274:323–35.
</cite> [<a href="https://doi.org/10.1016/0005-2736(72)90180-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/5049001/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deamer%20DW,%20Prince%20RC,%20Crofts%20AR.%20The%20response%20of%20fluorescent%20amines%20to%20pH%20gradients%20across%20liposome%20membranes.%20Biochimica%20et%20Biophysica%20Acta%20(BBA).%201972;274:323%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR152">
<span class="label">152.</span><cite>Johnston MJW, Semple SC, Klimuk SK, Edwards K, Eisenhardt ML, Leng EC, et al. Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations. Biochimica et Biophysica Acta (BBA). 2006;1758:55–64.
</cite> [<a href="https://doi.org/10.1016/j.bbamem.2006.01.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16487476/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Johnston%20MJW,%20Semple%20SC,%20Klimuk%20SK,%20Edwards%20K,%20Eisenhardt%20ML,%20Leng%20EC,%20et%20al.%20Therapeutically%20optimized%20rates%20of%20drug%20release%20can%20be%20achieved%20by%20varying%20the%20drug-to-lipid%20ratio%20in%20liposomal%20vincristine%20formulations.%20Biochimica%20et%20Biophysica%20Acta%20(BBA).%202006;1758:55%E2%80%9364." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR153">
<span class="label">153.</span><cite>Yu JY, Chuesiang P, Shin GH, Park HJ. Post-processing techniques for the improvement of liposome stability. Pharmaceutics. 2021;13:1023.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics13071023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8309137/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34371715/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu%20JY,%20Chuesiang%20P,%20Shin%20GH,%20Park%20HJ.%20Post-processing%20techniques%20for%20the%20improvement%20of%20liposome%20stability.%20Pharmaceutics.%202021;13:1023." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR154">
<span class="label">154.</span><cite>Giannopoulos-Dimitriou A, Saiti A, Petrou A, Vizirianakis IS, Fatouros DG. Liposome stability and integrity. Liposomes Drug Deliv. Elsevier; 2024. pp. 89–121.</cite>
</li>
<li id="CR155">
<span class="label">155.</span><cite>Xu X, Tian F, Pan Y, Zhang T, Deng L, Jiang H, et al. Emerging mechanistic insights into liposomal stability: full process management from production and storage to food application. Chem Eng J. 2025;505: 159552.</cite> [<a href="https://scholar.google.com/scholar_lookup?Xu%20X,%20Tian%20F,%20Pan%20Y,%20Zhang%20T,%20Deng%20L,%20Jiang%20H,%20et%20al.%20Emerging%20mechanistic%20insights%20into%20liposomal%20stability:%20full%20process%20management%20from%20production%20and%20storage%20to%20food%20application.%20Chem%20Eng%20J.%202025;505:%20159552." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR156">
<span class="label">156.</span><cite>Chen L, Wu Z, Wu X, Liao Y, Dai X, Shi X. The application of coarse-grained molecular dynamics to the evaluation of liposome physical stability. AAPS PharmSciTech. 2020;21:138.
</cite> [<a href="https://doi.org/10.1208/s12249-020-01680-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32419093/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20L,%20Wu%20Z,%20Wu%20X,%20Liao%20Y,%20Dai%20X,%20Shi%20X.%20The%20application%20of%20coarse-grained%20molecular%20dynamics%20to%20the%20evaluation%20of%20liposome%20physical%20stability.%20AAPS%20PharmSciTech.%202020;21:138." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR157">
<span class="label">157.</span><cite>Tai K, Rappolt M, He X, Wei Y, Zhu S, Zhang J, et al. Effect of β-sitosterol on the curcumin-loaded liposomes: vesicle characteristics, physicochemical stability, in vitro release and bioavailability. Food Chem. 2019;293:92–102.
</cite> [<a href="https://doi.org/10.1016/j.foodchem.2019.04.077" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31151654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tai%20K,%20Rappolt%20M,%20He%20X,%20Wei%20Y,%20Zhu%20S,%20Zhang%20J,%20et%20al.%20Effect%20of%20%CE%B2-sitosterol%20on%20the%20curcumin-loaded%20liposomes:%20vesicle%20characteristics,%20physicochemical%20stability,%20in%20vitro%20release%20and%20bioavailability.%20Food%20Chem.%202019;293:92%E2%80%93102." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR158">
<span class="label">158.</span><cite>Ingle SG, Pai RV, Monpara JD, Vavia PR. Liposils: an effective strategy for stabilizing Paclitaxel loaded liposomes by surface coating with silica. Eur J Pharm Sci. 2018;122:51–63.
</cite> [<a href="https://doi.org/10.1016/j.ejps.2018.06.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29936087/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ingle%20SG,%20Pai%20RV,%20Monpara%20JD,%20Vavia%20PR.%20Liposils:%20an%20effective%20strategy%20for%20stabilizing%20Paclitaxel%20loaded%20liposomes%20by%20surface%20coating%20with%20silica.%20Eur%20J%20Pharm%20Sci.%202018;122:51%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR159">
<span class="label">159.</span><cite>Maritim S, Boulas P, Lin Y. Comprehensive analysis of liposome formulation parameters and their influence on encapsulation, stability and drug release in Glibenclamide liposomes. Int J Pharm. 2021;592: 120051.
</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2020.120051" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33161039/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maritim%20S,%20Boulas%20P,%20Lin%20Y.%20Comprehensive%20analysis%20of%20liposome%20formulation%20parameters%20and%20their%20influence%20on%20encapsulation,%20stability%20and%20drug%20release%20in%20Glibenclamide%20liposomes.%20Int%20J%20Pharm.%202021;592:%20120051." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR160">
<span class="label">160.</span><cite>Metherel AH, Hogg RC, Buzikievich LM, Stark KD. Butylated hydroxytoluene can protect polyunsaturated fatty acids in dried blood spots from degradation for up to 8 weeks at room temperature. Lipids Health Dis. 2013;12:22. 10.1186/1476-511X-12-22.
</cite> [<a href="https://doi.org/10.1186/1476-511X-12-22" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3599643/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23425563/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Metherel%20AH,%20Hogg%20RC,%20Buzikievich%20LM,%20Stark%20KD.%20Butylated%20hydroxytoluene%20can%20protect%20polyunsaturated%20fatty%20acids%20in%20dried%20blood%20spots%20from%20degradation%20for%20up%20to%208%20weeks%20at%20room%20temperature.%20Lipids%20Health%20Dis.%202013;12:22.%2010.1186/1476-511X-12-22." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR161">
<span class="label">161.</span><cite>Scarpa M, Rigo A, Maiorino M, Ursini F. Formation of α-tocopherol radical and recycling of α-tocopherol by ascorbate during peroxidation of phosphatidylcholine liposomesan electron paramagnetic resonance study. Biochimica et Biophysica Acta (BBA). 1984;801:215–9.
</cite> [<a href="https://doi.org/10.1016/0304-4165(84)90070-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6089911/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Scarpa%20M,%20Rigo%20A,%20Maiorino%20M,%20Ursini%20F.%20Formation%20of%20%CE%B1-tocopherol%20radical%20and%20recycling%20of%20%CE%B1-tocopherol%20by%20ascorbate%20during%20peroxidation%20of%20phosphatidylcholine%20liposomesan%20electron%20paramagnetic%20resonance%20study.%20Biochimica%20et%20Biophysica%20Acta%20(BBA).%201984;801:215%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR162">
<span class="label">162.</span><cite>Alihosseini F, Ghaffari S, Dabirsiaghi AR, Haghighat S. Freeze-drying of ampicillin solid lipid nanoparticles using mannitol as cryoprotectant. Braz J Pharm Sci. 2015;51:797–802.</cite> [<a href="https://scholar.google.com/scholar_lookup?Alihosseini%20F,%20Ghaffari%20S,%20Dabirsiaghi%20AR,%20Haghighat%20S.%20Freeze-drying%20of%20ampicillin%20solid%20lipid%20nanoparticles%20using%20mannitol%20as%20cryoprotectant.%20Braz%20J%20Pharm%20Sci.%202015;51:797%E2%80%93802." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR163">
<span class="label">163.</span><cite>van Winden EC. Freeze-Drying of Liposomes: Theory and Practice. 2003. pp. 99–110.</cite> [<a href="https://doi.org/10.1016/S0076-6879(03)67008-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14611061/" class="usa-link">PubMed</a>]</li>
<li id="CR164">
<span class="label">164.</span><cite>Franzé S, Selmin F, Samaritani E, Minghetti P, Cilurzo F. Lyophilization of liposomal formulations: still necessary, still challenging. Pharmaceutics. 2018;10:139.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics10030139" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6161153/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30154315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Franz%C3%A9%20S,%20Selmin%20F,%20Samaritani%20E,%20Minghetti%20P,%20Cilurzo%20F.%20Lyophilization%20of%20liposomal%20formulations:%20still%20necessary,%20still%20challenging.%20Pharmaceutics.%202018;10:139." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR165">
<span class="label">165.</span><cite>Vishali DA, Monisha J, Sivakamasundari SK, Moses JA, Anandharamakrishnan C. Spray freeze drying: emerging applications in drug delivery. J Control Release. 2019;300:93–101.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2019.02.044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30836115/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vishali%20DA,%20Monisha%20J,%20Sivakamasundari%20SK,%20Moses%20JA,%20Anandharamakrishnan%20C.%20Spray%20freeze%20drying:%20emerging%20applications%20in%20drug%20delivery.%20J%20Control%20Release.%202019;300:93%E2%80%93101." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR166">
<span class="label">166.</span><cite>Ingvarsson PT, Yang M, Nielsen HM, Rantanen J, Foged C. Stabilization of liposomes during drying. Expert Opin Drug Deliv. 2011;8:375–88.
</cite> [<a href="https://doi.org/10.1517/17425247.2011.553219" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21294603/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ingvarsson%20PT,%20Yang%20M,%20Nielsen%20HM,%20Rantanen%20J,%20Foged%20C.%20Stabilization%20of%20liposomes%20during%20drying.%20Expert%20Opin%20Drug%20Deliv.%202011;8:375%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR167">
<span class="label">167.</span><cite>Ramana LN, Sethuraman S, Ranga U, Krishnan UM. Development of a liposomal nanodelivery system for nevirapine. J Biomed Sci. 2010;17:57.
</cite> [<a href="https://doi.org/10.1186/1423-0127-17-57" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2914021/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20624325/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ramana%20LN,%20Sethuraman%20S,%20Ranga%20U,%20Krishnan%20UM.%20Development%20of%20a%20liposomal%20nanodelivery%20system%20for%20nevirapine.%20J%20Biomed%20Sci.%202010;17:57." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR168">
<span class="label">168.</span><cite>Li J, Wang Q, Xia G, Adilijiang N, Li Y, Hou Z, et al. Recent advances in targeted drug delivery strategy for enhancing oncotherapy. Pharmaceutics. 2023;15:2233.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics15092233" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10534854/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37765202/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20J,%20Wang%20Q,%20Xia%20G,%20Adilijiang%20N,%20Li%20Y,%20Hou%20Z,%20et%20al.%20Recent%20advances%20in%20targeted%20drug%20delivery%20strategy%20for%20enhancing%20oncotherapy.%20Pharmaceutics.%202023;15:2233." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR169">
<span class="label">169.</span><cite>Uikey Dilip Kumar, Shende Shubham Maroti. Review on brain-targeted drug delivery. World J Adv Res Rev. 2023;18:1489–94.</cite> [<a href="https://scholar.google.com/scholar_lookup?Uikey%20Dilip%20Kumar,%20Shende%20Shubham%20Maroti.%20Review%20on%20brain-targeted%20drug%20delivery.%20World%20J%20Adv%20Res%20Rev.%202023;18:1489%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR170">
<span class="label">170.</span><cite>Chaudhari D, Mali DD, Chaudhari S. V. A short review on recent approches in targeted drug dilvairy system (TDDS). Asian J Res Pharm Sci. 2023;45–8.</cite>
</li>
<li id="CR171">
<span class="label">171.</span><cite>Cheng X, Xie Q, Sun Y. Advances in nanomaterial-based targeted drug delivery systems. Front Bioeng Biotechnol. 2023;11:1177151. 10.3389/fbioe.2023.1177151.
</cite> [<a href="https://doi.org/10.3389/fbioe.2023.1177151" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10133513/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37122851/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheng%20X,%20Xie%20Q,%20Sun%20Y.%20Advances%20in%20nanomaterial-based%20targeted%20drug%20delivery%20systems.%20Front%20Bioeng%20Biotechnol.%202023;11:1177151.%2010.3389/fbioe.2023.1177151." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR172">
<span class="label">172.</span><cite>Batra U, Waghule T, Saha RN, Singhvi G. Liposomal drug delivery. Nanoparticles Nanocarriers-Based pharm Formul. BENTHAM SCIENCE; 2022. pp. 303–32.</cite>
</li>
<li id="CR173">
<span class="label">173.</span><cite>Mundargi RC, Taneja N, Hadia JJ, Khopade AJ. Liposomes as Targeted Drug-Delivery Systems. 2022. pp. 69–125.</cite>
</li>
<li id="CR174">
<span class="label">174.</span><cite>Dewangan P, Mourya A, Singh PK, Chaudhary M, Sharma R, Bajwa N, et al. Drug delivery: the conceptual perspectives and therapeutic applications. Polym Conjug. Elsevier; 2023. pp. 1–38.</cite>
</li>
<li id="CR175">
<span class="label">175.</span><cite>Vesvoranan O, Liu BS, Zheng Y, Wagner WL, Sutlive J, Chen Z, et al. Active loading of pectin hydrogels for targeted drug delivery. Polymers. 2022;15: 92.
</cite> [<a href="https://doi.org/10.3390/polym15010092" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9824191/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36616442/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vesvoranan%20O,%20Liu%20BS,%20Zheng%20Y,%20Wagner%20WL,%20Sutlive%20J,%20Chen%20Z,%20et%20al.%20Active%20loading%20of%20pectin%20hydrogels%20for%20targeted%20drug%20delivery.%20Polymers.%202022;15:%2092." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR176">
<span class="label">176.</span><cite>Doshi KA. Basics of Targeted Drug Delivery. 2022. pp. 1–19.</cite>
</li>
<li id="CR177">
<span class="label">177.</span><cite>Li X, Luo JQ, Liao XQ, Zhang S, Yang LF, Wu T, et al. Allicin inhibits the growth of HONE-1 and HNE1 human nasopharyngeal carcinoma cells by inducing ferroptosis. Neoplasma. 2024;71:243–54.
</cite> [<a href="https://doi.org/10.4149/neo_2024_240108N8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38958714/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20X,%20Luo%20JQ,%20Liao%20XQ,%20Zhang%20S,%20Yang%20LF,%20Wu%20T,%20et%20al.%20Allicin%20inhibits%20the%20growth%20of%20HONE-1%20and%20HNE1%20human%20nasopharyngeal%20carcinoma%20cells%20by%20inducing%20ferroptosis.%20Neoplasma.%202024;71:243%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR178">
<span class="label">178.</span><cite>Azizi M, Kokabi H, Dianat-Moghadam H, Mehrmohammadi M. Passive targeting. Target Cancer Imaging. Elsevier; 2022. pp. 37–47.</cite>
</li>
<li id="CR179">
<span class="label">179.</span><cite>Gupta S, Bansal R, Gupta S, Jindal N, Jindal A. Nanocarriers and nanoparticles for skin care and dermatological treatments. Indian Dermatol Online J. 2013;4:267.
</cite> [<a href="https://doi.org/10.4103/2229-5178.120635" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3853888/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24350003/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gupta%20S,%20Bansal%20R,%20Gupta%20S,%20Jindal%20N,%20Jindal%20A.%20Nanocarriers%20and%20nanoparticles%20for%20skin%20care%20and%20dermatological%20treatments.%20Indian%20Dermatol%20Online%20J.%202013;4:267." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR180">
<span class="label">180.</span><cite>Ruiz VH, Encinas-Basurto D, Sun B, Eedara BB, Dickinson SE, Wondrak GT, et al. Design, physicochemical characterization, and in vitro permeation of innovative resatorvid topical formulations for targeted skin drug delivery. Pharmaceutics. 2022;14:700.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics14040700" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9026853/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35456534/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ruiz%20VH,%20Encinas-Basurto%20D,%20Sun%20B,%20Eedara%20BB,%20Dickinson%20SE,%20Wondrak%20GT,%20et%20al.%20Design,%20physicochemical%20characterization,%20and%20in%20vitro%20permeation%20of%20innovative%20resatorvid%20topical%20formulations%20for%20targeted%20skin%20drug%20delivery.%20Pharmaceutics.%202022;14:700." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR181">
<span class="label">181.</span><cite>Schneider-Rauber G, Argenta DF, Caon T. Emerging technologies to target drug delivery to the skin – the role of crystals and carrier-based systems in the case study of Dapsone. Pharm Res. 2020;37:240.
</cite> [<a href="https://doi.org/10.1007/s11095-020-02951-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33169237/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schneider-Rauber%20G,%20Argenta%20DF,%20Caon%20T.%20Emerging%20technologies%20to%20target%20drug%20delivery%20to%20the%20skin%20%E2%80%93%20the%20role%20of%20crystals%20and%20carrier-based%20systems%20in%20the%20case%20study%20of%20Dapsone.%20Pharm%20Res.%202020;37:240." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR182">
<span class="label">182.</span><cite>Ashton R, Leppard B. Differential diagnosis in dermatology. CRC; 2021.</cite>
</li>
<li id="CR183">
<span class="label">183.</span><cite>Yang J, Zhu J, Lu S, Qin H, Zhou W. Transdermal psoriasis treatment inspired by tumor microenvironment-mediated immunomodulation and advanced by exosomal engineering. J Control Release. 2025 ;382:113664. 10.1016/j.jconrel.2025.113664.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2025.113664" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40147535/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20J,%20Zhu%20J,%20Lu%20S,%20Qin%20H,%20Zhou%20W.%20Transdermal%20psoriasis%20treatment%20inspired%20by%20tumor%20microenvironment-mediated%20immunomodulation%20and%20advanced%20by%20exosomal%20engineering.%20J%20Control%20Release.%202025%20;382:113664.%2010.1016/j.jconrel.2025.113664." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR184">
<span class="label">184.</span><cite>Celebi Sozener Z, Ozdel Ozturk B, Cerci P, Turk M, Gorgulu Akin B, Akdis M, et al. Epithelial barrier hypothesis: effect of the external exposome on the microbiome and epithelial barriers in allergic disease. Allergy. 2022;77:1418–49.
</cite> [<a href="https://doi.org/10.1111/all.15240" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9306534/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35108405/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Celebi%20Sozener%20Z,%20Ozdel%20Ozturk%20B,%20Cerci%20P,%20Turk%20M,%20Gorgulu%20Akin%20B,%20Akdis%20M,%20et%20al.%20Epithelial%20barrier%20hypothesis:%20effect%20of%20the%20external%20exposome%20on%20the%20microbiome%20and%20epithelial%20barriers%20in%20allergic%20disease.%20Allergy.%202022;77:1418%E2%80%9349." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR185">
<span class="label">185.</span><cite>Elias PM, Wood LC, Feingold KR. Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermat. 1999;10:119–26.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10444104/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Elias%20PM,%20Wood%20LC,%20Feingold%20KR.%20Epidermal%20pathogenesis%20of%20inflammatory%20dermatoses.%20Am%20J%20Contact%20Dermat.%201999;10:119%E2%80%9326." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR186">
<span class="label">186.</span><cite>Kumari K, Nandi A, Sinha A, Ghosh A, Sengupta S, Saha U, et al. The paradigm of prophylactic viral outbreaks measures by microbial biosurfactants. J Infect Public Health. 2023;16:575–87.
</cite> [<a href="https://doi.org/10.1016/j.jiph.2023.02.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9940476/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36840992/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kumari%20K,%20Nandi%20A,%20Sinha%20A,%20Ghosh%20A,%20Sengupta%20S,%20Saha%20U,%20et%20al.%20The%20paradigm%20of%20prophylactic%20viral%20outbreaks%20measures%20by%20microbial%20biosurfactants.%20J%20Infect%20Public%20Health.%202023;16:575%E2%80%9387." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR187">
<span class="label">187.</span><cite>Zarreen Simnani F, Singh D, Patel P, Choudhury A, Sinha A, Nandi A, et al. Nanocarrier vaccine therapeutics for global infectious and chronic diseases. Mater Today. 2023;66:371–408.</cite> [<a href="https://scholar.google.com/scholar_lookup?Zarreen%20Simnani%20F,%20Singh%20D,%20Patel%20P,%20Choudhury%20A,%20Sinha%20A,%20Nandi%20A,%20et%20al.%20Nanocarrier%20vaccine%20therapeutics%20for%20global%20infectious%20and%20chronic%20diseases.%20Mater%20Today.%202023;66:371%E2%80%93408." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR188">
<span class="label">188.</span><cite>Polkowska-Pruszyńska B, Gerkowicz A, Krasowska D. The gut microbiome alterations in allergic and inflammatory skin diseases – an update. J Eur Acad Dermatol Venereol. 2020;34:455–64.
</cite> [<a href="https://doi.org/10.1111/jdv.15951" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31520544/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Polkowska-Pruszy%C5%84ska%20B,%20Gerkowicz%20A,%20Krasowska%20D.%20The%20gut%20microbiome%20alterations%20in%20allergic%20and%20inflammatory%20skin%20diseases%20%E2%80%93%20an%20update.%20J%20Eur%20Acad%20Dermatol%20Venereol.%202020;34:455%E2%80%9364." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR189">
<span class="label">189.</span><cite>Cappiello F, Liu H, Editorial. Recent advances in skin disorders: from basic mechanisms to therapies. Front Cell Dev Biol. 2024;12.</cite> [<a href="https://doi.org/10.3389/fcell.2024.1379183" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10933044/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38481528/" class="usa-link">PubMed</a>]</li>
<li id="CR190">
<span class="label">190.</span><cite>Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol. 2009;129:1892–908.
</cite> [<a href="https://doi.org/10.1038/jid.2009.133" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19494826/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cork%20MJ,%20Danby%20SG,%20Vasilopoulos%20Y,%20Hadgraft%20J,%20Lane%20ME,%20Moustafa%20M,%20et%20al.%20Epidermal%20barrier%20dysfunction%20in%20atopic%20dermatitis.%20J%20Invest%20Dermatol.%202009;129:1892%E2%80%93908." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR191">
<span class="label">191.</span><cite>Donnelly RF, Singh TRR, Garland MJ, Migalska K, Majithiya R, McCrudden CM, et al. Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery. Adv Funct Mater. 2012;22:4879–90.
</cite> [<a href="https://doi.org/10.1002/adfm.201200864" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3627464/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23606824/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Donnelly%20RF,%20Singh%20TRR,%20Garland%20MJ,%20Migalska%20K,%20Majithiya%20R,%20McCrudden%20CM,%20et%20al.%20Hydrogel-forming%20microneedle%20arrays%20for%20enhanced%20transdermal%20drug%20delivery.%20Adv%20Funct%20Mater.%202012;22:4879%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR192">
<span class="label">192.</span><cite>Lakshmanan S, Gupta GK, Avci P, Chandran R, Sadasivam M, Jorge AES, et al. Physical energy for drug delivery; poration, concentration and activation. Adv Drug Deliv Rev. 2014; 71:98–114. 10.1016/j.addr.2013.05.010.
</cite> [<a href="https://doi.org/10.1016/j.addr.2013.05.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3849347/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23751778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lakshmanan%20S,%20Gupta%20GK,%20Avci%20P,%20Chandran%20R,%20Sadasivam%20M,%20Jorge%20AES,%20et%20al.%20Physical%20energy%20for%20drug%20delivery;%20poration,%20concentration%20and%20activation.%20Adv%20Drug%20Deliv%20Rev.%202014;%2071:98%E2%80%93114.%2010.1016/j.addr.2013.05.010." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR193">
<span class="label">193.</span><cite>Abtahi-Naeini B, Hadian S, Sokhanvari F, Hariri A, Varshosaz J, Shahmoradi Z, et al. Effect of adjunctive topical liposomal Azithromycin on systemic Azithromycin on old world cutaneous leishmaniasis: A pilot clinical study. Iran J Pharm Res. 2021;20:383–9.
</cite> [<a href="https://doi.org/10.22037/ijpr.2020.113710.14445" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8457710/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34567168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Abtahi-Naeini%20B,%20Hadian%20S,%20Sokhanvari%20F,%20Hariri%20A,%20Varshosaz%20J,%20Shahmoradi%20Z,%20et%20al.%20Effect%20of%20adjunctive%20topical%20liposomal%20Azithromycin%20on%20systemic%20Azithromycin%20on%20old%20world%20cutaneous%20leishmaniasis:%20A%20pilot%20clinical%20study.%20Iran%20J%20Pharm%20Res.%202021;20:383%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR194">
<span class="label">194.</span><cite>Lalvand M, Hashemi SJ, Bayat M. Effect of fluconazole and terbinafine nanoparticles on the treatment of dermatophytosis induced by <em>trichophyton mentagrophytes</em> in Guinea pig. Iran J Microbiol. 2021. 10.18502/ijm.v13i5.7424.
</cite> [<a href="https://doi.org/10.18502/ijm.v13i5.7424" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8629829/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34900158/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lalvand%20M,%20Hashemi%20SJ,%20Bayat%20M.%20Effect%20of%20fluconazole%20and%20terbinafine%20nanoparticles%20on%20the%20treatment%20of%20dermatophytosis%20induced%20by%20trichophyton%20mentagrophytes%20in%20Guinea%20pig.%20Iran%20J%20Microbiol.%202021.%2010.18502/ijm.v13i5.7424." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR195">
<span class="label">195.</span><cite>Jain H, Geetanjali D, Dalvi H, Bhat A, Godugu C, Srivastava S. Liposome mediated topical delivery of ibrutinib and curcumin as a synergistic approach to combat imiquimod induced psoriasis. J Drug Deliv Sci Technol. 2022;68: 103103.</cite> [<a href="https://scholar.google.com/scholar_lookup?Jain%20H,%20Geetanjali%20D,%20Dalvi%20H,%20Bhat%20A,%20Godugu%20C,%20Srivastava%20S.%20Liposome%20mediated%20topical%20delivery%20of%20ibrutinib%20and%20curcumin%20as%20a%20synergistic%20approach%20to%20combat%20imiquimod%20induced%20psoriasis.%20J%20Drug%20Deliv%20Sci%20Technol.%202022;68:%20103103." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR196">
<span class="label">196.</span><cite>Desai JV, Urban A, Swaim DZ, Colton B, Kibathi LW, Ferrè EMN, et al. Efficacy of cochleated amphotericin B in mouse and human mucocutaneous candidiasis. Antimicrob Agents Chemother. 2022;66:e00308-22. 10.1128/aac.00308-22.
</cite> [<a href="https://doi.org/10.1128/aac.00308-22" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9295580/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35699443/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Desai%20JV,%20Urban%20A,%20Swaim%20DZ,%20Colton%20B,%20Kibathi%20LW,%20Ferr%C3%A8%20EMN,%20et%20al.%20Efficacy%20of%20cochleated%20amphotericin%20B%20in%20mouse%20and%20human%20mucocutaneous%20candidiasis.%20Antimicrob%20Agents%20Chemother.%202022;66:e00308-22.%2010.1128/aac.00308-22." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR197">
<span class="label">197.</span><cite>Horev A, Sagi O, Zur E, Ben-Shimol S. Topical liposomal amphotericin B gel treatment for cutaneous leishmaniasis caused by <em>Leishmania</em> major: a double‐blind, randomized, placebo‐controlled, pilot study. Int J Dermatol. 2023;62:40–7.
</cite> [<a href="https://doi.org/10.1111/ijd.16407" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36040071/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Horev%20A,%20Sagi%20O,%20Zur%20E,%20Ben-Shimol%20S.%20Topical%20liposomal%20amphotericin%20B%20gel%20treatment%20for%20cutaneous%20leishmaniasis%20caused%20by%20Leishmania%20major:%20a%20double%E2%80%90blind,%20randomized,%20placebo%E2%80%90controlled,%20pilot%20study.%20Int%20J%20Dermatol.%202023;62:40%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR198">
<span class="label">198.</span><cite>Zhang Z, Huo J, Feng L, Wang J, Fan X, Wang W. Development and characterization of a <em>vaccinium vitis-idaea</em> liposomal gel for the treatment of atopic dermatitis. Drug Dev Ind Pharm. 2025;51:273–83.
</cite> [<a href="https://doi.org/10.1080/03639045.2025.2467857" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39957257/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20Z,%20Huo%20J,%20Feng%20L,%20Wang%20J,%20Fan%20X,%20Wang%20W.%20Development%20and%20characterization%20of%20a%20vaccinium%20vitis-idaea%20liposomal%20gel%20for%20the%20treatment%20of%20atopic%20dermatitis.%20Drug%20Dev%20Ind%20Pharm.%202025;51:273%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR199">
<span class="label">199.</span><cite>Javia A, Misra A, Thakkar H. Liposomes encapsulating novel antimicrobial peptide omiganan: characterization and its pharmacodynamic evaluation in atopic dermatitis and psoriasis mice model. Int J Pharm. 2022;624: 122045.
</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2022.122045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35878872/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Javia%20A,%20Misra%20A,%20Thakkar%20H.%20Liposomes%20encapsulating%20novel%20antimicrobial%20peptide%20omiganan:%20characterization%20and%20its%20pharmacodynamic%20evaluation%20in%20atopic%20dermatitis%20and%20psoriasis%20mice%20model.%20Int%20J%20Pharm.%202022;624:%20122045." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR200">
<span class="label">200.</span><cite>Menêses AG, Ferreira EB, Vieira LAC, Bontempo P, de SM, Guerra ENS, Ciol MA, et al. Comparison of liposomal gel with and without addition of chamomile for prevention of radiation dermatitis in head and neck cancer patients: A randomized controlled trial. Radiother Oncol. 2024;199:110440.
</cite> [<a href="https://doi.org/10.1016/j.radonc.2024.110440" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39032836/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Men%C3%AAses%20AG,%20Ferreira%20EB,%20Vieira%20LAC,%20Bontempo%20P,%20de%20SM,%20Guerra%20ENS,%20Ciol%20MA,%20et%20al.%20Comparison%20of%20liposomal%20gel%20with%20and%20without%20addition%20of%20chamomile%20for%20prevention%20of%20radiation%20dermatitis%20in%20head%20and%20neck%20cancer%20patients:%20A%20randomized%20controlled%20trial.%20Radiother%20Oncol.%202024;199:110440." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR201">
<span class="label">201.</span><cite>LaMastro V, Campbell KM, Gonzalez P, Meng-Saccoccio T, Shukla A. Antifungal liposomes: lipid saturation and cholesterol concentration impact interaction with fungal and mammalian cells. J Biomed Mater Res A. 2023;111:644–59.
</cite> [<a href="https://doi.org/10.1002/jbm.a.37501" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36740998/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?LaMastro%20V,%20Campbell%20KM,%20Gonzalez%20P,%20Meng-Saccoccio%20T,%20Shukla%20A.%20Antifungal%20liposomes:%20lipid%20saturation%20and%20cholesterol%20concentration%20impact%20interaction%20with%20fungal%20and%20mammalian%20cells.%20J%20Biomed%20Mater%20Res%20A.%202023;111:644%E2%80%9359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR202">
<span class="label">202.</span><cite>Alobeidat S, Athamneh T. Nanoliposomes as drug delivery systems for antifungal therapy. Precis Nanomed. 2022;5(4):946–62. 10.33218/001c.56154.</cite> [<a href="https://scholar.google.com/scholar_lookup?Alobeidat%20S,%20Athamneh%20T.%20Nanoliposomes%20as%20drug%20delivery%20systems%20for%20antifungal%20therapy.%20Precis%20Nanomed.%202022;5(4):946%E2%80%9362.%2010.33218/001c.56154." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR203">
<span class="label">203.</span><cite>dos Santos RF, da Costa B, Campo LF, de Souza VS, Pereira SC, Coelho FL, et al. Mini-emulsions based on protic ionic liquids and oleic acid for treatment of dermatophytosis caused by <em>Microsporum canis</em>. New J Chem. 2023;47:10529–40.</cite> [<a href="https://scholar.google.com/scholar_lookup?dos%20Santos%20RF,%20da%20Costa%20B,%20Campo%20LF,%20de%20Souza%20VS,%20Pereira%20SC,%20Coelho%20FL,%20et%20al.%20Mini-emulsions%20based%20on%20protic%20ionic%20liquids%20and%20oleic%20acid%20for%20treatment%20of%20dermatophytosis%20caused%20by%20Microsporum%20canis.%20New%20J%20Chem.%202023;47:10529%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR204">
<span class="label">204.</span><cite>Kumari K, Behera HT, Nayak PP, Sinha A, Nandi A, Ghosh A, et al. Amelioration of lipopeptide biosurfactants for enhanced antibacterial and biocompatibility through molecular antioxidant property by methoxy and carboxyl moieties. Biomed Pharmacother. 2023;161:114493. 10.1016/j.biopha.2023.114493.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2023.114493" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36906974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kumari%20K,%20Behera%20HT,%20Nayak%20PP,%20Sinha%20A,%20Nandi%20A,%20Ghosh%20A,%20et%20al.%20Amelioration%20of%20lipopeptide%20biosurfactants%20for%20enhanced%20antibacterial%20and%20biocompatibility%20through%20molecular%20antioxidant%20property%20by%20methoxy%20and%20carboxyl%20moieties.%20Biomed%20Pharmacother.%202023;161:114493.%2010.1016/j.biopha.2023.114493." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR205">
<span class="label">205.</span><cite>Wang Y. Liposome as a delivery system for the treatment of biofilm-mediated infections. J Appl Microbiol. 2021;131:2626–39.
</cite> [<a href="https://doi.org/10.1111/jam.15053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33650748/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y.%20Liposome%20as%20a%20delivery%20system%20for%20the%20treatment%20of%20biofilm-mediated%20infections.%20J%20Appl%20Microbiol.%202021;131:2626%E2%80%9339." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR206">
<span class="label">206.</span><cite>Alhariri M, Azghani A, Omri A. Liposomal antibiotics for the treatment of infectious diseases. Expert OpinDrug Deliv. 2013;10(11):1515–32. 10.1517/17425247.2013.822860.</cite> [<a href="https://doi.org/10.1517/17425247.2013.822860" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23886421/" class="usa-link">PubMed</a>]</li>
<li id="CR207">
<span class="label">207.</span><cite>Rashighi M, Harris JE. Vitiligo pathogenesis and emerging treatments. Dermatol Clin. 2017;35:257–65.
</cite> [<a href="https://doi.org/10.1016/j.det.2016.11.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5362109/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28317534/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rashighi%20M,%20Harris%20JE.%20Vitiligo%20pathogenesis%20and%20emerging%20treatments.%20Dermatol%20Clin.%202017;35:257%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR208">
<span class="label">208.</span><cite>Doppalapudi S, Mahira S, Khan W. Development and in vitro assessment of psoralen and resveratrol co-loaded ultradeformable liposomes for the treatment of vitiligo. J Photochem Photobiol B-Biol. 2017;174:44–57.</cite> [<a href="https://doi.org/10.1016/j.jphotobiol.2017.07.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28753523/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Doppalapudi%20S,%20Mahira%20S,%20Khan%20W.%20Development%20and%20in%20vitro%20assessment%20of%20psoralen%20and%20resveratrol%20co-loaded%20ultradeformable%20liposomes%20for%20the%20treatment%20of%20vitiligo.%20J%20Photochem%20Photobiol%20B-Biol.%202017;174:44%E2%80%9357." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR209">
<span class="label">209.</span><cite>Saxena S, Kushwaha P, Shukla B, Ahmad M. Design and characterization of dual-pronged liposome‐embedded gel for enhanced dermal delivery. J Surfactants Deterg. 2023;26:867–79.</cite> [<a href="https://scholar.google.com/scholar_lookup?Saxena%20S,%20Kushwaha%20P,%20Shukla%20B,%20Ahmad%20M.%20Design%20and%20characterization%20of%20dual-pronged%20liposome%E2%80%90embedded%20gel%20for%20enhanced%20dermal%20delivery.%20J%20Surfactants%20Deterg.%202023;26:867%E2%80%9379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR210">
<span class="label">210.</span><cite>Das S, Kaur S. Nano-lipid-carriers for the treatment of vitiligo: a recent update, pathophysiology and mechanism of drug delivery. Curr Mol Pharmacol. 2021;14:306–20.
</cite> [<a href="https://doi.org/10.2174/1874467213999201109220714" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33172383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Das%20S,%20Kaur%20S.%20Nano-lipid-carriers%20for%20the%20treatment%20of%20vitiligo:%20a%20recent%20update,%20pathophysiology%20and%20mechanism%20of%20drug%20delivery.%20Curr%20Mol%20Pharmacol.%202021;14:306%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR211">
<span class="label">211.</span><cite>Passeron T. Combined/Sequential/Integrated therapies for vitiligo. Vitiligo. Cham: Springer International Publishing; 2019. pp. 411–20.</cite> [<a href="https://scholar.google.com/scholar_lookup?Passeron%20T.%20Combined/Sequential/Integrated%20therapies%20for%20vitiligo.%20Vitiligo.%20Cham:%20Springer%20International%20Publishing;%202019.%20pp.%20411%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR212">
<span class="label">212.</span><cite>Kim J, Song HS. Bee venom within liposomes synergistically inhibit atopic dermatitis in mice. J Acupunct Res. 2022;39:40–8.</cite> [<a href="https://scholar.google.com/scholar_lookup?Kim%20J,%20Song%20HS.%20Bee%20venom%20within%20liposomes%20synergistically%20inhibit%20atopic%20dermatitis%20in%20mice.%20J%20Acupunct%20Res.%202022;39:40%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR213">
<span class="label">213.</span><cite>Bhattacharyya S, Si A, Ray S. Liposomes as a skin delivery system for cosmeceuticals. Nanocosmeceuticals. Elsevier; 2022. pp. 209–35.</cite>
</li>
<li id="CR214">
<span class="label">214.</span><cite>Al Saqr A, Aldawsari MF, Alrbyawi H, Poudel I, Annaji M, Mulabagal V, et al. Co-delivery of hispolon and doxorubicin liposomes improves efficacy against melanoma cells. AAPS PharmSciTech. 2020;21:304.
</cite> [<a href="https://doi.org/10.1208/s12249-020-01846-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33150503/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Al%20Saqr%20A,%20Aldawsari%20MF,%20Alrbyawi%20H,%20Poudel%20I,%20Annaji%20M,%20Mulabagal%20V,%20et%20al.%20Co-delivery%20of%20hispolon%20and%20doxorubicin%20liposomes%20improves%20efficacy%20against%20melanoma%20cells.%20AAPS%20PharmSciTech.%202020;21:304." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR215">
<span class="label">215.</span><cite>Economidou SN, Lamprou DA, Douroumis D. 3D printing applications for transdermal drug delivery. Int J Pharm. 2018;544:415–24.
</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2018.01.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29355656/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Economidou%20SN,%20Lamprou%20DA,%20Douroumis%20D.%203D%20printing%20applications%20for%20transdermal%20drug%20delivery.%20Int%20J%20Pharm.%202018;544:415%E2%80%9324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR216">
<span class="label">216.</span><cite>Barry B. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 2001;14:101–14.
</cite> [<a href="https://doi.org/10.1016/s0928-0987(01)00167-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11500256/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Barry%20B.%20Novel%20mechanisms%20and%20devices%20to%20enable%20successful%20transdermal%20drug%20delivery.%20Eur%20J%20Pharm%20Sci.%202001;14:101%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR217">
<span class="label">217.</span><cite>Richardson M. Understanding the structure and function of the skin. Nurs Times. 99:46–8.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/13677123/" class="usa-link">PubMed</a>]</li>
<li id="CR218">
<span class="label">218.</span><cite>Dias-Ferreira J, Fernandes AR, Soriano JL, Naveros BC, Severino P, da Silva CF, et al. Skin rejuvenation: biopolymers applied to UV sunscreens and sheet masks. Biopolym Membr Film. Elsevier; 2020. pp. 309–30.</cite>
</li>
<li id="CR219">
<span class="label">219.</span><cite>Kramer JA, Bielitzki J. Integumentary System Diseases of Nonhuman Primates. Nonhum Primates Biomed Res. Elsevier; 2012. pp. 563–87.</cite>
</li>
<li id="CR220">
<span class="label">220.</span><cite>Pappinen S, Pryazhnikov E, Khiroug L, Ericson MB, Yliperttula M, Urtti A. Organotypic cell cultures and two-photon imaging: tools for in vitro and in vivo assessment of percutaneous drug delivery and skin toxicity. J Control Release. 2012;161:656–67.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2012.03.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22465394/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pappinen%20S,%20Pryazhnikov%20E,%20Khiroug%20L,%20Ericson%20MB,%20Yliperttula%20M,%20Urtti%20A.%20Organotypic%20cell%20cultures%20and%20two-photon%20imaging:%20tools%20for%20in%20vitro%20and%20in%20vivo%20assessment%20of%20percutaneous%20drug%20delivery%20and%20skin%20toxicity.%20J%20Control%20Release.%202012;161:656%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR221">
<span class="label">221.</span><cite>Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol. 2005;125:183–200.
</cite> [<a href="https://doi.org/10.1111/j.0022-202X.2005.23668.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16098026/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Elias%20PM.%20Stratum%20corneum%20defensive%20functions:%20an%20integrated%20view.%20J%20Invest%20Dermatol.%202005;125:183%E2%80%93200." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR222">
<span class="label">222.</span><cite>Verma D. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm. 2003;258:141–51.
</cite> [<a href="https://doi.org/10.1016/s0378-5173(03)00183-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12753761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Verma%20D.%20Particle%20size%20of%20liposomes%20influences%20dermal%20delivery%20of%20substances%20into%20skin.%20Int%20J%20Pharm.%202003;258:141%E2%80%9351." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR223">
<span class="label">223.</span><cite>Wertz PW. Roles of lipids in the permeability barriers of skin and oral mucosa. Int J Mol Sci. 2021;22:5229.
</cite> [<a href="https://doi.org/10.3390/ijms22105229" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8155912/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34063352/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wertz%20PW.%20Roles%20of%20lipids%20in%20the%20permeability%20barriers%20of%20skin%20and%20oral%20mucosa.%20Int%20J%20Mol%20Sci.%202021;22:5229." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR224">
<span class="label">224.</span><cite>Grayson S, Elias PM. Isolation and lipid biochemical characterization of stratum corneum membrane complexes: implications for the cutaneous permeability barrier. J Invest Dermatol. 1982;78:128–35.
</cite> [<a href="https://doi.org/10.1111/1523-1747.ep12505953" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7057048/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Grayson%20S,%20Elias%20PM.%20Isolation%20and%20lipid%20biochemical%20characterization%20of%20stratum%20corneum%20membrane%20complexes:%20implications%20for%20the%20cutaneous%20permeability%20barrier.%20J%20Invest%20Dermatol.%201982;78:128%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR225">
<span class="label">225.</span><cite>Schaefer H, Stüttgen G, Zesch A, Schalla W, Gazith J. Quantitative determination of percutaneous absorption of radiolabeled drugs in vitro and in vivo by human Skin1. pp. 80–94.</cite> [<a href="https://doi.org/10.1159/000401278" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/752460/" class="usa-link">PubMed</a>]</li>
<li id="CR226">
<span class="label">226.</span><cite>Hani Yousef M, Alhajj. Sandeep Sharma. Anatomy, Skin (Integument), Epidermis. StatPearls [Internet]. 2022.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/29262154/" class="usa-link">PubMed</a>]</li>
<li id="CR227">
<span class="label">227.</span><cite>Kitaoka M, Wakabayashi R, Kamiya N, Goto M. Solid-in-oil nanodispersions for transdermal drug delivery systems. Biotechnol J. 2016;11:1375–85.
</cite> [<a href="https://doi.org/10.1002/biot.201600081" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5132072/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27529824/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kitaoka%20M,%20Wakabayashi%20R,%20Kamiya%20N,%20Goto%20M.%20Solid-in-oil%20nanodispersions%20for%20transdermal%20drug%20delivery%20systems.%20Biotechnol%20J.%202016;11:1375%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR228">
<span class="label">228.</span><cite>Erdő F, Hashimoto N, Karvaly G, Nakamichi N, Kato Y. Critical evaluation and methodological positioning of the transdermal Microdialysis technique. A review. J Control Release. 2016;233:147–61.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2016.05.035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27196741/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Erd%C5%91%20F,%20Hashimoto%20N,%20Karvaly%20G,%20Nakamichi%20N,%20Kato%20Y.%20Critical%20evaluation%20and%20methodological%20positioning%20of%20the%20transdermal%20Microdialysis%20technique.%20A%20review.%20J%20Control%20Release.%202016;233:147%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR229">
<span class="label">229.</span><cite>Alkilani A, McCrudden MT, Donnelly R. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015;7:438–70.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics7040438" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4695828/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26506371/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alkilani%20A,%20McCrudden%20MT,%20Donnelly%20R.%20Transdermal%20drug%20delivery:%20innovative%20pharmaceutical%20developments%20based%20on%20disruption%20of%20the%20barrier%20properties%20of%20the%20stratum%20corneum.%20Pharmaceutics.%202015;7:438%E2%80%9370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR230">
<span class="label">230.</span><cite>Schuetz YB, Naik A, Guy RH, Kalia YN. Emerging strategies for the transdermal delivery of peptide and protein drugs. Expert Opin Drug Deliv. 2005;2:533–48.
</cite> [<a href="https://doi.org/10.1517/17425247.2.3.533" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16296773/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schuetz%20YB,%20Naik%20A,%20Guy%20RH,%20Kalia%20YN.%20Emerging%20strategies%20for%20the%20transdermal%20delivery%20of%20peptide%20and%20protein%20drugs.%20Expert%20Opin%20Drug%20Deliv.%202005;2:533%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR231">
<span class="label">231.</span><cite>Mitragotri S. Devices for overcoming biological barriers: the use of physical forces to disrupt the barriers. Adv Drug Deliv Rev. 2013;65:100–3.
</cite> [<a href="https://doi.org/10.1016/j.addr.2012.07.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22960787/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mitragotri%20S.%20Devices%20for%20overcoming%20biological%20barriers:%20the%20use%20of%20physical%20forces%20to%20disrupt%20the%20barriers.%20Adv%20Drug%20Deliv%20Rev.%202013;65:100%E2%80%933." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR232">
<span class="label">232.</span><cite>Polat BE, Hart D, Langer R, Blankschtein D. Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends. J Control Release. 2011;152:330–48.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2011.01.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3436072/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21238514/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Polat%20BE,%20Hart%20D,%20Langer%20R,%20Blankschtein%20D.%20Ultrasound-mediated%20transdermal%20drug%20delivery:%20mechanisms,%20scope,%20and%20emerging%20trends.%20J%20Control%20Release.%202011;152:330%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR233">
<span class="label">233.</span><cite>Seah BC-Q, Teo BM. Recent advances in ultrasound-based transdermal drug delivery. Int J Nanomedicine. 2018;13:7749–63.
</cite> [<a href="https://doi.org/10.2147/IJN.S174759" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6251463/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30538456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Seah%20BC-Q,%20Teo%20BM.%20Recent%20advances%20in%20ultrasound-based%20transdermal%20drug%20delivery.%20Int%20J%20Nanomedicine.%202018;13:7749%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR234">
<span class="label">234.</span><cite>Marathe D, Bhuvanashree VS, Mehta CH, Nayak TA. UY. Low-Frequency Sonophoresis: A Promising Strategy for Enhanced Transdermal Delivery. Oliveira M, editor. Adv Pharmacol Pharm Sci. 2024;2024.</cite> [<a href="https://doi.org/10.1155/2024/1247450" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11208788/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38938593/" class="usa-link">PubMed</a>]</li>
<li id="CR235">
<span class="label">235.</span><cite>Than A, Zan P, Chen P. Transdermal theranostics. VIEW. 2020;1.</cite>
</li>
<li id="CR236">
<span class="label">236.</span><cite>Kim Y-S, Ko MJ, Moon H, Sim W, Cho AS, Gil G, et al. Ultrasound-responsive liposomes for targeted drug delivery combined with focused ultrasound. Pharmaceutics. 2022;14:1314.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics14071314" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9315635/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35890210/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20Y-S,%20Ko%20MJ,%20Moon%20H,%20Sim%20W,%20Cho%20AS,%20Gil%20G,%20et%20al.%20Ultrasound-responsive%20liposomes%20for%20targeted%20drug%20delivery%20combined%20with%20focused%20ultrasound.%20Pharmaceutics.%202022;14:1314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR237">
<span class="label">237.</span><cite>Narwade PS, Bora VG, Mhaske PS, Sheikh AA, Biyani KR. Review on needle free injection technology. Asian J Pharm Res Dev. 2023;11:52–8.</cite> [<a href="https://scholar.google.com/scholar_lookup?Narwade%20PS,%20Bora%20VG,%20Mhaske%20PS,%20Sheikh%20AA,%20Biyani%20KR.%20Review%20on%20needle%20free%20injection%20technology.%20Asian%20J%20Pharm%20Res%20Dev.%202023;11:52%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR238">
<span class="label">238.</span><cite>Gratieri T, Alberti I, Lapteva M, Kalia YN. Next generation intra- and transdermal therapeutic systems: using non- and minimally-invasive technologies to increase drug delivery into and across the skin. Eur J Pharm Sci. 2013;50:609–22.
</cite> [<a href="https://doi.org/10.1016/j.ejps.2013.03.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23567467/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gratieri%20T,%20Alberti%20I,%20Lapteva%20M,%20Kalia%20YN.%20Next%20generation%20intra-%20and%20transdermal%20therapeutic%20systems:%20using%20non-%20and%20minimally-invasive%20technologies%20to%20increase%20drug%20delivery%20into%20and%20across%20the%20skin.%20Eur%20J%20Pharm%20Sci.%202013;50:609%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR239">
<span class="label">239.</span><cite>Curdy C, Kalia YN, Guy RH. Non-invasive assessment of the effects of iontophoresis on human skin in-vivo. J Pharm Pharmacol. 2010;53:769–77.</cite> [<a href="https://doi.org/10.1211/0022357011776117" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11428652/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Curdy%20C,%20Kalia%20YN,%20Guy%20RH.%20Non-invasive%20assessment%20of%20the%20effects%20of%20iontophoresis%20on%20human%20skin%20in-vivo.%20J%20Pharm%20Pharmacol.%202010;53:769%E2%80%9377." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR240">
<span class="label">240.</span><cite>Ramos ALSC. FDA evaluating the risk of burns and scars with Zecuity (sumatriptan) migraine patch. 2016;66.</cite>
</li>
<li id="CR241">
<span class="label">241.</span><cite>Yi J, Barrow AJ, Yu N, O’Neill BE. Efficient electroporation of liposomes doped with pore stabilizing Nisin. J Liposome Res. 2013;23:197–202.
</cite> [<a href="https://doi.org/10.3109/08982104.2013.788024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23594238/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yi%20J,%20Barrow%20AJ,%20Yu%20N,%20O%E2%80%99Neill%20BE.%20Efficient%20electroporation%20of%20liposomes%20doped%20with%20pore%20stabilizing%20Nisin.%20J%20Liposome%20Res.%202013;23:197%E2%80%93202." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR242">
<span class="label">242.</span><cite>Pliquett UF, Martin GT, Weaver JC. Kinetics of the temperature rise within human stratum corneum during electroporation and pulsed high-voltage iontophoresis. Bioelectrochemistry. 2002;57:65–72.
</cite> [<a href="https://doi.org/10.1016/s1567-5394(01)00177-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12049758/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pliquett%20UF,%20Martin%20GT,%20Weaver%20JC.%20Kinetics%20of%20the%20temperature%20rise%20within%20human%20stratum%20corneum%20during%20electroporation%20and%20pulsed%20high-voltage%20iontophoresis.%20Bioelectrochemistry.%202002;57:65%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR243">
<span class="label">243.</span><cite>Banga AK, Bose S, Ghosh TK. Iontophoresis and electroporation: comparisons and contrasts. Int J Pharm. 1999;179:1–19.
</cite> [<a href="https://doi.org/10.1016/s0378-5173(98)00360-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10053197/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Banga%20AK,%20Bose%20S,%20Ghosh%20TK.%20Iontophoresis%20and%20electroporation:%20comparisons%20and%20contrasts.%20Int%20J%20Pharm.%201999;179:1%E2%80%9319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR244">
<span class="label">244.</span><cite>Denet A-R, Vanbever R, Préat V. Skin electroporation for transdermal and topical delivery. Adv Drug Deliv Rev. 2004;56(5):659–74.
</cite> [<a href="https://doi.org/10.1016/j.addr.2003.10.027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15019751/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Denet%20A-R,%20Vanbever%20R,%20Pr%C3%A9at%20V.%20Skin%20electroporation%20for%20transdermal%20and%20topical%20delivery.%20Adv%20Drug%20Deliv%20Rev.%202004;56(5):659%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR245">
<span class="label">245.</span><cite>Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J. 1982;1:841–5.
</cite> [<a href="https://doi.org/10.1002/j.1460-2075.1982.tb01257.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC553119/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6329708/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Neumann%20E,%20Schaefer-Ridder%20M,%20Wang%20Y,%20Hofschneider%20PH.%20Gene%20transfer%20into%20mouse%20lyoma%20cells%20by%20electroporation%20in%20high%20electric%20fields.%20EMBO%20J.%201982;1:841%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR246">
<span class="label">246.</span><cite>Murthy SN, Zhao Y-L, Marlan K, Hui SW, Kazim AL, Sen A. Lipid and electroosmosis enhanced transdermal delivery of insulin by electroporation. J Pharm Sci. 2006;95:2041–50.
</cite> [<a href="https://doi.org/10.1002/jps.20682" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16850446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Murthy%20SN,%20Zhao%20Y-L,%20Marlan%20K,%20Hui%20SW,%20Kazim%20AL,%20Sen%20A.%20Lipid%20and%20electroosmosis%20enhanced%20transdermal%20delivery%20of%20insulin%20by%20electroporation.%20J%20Pharm%20Sci.%202006;95:2041%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR247">
<span class="label">247.</span><cite>Kanikkannan N. Iontophoresis-Based Transdermal Delivery Syst BioDrugs. 2002;16:339–47.</cite> [<a href="https://doi.org/10.2165/00063030-200216050-00003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12408738/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kanikkannan%20N.%20Iontophoresis-Based%20Transdermal%20Delivery%20Syst%20BioDrugs.%202002;16:339%E2%80%9347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR248">
<span class="label">248.</span><cite>Kalia YN, Naik A, Garrison J, Guy RH. Iontophoretic drug delivery. Adv Drug Deliv Rev. 2004;56:619–58.
</cite> [<a href="https://doi.org/10.1016/j.addr.2003.10.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15019750/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kalia%20YN,%20Naik%20A,%20Garrison%20J,%20Guy%20RH.%20Iontophoretic%20drug%20delivery.%20Adv%20Drug%20Deliv%20Rev.%202004;56:619%E2%80%9358." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR249">
<span class="label">249.</span><cite>Dasht Bozorg B, Bhattaccharjee SA, Somayaji MR, Banga AK. Topical and transdermal delivery with diseased human skin: passive and iontophoretic delivery of hydrocortisone into psoriatic and eczematous skin. Drug Deliv Transl Res. 2022;12:197–212.
</cite> [<a href="https://doi.org/10.1007/s13346-021-00897-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9351627/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33432519/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dasht%20Bozorg%20B,%20Bhattaccharjee%20SA,%20Somayaji%20MR,%20Banga%20AK.%20Topical%20and%20transdermal%20delivery%20with%20diseased%20human%20skin:%20passive%20and%20iontophoretic%20delivery%20of%20hydrocortisone%20into%20psoriatic%20and%20eczematous%20skin.%20Drug%20Deliv%20Transl%20Res.%202022;12:197%E2%80%93212." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR250">
<span class="label">250.</span><cite>Schoellhammer CM, Blankschtein D, Langer R. Skin permeabilization for transdermal drug delivery: recent advances and future prospects. Expert Opin Drug Deliv. 2014;11:393–407.
</cite> [<a href="https://doi.org/10.1517/17425247.2014.875528" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3980659/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24392787/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schoellhammer%20CM,%20Blankschtein%20D,%20Langer%20R.%20Skin%20permeabilization%20for%20transdermal%20drug%20delivery:%20recent%20advances%20and%20future%20prospects.%20Expert%20Opin%20Drug%20Deliv.%202014;11:393%E2%80%93407." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR251">
<span class="label">251.</span><cite>Hasan M, Khatun A, Fukuta T, Kogure K. Noninvasive transdermal delivery of liposomes by weak electric current. Adv Drug Deliv Rev. 2020;154–155:227–35.
</cite> [<a href="https://doi.org/10.1016/j.addr.2020.06.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32589904/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hasan%20M,%20Khatun%20A,%20Fukuta%20T,%20Kogure%20K.%20Noninvasive%20transdermal%20delivery%20of%20liposomes%20by%20weak%20electric%20current.%20Adv%20Drug%20Deliv%20Rev.%202020;154%E2%80%93155:227%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR252">
<span class="label">252.</span><cite>Vutla NB, Betageri GV, Banga AK. Transdermal lontophoretic delivery of enkephalin formulated in liposomes. J Pharm Sci. 1996;85:5–8.
</cite> [<a href="https://doi.org/10.1021/js950349y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8926583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vutla%20NB,%20Betageri%20GV,%20Banga%20AK.%20Transdermal%20lontophoretic%20delivery%20of%20enkephalin%20formulated%20in%20liposomes.%20J%20Pharm%20Sci.%201996;85:5%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR253">
<span class="label">253.</span><cite>Liatsopoulou A, Varvaresou A, Mellou F, Protopapa E. Iontophoresis in dermal delivery: a review of applications in dermato-cosmetic and aesthetic sciences. Int J Cosmet Sci. 2023;45:117–32.
</cite> [<a href="https://doi.org/10.1111/ics.12824" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36326063/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liatsopoulou%20A,%20Varvaresou%20A,%20Mellou%20F,%20Protopapa%20E.%20Iontophoresis%20in%20dermal%20delivery:%20a%20review%20of%20applications%20in%20dermato-cosmetic%20and%20aesthetic%20sciences.%20Int%20J%20Cosmet%20Sci.%202023;45:117%E2%80%9332." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR254">
<span class="label">254.</span><cite>Lin C-H, Aljuffali IA, Fang J-Y. Lasers as an approach for promoting drug delivery via skin. Expert Opin Drug Deliv. 2014;11:599–614.
</cite> [<a href="https://doi.org/10.1517/17425247.2014.885501" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24490743/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin%20C-H,%20Aljuffali%20IA,%20Fang%20J-Y.%20Lasers%20as%20an%20approach%20for%20promoting%20drug%20delivery%20via%20skin.%20Expert%20Opin%20Drug%20Deliv.%202014;11:599%E2%80%93614." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR255">
<span class="label">255.</span><cite>Alexander A, Dwivedi S, Ajazuddin, Giri TK, Saraf S, Saraf S, et al. Approaches for breaking the barriers of drug permeation through transdermal drug delivery. J Control Release. 2012;164:26–40.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2012.09.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23064010/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alexander%20A,%20Dwivedi%20S,%20Ajazuddin,%20Giri%20TK,%20Saraf%20S,%20Saraf%20S,%20et%20al.%20Approaches%20for%20breaking%20the%20barriers%20of%20drug%20permeation%20through%20transdermal%20drug%20delivery.%20J%20Control%20Release.%202012;164:26%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR256">
<span class="label">256.</span><cite>Lee W-R, Pan T-L, Wang P-W, Zhuo R-Z, Huang C-M, Fang J-Y. Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination. J Control Release. 2008;128:200–8.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2008.03.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18471920/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20W-R,%20Pan%20T-L,%20Wang%20P-W,%20Zhuo%20R-Z,%20Huang%20C-M,%20Fang%20J-Y.%20Erbium:YAG%20laser%20enhances%20transdermal%20peptide%20delivery%20and%20skin%20vaccination.%20J%20Control%20Release.%202008;128:200%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR257">
<span class="label">257.</span><cite>Lee W-R, Shen S-C, Pai M-H, Yang H-H, Yuan C-Y, Fang J-Y. Fractional laser as a tool to enhance the skin permeation of 5-aminolevulinic acid with minimal skin disruption: a comparison with conventional erbium:yag laser. J Control Release. 2010;145:124–33.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2010.03.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20359510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20W-R,%20Shen%20S-C,%20Pai%20M-H,%20Yang%20H-H,%20Yuan%20C-Y,%20Fang%20J-Y.%20Fractional%20laser%20as%20a%20tool%20to%20enhance%20the%20skin%20permeation%20of%205-aminolevulinic%20acid%20with%20minimal%20skin%20disruption:%20a%20comparison%20with%20conventional%20erbium:yag%20laser.%20J%20Control%20Release.%202010;145:124%E2%80%9333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR258">
<span class="label">258.</span><cite>Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes — novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 2000;65:403–18.
</cite> [<a href="https://doi.org/10.1016/s0168-3659(99)00222-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10699298/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Touitou%20E,%20Dayan%20N,%20Bergelson%20L,%20Godin%20B,%20Eliaz%20M.%20Ethosomes%20%E2%80%94%20novel%20vesicular%20carriers%20for%20enhanced%20delivery:%20characterization%20and%20skin%20penetration%20properties.%20J%20Control%20Release.%202000;65:403%E2%80%9318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR259">
<span class="label">259.</span><cite>Parhi R, Mandru A. Enhancement of skin permeability with thermal ablation techniques: concept to commercial products. Drug Deliv Transl Res. 2021;11:817–41.
</cite> [<a href="https://doi.org/10.1007/s13346-020-00823-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7372979/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32696221/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Parhi%20R,%20Mandru%20A.%20Enhancement%20of%20skin%20permeability%20with%20thermal%20ablation%20techniques:%20concept%20to%20commercial%20products.%20Drug%20Deliv%20Transl%20Res.%202021;11:817%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR260">
<span class="label">260.</span><cite>Neupane R, Boddu SHS, Renukuntla J, Babu RJ, Tiwari AK. Alternatives to biological skin in permeation studies: current trends and possibilities. Pharmaceutics. 2020;12:152.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics12020152" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7076422/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32070011/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Neupane%20R,%20Boddu%20SHS,%20Renukuntla%20J,%20Babu%20RJ,%20Tiwari%20AK.%20Alternatives%20to%20biological%20skin%20in%20permeation%20studies:%20current%20trends%20and%20possibilities.%20Pharmaceutics.%202020;12:152." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR261">
<span class="label">261.</span><cite>Pascoa H, Diniz DGA, Florentino IF, Costa EA, Bara MTF. Microemulsion based on <em>pterodon emarginatus</em> oil and its anti-inflammatory potential. Braz J Pharm Sci. 2015;51(1):117–25.</cite> [<a href="https://scholar.google.com/scholar_lookup?Pascoa%20H,%20Diniz%20DGA,%20Florentino%20IF,%20Costa%20EA,%20Bara%20MTF.%20Microemulsion%20based%20on%20pterodon%20emarginatus%20oil%20and%20its%20anti-inflammatory%20potential.%20Braz%20J%20Pharm%20Sci.%202015;51(1):117%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR262">
<span class="label">262.</span><cite>Andrews SN, Jeong E, Prausnitz MR. Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum. Pharm Res. 2013;30:1099–109.
</cite> [<a href="https://doi.org/10.1007/s11095-012-0946-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3596453/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23196771/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Andrews%20SN,%20Jeong%20E,%20Prausnitz%20MR.%20Transdermal%20delivery%20of%20molecules%20is%20limited%20by%20full%20epidermis,%20not%20just%20stratum%20corneum.%20Pharm%20Res.%202013;30:1099%E2%80%93109." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR263">
<span class="label">263.</span><cite>Larrañeta E, Lutton REM, Woolfson AD, Donnelly RF. Microneedle arrays as transdermal and intradermal drug delivery systems: materials science, manufacture and commercial development. Mater Sci Eng R Rep. 2016;104:1–32.</cite> [<a href="https://scholar.google.com/scholar_lookup?Larra%C3%B1eta%20E,%20Lutton%20REM,%20Woolfson%20AD,%20Donnelly%20RF.%20Microneedle%20arrays%20as%20transdermal%20and%20intradermal%20drug%20delivery%20systems:%20materials%20science,%20manufacture%20and%20commercial%20development.%20Mater%20Sci%20Eng%20R%20Rep.%202016;104:1%E2%80%9332." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR264">
<span class="label">264.</span><cite>Tuan-Mahmood T-M, McCrudden MTC, Torrisi BM, McAlister E, Garland MJ, Singh TRR, et al. Microneedles for intradermal and transdermal drug delivery. Eur J Pharm Sci. 2013;50:623–37.
</cite> [<a href="https://doi.org/10.1016/j.ejps.2013.05.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4119996/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23680534/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tuan-Mahmood%20T-M,%20McCrudden%20MTC,%20Torrisi%20BM,%20McAlister%20E,%20Garland%20MJ,%20Singh%20TRR,%20et%20al.%20Microneedles%20for%20intradermal%20and%20transdermal%20drug%20delivery.%20Eur%20J%20Pharm%20Sci.%202013;50:623%E2%80%9337." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR265">
<span class="label">265.</span><cite>Sivamani RK, Liepmann D, Maibach HI. Microneedles and transdermal applications. Expert Opin Drug Deliv. 2007;4:19–25.
</cite> [<a href="https://doi.org/10.1517/17425247.4.1.19" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17184159/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sivamani%20RK,%20Liepmann%20D,%20Maibach%20HI.%20Microneedles%20and%20transdermal%20applications.%20Expert%20Opin%20Drug%20Deliv.%202007;4:19%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR266">
<span class="label">266.</span><cite>Indermun S, Luttge R, Choonara YE, Kumar P, du Toit LC, Modi G, et al. Current advances in the fabrication of microneedles for transdermal delivery. J Control Release. 2014;185:130–8.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2014.04.052" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24806483/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Indermun%20S,%20Luttge%20R,%20Choonara%20YE,%20Kumar%20P,%20du%20Toit%20LC,%20Modi%20G,%20et%20al.%20Current%20advances%20in%20the%20fabrication%20of%20microneedles%20for%20transdermal%20delivery.%20J%20Control%20Release.%202014;185:130%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR267">
<span class="label">267.</span><cite>Gerstel MS, Place VA. Drug Delivery Device. 1978. pp. 1–13.</cite>
</li>
<li id="CR268">
<span class="label">268.</span><cite>Ita K. Dissolving microneedles for transdermal drug delivery: advances and challenges. Biomed Pharmacother. 2017;93:1116–27.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2017.07.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28738520/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ita%20K.%20Dissolving%20microneedles%20for%20transdermal%20drug%20delivery:%20advances%20and%20challenges.%20Biomed%20Pharmacother.%202017;93:1116%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR269">
<span class="label">269.</span><cite>Yung KL, Xu Y, Kang C, Liu H, Tam KF, Ko SM, et al. Sharp tipped plastic hollow microneedle array by microinjection moulding. J Micromech Microeng. 2012;22: 015016.</cite> [<a href="https://scholar.google.com/scholar_lookup?Yung%20KL,%20Xu%20Y,%20Kang%20C,%20Liu%20H,%20Tam%20KF,%20Ko%20SM,%20et%20al.%20Sharp%20tipped%20plastic%20hollow%20microneedle%20array%20by%20microinjection%20moulding.%20J%20Micromech%20Microeng.%202012;22:%20015016." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR270">
<span class="label">270.</span><cite>Halder J, Gupta S, Kumari R, Gupta G, Das, Rai VK. Microneedle array: applications, recent advances, and clinical pertinence in transdermal drug delivery. J Pharm Innov. 2021;16:558–65.
</cite> [<a href="https://doi.org/10.1007/s12247-020-09460-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7276250/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32837607/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Halder%20J,%20Gupta%20S,%20Kumari%20R,%20Gupta%20G,%20Das,%20Rai%20VK.%20Microneedle%20array:%20applications,%20recent%20advances,%20and%20clinical%20pertinence%20in%20transdermal%20drug%20delivery.%20J%20Pharm%20Innov.%202021;16:558%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR271">
<span class="label">271.</span><cite>Gill HS, Denson DD, Burris BA, Prausnitz MR. Effect of microneedle design on pain in human volunteers. Clin J Pain. 2008;24:585–94.
</cite> [<a href="https://doi.org/10.1097/AJP.0b013e31816778f9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2917250/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18716497/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gill%20HS,%20Denson%20DD,%20Burris%20BA,%20Prausnitz%20MR.%20Effect%20of%20microneedle%20design%20on%20pain%20in%20human%20volunteers.%20Clin%20J%20Pain.%202008;24:585%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR272">
<span class="label">272.</span><cite>Ita K. Transdermal delivery of drugs with microneedles—potential and challenges. Pharmaceutics. 2015;7:90–105.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics7030090" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4588187/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26131647/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ita%20K.%20Transdermal%20delivery%20of%20drugs%20with%20microneedles%E2%80%94potential%20and%20challenges.%20Pharmaceutics.%202015;7:90%E2%80%93105." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR273">
<span class="label">273.</span><cite>Kim Y-C, Park J-H, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev. 2012;64:1547–68.
</cite> [<a href="https://doi.org/10.1016/j.addr.2012.04.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3419303/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22575858/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20Y-C,%20Park%20J-H,%20Prausnitz%20MR.%20Microneedles%20for%20drug%20and%20vaccine%20delivery.%20Adv%20Drug%20Deliv%20Rev.%202012;64:1547%E2%80%9368." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR274">
<span class="label">274.</span><cite>Opatha SAT, Titapiwatanakun V, Chutoprapat R. Transfersomes: a promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics. 2020;12:855.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics12090855" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7559928/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32916782/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Opatha%20SAT,%20Titapiwatanakun%20V,%20Chutoprapat%20R.%20Transfersomes:%20a%20promising%20nanoencapsulation%20technique%20for%20transdermal%20drug%20delivery.%20Pharmaceutics.%202020;12:855." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR275">
<span class="label">275.</span><cite>van der Maaden K, Jiskoot W, Bouwstra J. Microneedle technologies for (trans)dermal drug and vaccine delivery. J Control Release. 2012;161:645–55.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2012.01.042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22342643/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20der%20Maaden%20K,%20Jiskoot%20W,%20Bouwstra%20J.%20Microneedle%20technologies%20for%20(trans)dermal%20drug%20and%20vaccine%20delivery.%20J%20Control%20Release.%202012;161:645%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR276">
<span class="label">276.</span><cite>Donnelly RF, Singh TRR, Woolfson AD. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv. 2010;17:187–207.
</cite> [<a href="https://doi.org/10.3109/10717541003667798" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2906704/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20297904/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Donnelly%20RF,%20Singh%20TRR,%20Woolfson%20AD.%20Microneedle-based%20drug%20delivery%20systems:%20microfabrication,%20drug%20delivery,%20and%20safety.%20Drug%20Deliv.%202010;17:187%E2%80%93207." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR277">
<span class="label">277.</span><cite>Lademann J, Jacobi U, Surber C, Weigmann H-J, Fluhr JW. The tape stripping procedure – evaluation of some critical parameters. Eur J Pharm Biopharm. 2009;72:317–23.
</cite> [<a href="https://doi.org/10.1016/j.ejpb.2008.08.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18775778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lademann%20J,%20Jacobi%20U,%20Surber%20C,%20Weigmann%20H-J,%20Fluhr%20JW.%20The%20tape%20stripping%20procedure%20%E2%80%93%20evaluation%20of%20some%20critical%20parameters.%20Eur%20J%20Pharm%20Biopharm.%202009;72:317%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR278">
<span class="label">278.</span><cite>Mohd Ariffin NH, Hasham R. Assessment of non-invasive techniques and herbal-based products on dermatological physiology and intercellular lipid properties. Heliyon. 2020;6: e03955.
</cite> [<a href="https://doi.org/10.1016/j.heliyon.2020.e03955" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7251381/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32478187/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mohd%20Ariffin%20NH,%20Hasham%20R.%20Assessment%20of%20non-invasive%20techniques%20and%20herbal-based%20products%20on%20dermatological%20physiology%20and%20intercellular%20lipid%20properties.%20Heliyon.%202020;6:%20e03955." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR279">
<span class="label">279.</span><cite>Jeong WY, Kwon M, Choi HE, Kim KS. Recent advances in transdermal drug delivery systems: a review. Biomater Res. 2021;25(1):s40824-021-0022. 10.1186/s40824-021-00226-6.</cite> [<a href="https://doi.org/10.1186/s40824-021-00226-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8317283/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34321111/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jeong%20WY,%20Kwon%20M,%20Choi%20HE,%20Kim%20KS.%20Recent%20advances%20in%20transdermal%20drug%20delivery%20systems:%20a%20review.%20Biomater%20Res.%202021;25(1):s40824-021-0022.%2010.1186/s40824-021-00226-6." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR280">
<span class="label">280.</span><cite>Escobar-Chavez JJ, Merino-Sanjuán V, López-Cervantes M, Urban-Morlan Z, Piñón-Segundo E, Quintanar-Guerrero D, et al. The tape-stripping technique as a method for drug quantification in skin. J Pharm Pharm Sci. 2008;11:104.
</cite> [<a href="https://doi.org/10.18433/j3201z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18445368/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Escobar-Chavez%20JJ,%20Merino-Sanju%C3%A1n%20V,%20L%C3%B3pez-Cervantes%20M,%20Urban-Morlan%20Z,%20Pi%C3%B1%C3%B3n-Segundo%20E,%20Quintanar-Guerrero%20D,%20et%20al.%20The%20tape-stripping%20technique%20as%20a%20method%20for%20drug%20quantification%20in%20skin.%20J%20Pharm%20Pharm%20Sci.%202008;11:104." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR281">
<span class="label">281.</span><cite>Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochimica et Biophysica Acta (BBA). 1992;1104:226–32.
</cite> [<a href="https://doi.org/10.1016/0005-2736(92)90154-e" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1550849/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cevc%20G,%20Blume%20G.%20Lipid%20vesicles%20penetrate%20into%20intact%20skin%20owing%20to%20the%20transdermal%20osmotic%20gradients%20and%20hydration%20force.%20Biochimica%20et%20Biophysica%20Acta%20(BBA).%201992;1104:226%E2%80%9332." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR282">
<span class="label">282.</span><cite>Kapoor MS, GuhaSarkar S, Banerjee R. Stratum corneum modulation by chemical enhancers and lipid nanostructures: implications for transdermal drug delivery. Ther Deliv. 2017;8:701–18.
</cite> [<a href="https://doi.org/10.4155/tde-2017-0045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28730938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kapoor%20MS,%20GuhaSarkar%20S,%20Banerjee%20R.%20Stratum%20corneum%20modulation%20by%20chemical%20enhancers%20and%20lipid%20nanostructures:%20implications%20for%20transdermal%20drug%20delivery.%20Ther%20Deliv.%202017;8:701%E2%80%9318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR283">
<span class="label">283.</span><cite>Kováčik A, Kopečná M, Vávrová K. Permeation enhancers in transdermal drug delivery: benefits and limitations. Expert Opin Drug Deliv. 2020;17:145–55.
</cite> [<a href="https://doi.org/10.1080/17425247.2020.1713087" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31910342/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kov%C3%A1%C4%8Dik%20A,%20Kope%C4%8Dn%C3%A1%20M,%20V%C3%A1vrov%C3%A1%20K.%20Permeation%20enhancers%20in%20transdermal%20drug%20delivery:%20benefits%20and%20limitations.%20Expert%20Opin%20Drug%20Deliv.%202020;17:145%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR284">
<span class="label">284.</span><cite>Bauerová K, Matušová D, Kassai Z. Chemical enhancers for transdermal drug transport. Eur J Drug Metab Pharmacokinet. 2001;26:85–94.
</cite> [<a href="https://doi.org/10.1007/BF03190381" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11554439/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bauerov%C3%A1%20K,%20Matu%C5%A1ov%C3%A1%20D,%20Kassai%20Z.%20Chemical%20enhancers%20for%20transdermal%20drug%20transport.%20Eur%20J%20Drug%20Metab%20Pharmacokinet.%202001;26:85%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR285">
<span class="label">285.</span><cite>Marwah H, Garg T, Goyal AK, Rath G. Permeation enhancer strategies in transdermal drug delivery. Drug Deliv. 2016;23:564–78.
</cite> [<a href="https://doi.org/10.3109/10717544.2014.935532" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25006687/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Marwah%20H,%20Garg%20T,%20Goyal%20AK,%20Rath%20G.%20Permeation%20enhancer%20strategies%20in%20transdermal%20drug%20delivery.%20Drug%20Deliv.%202016;23:564%E2%80%9378." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR286">
<span class="label">286.</span><cite>Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2004;56:603–18.
</cite> [<a href="https://doi.org/10.1016/j.addr.2003.10.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15019749/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Williams%20AC,%20Barry%20BW.%20Penetration%20enhancers.%20Adv%20Drug%20Deliv%20Rev.%202004;56:603%E2%80%9318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR287">
<span class="label">287.</span><cite>Barry BW. Mode of action of penetration enhancers in human skin. J Control Release. 1987;6:85–97.</cite> [<a href="https://scholar.google.com/scholar_lookup?Barry%20BW.%20Mode%20of%20action%20of%20penetration%20enhancers%20in%20human%20skin.%20J%20Control%20Release.%201987;6:85%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR288">
<span class="label">288.</span><cite>Godin B, Touitou E. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J Control Release. 2004;94:365–79.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2003.10.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14744487/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Godin%20B,%20Touitou%20E.%20Mechanism%20of%20bacitracin%20permeation%20enhancement%20through%20the%20skin%20and%20cellular%20membranes%20from%20an%20ethosomal%20carrier.%20J%20Control%20Release.%202004;94:365%E2%80%9379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR289">
<span class="label">289.</span><cite>Jain S, Patel N, Madan P, Lin S. Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route. Pharm Dev Technol. 2015;20:473–89.
</cite> [<a href="https://doi.org/10.3109/10837450.2014.882939" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24490793/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jain%20S,%20Patel%20N,%20Madan%20P,%20Lin%20S.%20Quality%20by%20design%20approach%20for%20formulation,%20evaluation%20and%20statistical%20optimization%20of%20diclofenac-loaded%20ethosomes%20via%20transdermal%20route.%20Pharm%20Dev%20Technol.%202015;20:473%E2%80%9389." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR290">
<span class="label">290.</span><cite>Jain S, Patel N, Shah MK, Khatri P, Vora N. Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application. J Pharm Sci. 2017;106:423–45.
</cite> [<a href="https://doi.org/10.1016/j.xphs.2016.10.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27865609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jain%20S,%20Patel%20N,%20Shah%20MK,%20Khatri%20P,%20Vora%20N.%20Recent%20advances%20in%20lipid-based%20vesicles%20and%20particulate%20carriers%20for%20topical%20and%20transdermal%20application.%20J%20Pharm%20Sci.%202017;106:423%E2%80%9345." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR291">
<span class="label">291.</span><cite>Abouhussein DMN. Enhanced transdermal permeation of BCS class IV aprepitant using binary ethosome: optimization, characterization and ex vivo permeation. J Drug Deliv Sci Technol. 2021;61: 102185.</cite> [<a href="https://scholar.google.com/scholar_lookup?Abouhussein%20DMN.%20Enhanced%20transdermal%20permeation%20of%20BCS%20class%20IV%20aprepitant%20using%20binary%20ethosome:%20optimization,%20characterization%20and%20ex%20vivo%20permeation.%20J%20Drug%20Deliv%20Sci%20Technol.%202021;61:%20102185." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR292">
<span class="label">292.</span><cite>Makhmalzade B, Chavoshy F. Polymeric micelles as cutaneous drug delivery system in normal skin and dermatological disorders. J Adv Pharm Technol Res. 2018;9:2.
</cite> [<a href="https://doi.org/10.4103/japtr.JAPTR_314_17" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5801582/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29441317/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Makhmalzade%20B,%20Chavoshy%20F.%20Polymeric%20micelles%20as%20cutaneous%20drug%20delivery%20system%20in%20normal%20skin%20and%20dermatological%20disorders.%20J%20Adv%20Pharm%20Technol%20Res.%202018;9:2." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR293">
<span class="label">293.</span><cite>Zielinska A, Carreiró F, Oliveira AM, Neves A, Pires B, Nagasamy Venkatesh D et al. Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology. Mol 2020, Vol 25, Page 3731. 2020;25:3731.</cite> [<a href="https://doi.org/10.3390/molecules25163731" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7464532/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32824172/" class="usa-link">PubMed</a>]</li>
<li id="CR294">
<span class="label">294.</span><cite>Honeywell-Nguyen PL, Bouwstra JA. Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol. 2005;2:67–74.
</cite> [<a href="https://doi.org/10.1016/j.ddtec.2005.05.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24981757/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Honeywell-Nguyen%20PL,%20Bouwstra%20JA.%20Vesicles%20as%20a%20tool%20for%20transdermal%20and%20dermal%20delivery.%20Drug%20Discov%20Today%20Technol.%202005;2:67%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR295">
<span class="label">295.</span><cite>Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. Pharmazie. 2007;62:133–7.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/17341034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Elsayed%20MMA,%20Abdallah%20OY,%20Naggar%20VF,%20Khalafallah%20NM.%20Deformable%20liposomes%20and%20ethosomes%20as%20carriers%20for%20skin%20delivery%20of%20ketotifen.%20Pharmazie.%202007;62:133%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR296">
<span class="label">296.</span><cite>Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev. 2011;63:470–91.
</cite> [<a href="https://doi.org/10.1016/j.addr.2011.01.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21315122/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Prow%20TW,%20Grice%20JE,%20Lin%20LL,%20Faye%20R,%20Butler%20M,%20Becker%20W,%20et%20al.%20Nanoparticles%20and%20microparticles%20for%20skin%20drug%20delivery.%20Adv%20Drug%20Deliv%20Rev.%202011;63:470%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR297">
<span class="label">297.</span><cite>Discher DE, Eisenberg A. Polymer vesicles. Science. 2002;297:967–73.
</cite> [<a href="https://doi.org/10.1126/science.1074972" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12169723/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Discher%20DE,%20Eisenberg%20A.%20Polymer%20vesicles.%20Science.%202002;297:967%E2%80%9373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR298">
<span class="label">298.</span><cite>Roy A, Nishchaya K, Rai VK. Nanoemulsion-based dosage forms for the transdermal drug delivery applications: A review of recent advances. Expert Opin Drug Deliv. 2022;19:303–19.
</cite> [<a href="https://doi.org/10.1080/17425247.2022.2045944" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35196938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Roy%20A,%20Nishchaya%20K,%20Rai%20VK.%20Nanoemulsion-based%20dosage%20forms%20for%20the%20transdermal%20drug%20delivery%20applications:%20A%20review%20of%20recent%20advances.%20Expert%20Opin%20Drug%20Deliv.%202022;19:303%E2%80%9319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR299">
<span class="label">299.</span><cite>Rai VK, Mishra N, Yadav KS, Yadav NP. Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications. J Control Release. 2018;270:203–25.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2017.11.049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29199062/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rai%20VK,%20Mishra%20N,%20Yadav%20KS,%20Yadav%20NP.%20Nanoemulsion%20as%20pharmaceutical%20carrier%20for%20dermal%20and%20transdermal%20drug%20delivery:%20formulation%20development,%20stability%20issues,%20basic%20considerations%20and%20applications.%20J%20Control%20Release.%202018;270:203%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR300">
<span class="label">300.</span><cite>Preeti SS, Malik R, Bhatia S, Al Harrasi A, Rani C et al. Nanoemulsion: An Emerging Novel Technology for Improving the Bioavailability of Drugs. Bolla PK, editor. Scientifica (Cairo). 2023;2023:1–25.</cite> [<a href="https://doi.org/10.1155/2023/6640103" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10625491/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37928749/" class="usa-link">PubMed</a>]</li>
<li id="CR301">
<span class="label">301.</span><cite>Sithole MN, Marais S, Maree SM, Du Plessis LH, Du Plessis J, Gerber M. Development and characterization of nano-emulsions and nano-emulgels for transdermal delivery of statins. Expert Opin Drug Deliv. 2021;18:789–801.
</cite> [<a href="https://doi.org/10.1080/17425247.2021.1867533" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33393386/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sithole%20MN,%20Marais%20S,%20Maree%20SM,%20Du%20Plessis%20LH,%20Du%20Plessis%20J,%20Gerber%20M.%20Development%20and%20characterization%20of%20nano-emulsions%20and%20nano-emulgels%20for%20transdermal%20delivery%20of%20statins.%20Expert%20Opin%20Drug%20Deliv.%202021;18:789%E2%80%93801." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR302">
<span class="label">302.</span><cite>Shakeel F, Baboota S, Ahuja A, All J, Shafiq S. Skin permeation mechanism of aceclofenac using novel nanoemulsion formulation. Pharmazie. 2008;63:580–4.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/18771006/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shakeel%20F,%20Baboota%20S,%20Ahuja%20A,%20All%20J,%20Shafiq%20S.%20Skin%20permeation%20mechanism%20of%20aceclofenac%20using%20novel%20nanoemulsion%20formulation.%20Pharmazie.%202008;63:580%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR303">
<span class="label">303.</span><cite>Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366:170–84.
</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2008.10.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18992314/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pardeike%20J,%20Hommoss%20A,%20M%C3%BCller%20RH.%20Lipid%20nanoparticles%20(SLN,%20NLC)%20in%20cosmetic%20and%20pharmaceutical%20dermal%20products.%20Int%20J%20Pharm.%202009;366:170%E2%80%9384." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR304">
<span class="label">304.</span><cite>Moravedeh R, Zargari Samadnezhad N, Asadalizadeh M, Abbasi M, Nadaki A. Enhanced anticancer potential of curcumin-loaded liposomal nanoparticles in oral cancer treatment. Asian Pac J Cancer Biol. 2025;10:293–9.</cite> [<a href="https://scholar.google.com/scholar_lookup?Moravedeh%20R,%20Zargari%20Samadnezhad%20N,%20Asadalizadeh%20M,%20Abbasi%20M,%20Nadaki%20A.%20Enhanced%20anticancer%20potential%20of%20curcumin-loaded%20liposomal%20nanoparticles%20in%20oral%20cancer%20treatment.%20Asian%20Pac%20J%20Cancer%20Biol.%202025;10:293%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR305">
<span class="label">305.</span><cite>Tadros T, Izquierdo P, Esquena J, Solans C. Formation and stability of nano-emulsions. Adv Colloid Interface Sci. 2004;108–109:303–18.
</cite> [<a href="https://doi.org/10.1016/j.cis.2003.10.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15072948/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tadros%20T,%20Izquierdo%20P,%20Esquena%20J,%20Solans%20C.%20Formation%20and%20stability%20of%20nano-emulsions.%20Adv%20Colloid%20Interface%20Sci.%202004;108%E2%80%93109:303%E2%80%9318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR306">
<span class="label">306.</span><cite>Sawant RR, Torchilin VP. Challenges in development of targeted liposomal therapeutics. AAPS J 2012 142. 2012;14:303–15.</cite> [<a href="https://doi.org/10.1208/s12248-012-9330-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3326155/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22415612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sawant%20RR,%20Torchilin%20VP.%20Challenges%20in%20development%20of%20targeted%20liposomal%20therapeutics.%20AAPS%20J%202012%20142.%202012;14:303%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR307">
<span class="label">307.</span><cite>Dragicevic-Curic N, Fahr A. Liposomes in topical photodynamic therapy. Expert Opin Drug Deliv. 2012;9:1015–32.
</cite> [<a href="https://doi.org/10.1517/17425247.2012.697894" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22731896/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dragicevic-Curic%20N,%20Fahr%20A.%20Liposomes%20in%20topical%20photodynamic%20therapy.%20Expert%20Opin%20Drug%20Deliv.%202012;9:1015%E2%80%9332." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR308">
<span class="label">308.</span><cite>Liu J, Huang Y, Kumar A, Tan A, Jin S, Mozhi A, et al. pH-sensitive nano-systems for drug delivery in cancer therapy. Biotechnol Adv. 2014;32:693–710.
</cite> [<a href="https://doi.org/10.1016/j.biotechadv.2013.11.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24309541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20J,%20Huang%20Y,%20Kumar%20A,%20Tan%20A,%20Jin%20S,%20Mozhi%20A,%20et%20al.%20pH-sensitive%20nano-systems%20for%20drug%20delivery%20in%20cancer%20therapy.%20Biotechnol%20Adv.%202014;32:693%E2%80%93710." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR309">
<span class="label">309.</span><cite>Kwon TK, Kim J-C. In vitro skin permeation and anti-atopic efficacy of lipid nanocarriers containing water soluble extracts of <em>Houttuynia cordata</em>. Drug Dev Ind Pharm. 2014;40:1350–7.
</cite> [<a href="https://doi.org/10.3109/03639045.2013.819883" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23886304/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kwon%20TK,%20Kim%20J-C.%20In%20vitro%20skin%20permeation%20and%20anti-atopic%20efficacy%20of%20lipid%20nanocarriers%20containing%20water%20soluble%20extracts%20of%20Houttuynia%20cordata.%20Drug%20Dev%20Ind%20Pharm.%202014;40:1350%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR310">
<span class="label">310.</span><cite>Jain A, Pooladanda V, Bulbake U, Doppalapudi S, Rafeeqi TA, Godugu C, et al. Liposphere mediated topical delivery of thymoquinone in the treatment of psoriasis. Nanomedicine. 2017;13:2251–62.
</cite> [<a href="https://doi.org/10.1016/j.nano.2017.06.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28647592/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jain%20A,%20Pooladanda%20V,%20Bulbake%20U,%20Doppalapudi%20S,%20Rafeeqi%20TA,%20Godugu%20C,%20et%20al.%20Liposphere%20mediated%20topical%20delivery%20of%20thymoquinone%20in%20the%20treatment%20of%20psoriasis.%20Nanomedicine.%202017;13:2251%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR311">
<span class="label">311.</span><cite>Souto EB, Macedo AS, Dias-Ferreira J, Cano A, Zielińska A, Matos CM. Elastic and ultradeformable liposomes for transdermal delivery of active pharmaceutical ingredients (APIs). Int J Mol Sci. 2021;22:9743.
</cite> [<a href="https://doi.org/10.3390/ijms22189743" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8472566/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34575907/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Souto%20EB,%20Macedo%20AS,%20Dias-Ferreira%20J,%20Cano%20A,%20Zieli%C5%84ska%20A,%20Matos%20CM.%20Elastic%20and%20ultradeformable%20liposomes%20for%20transdermal%20delivery%20of%20active%20pharmaceutical%20ingredients%20(APIs).%20Int%20J%20Mol%20Sci.%202021;22:9743." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR312">
<span class="label">312.</span><cite>Subongkot T, Ngawhirunpat T, Opanasopit P. Development of ultradeformable liposomes with fatty acids for enhanced dermal rosmarinic acid delivery. Pharmaceutics. 2021;13:404.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics13030404" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8003044/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33803716/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Subongkot%20T,%20Ngawhirunpat%20T,%20Opanasopit%20P.%20Development%20of%20ultradeformable%20liposomes%20with%20fatty%20acids%20for%20enhanced%20dermal%20rosmarinic%20acid%20delivery.%20Pharmaceutics.%202021;13:404." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR313">
<span class="label">313.</span><cite>Rajan R, Jose S, Biju Mukund V, Vasudevan D. Transferosomes - a vesicular transdermal delivery system for enhanced drug permeation. J Adv Pharm Technol Res. 2011;2:138.
</cite> [<a href="https://doi.org/10.4103/2231-4040.85524" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3217704/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22171309/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rajan%20R,%20Jose%20S,%20Biju%20Mukund%20V,%20Vasudevan%20D.%20Transferosomes%20-%20a%20vesicular%20transdermal%20delivery%20system%20for%20enhanced%20drug%20permeation.%20J%20Adv%20Pharm%20Technol%20Res.%202011;2:138." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR314">
<span class="label">314.</span><cite>Lakshmi PK, Pulla G. Vesicles - mechanism of transdermal permeation: a review. Asian J Pharm Clin Res. 2012;5(1):18–25.</cite> [<a href="https://scholar.google.com/scholar_lookup?Lakshmi%20PK,%20Pulla%20G.%20Vesicles%20-%20mechanism%20of%20transdermal%20permeation:%20a%20review.%20Asian%20J%20Pharm%20Clin%20Res.%202012;5(1):18%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR315">
<span class="label">315.</span><cite>Souto EB, Fangueiro JF, Fernandes AR, Cano A, Sanchez-Lopez E, Garcia ML, et al. Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery. Heliyon. 2022;8: e08938.
</cite> [<a href="https://doi.org/10.1016/j.heliyon.2022.e08938" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8851252/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35198788/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Souto%20EB,%20Fangueiro%20JF,%20Fernandes%20AR,%20Cano%20A,%20Sanchez-Lopez%20E,%20Garcia%20ML,%20et%20al.%20Physicochemical%20and%20biopharmaceutical%20aspects%20influencing%20skin%20permeation%20and%20role%20of%20SLN%20and%20NLC%20for%20skin%20drug%20delivery.%20Heliyon.%202022;8:%20e08938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR316">
<span class="label">316.</span><cite>El Maghraby GM, Barry BW, Williams AC. Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci. 2008;34:203–22.
</cite> [<a href="https://doi.org/10.1016/j.ejps.2008.05.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18572392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?El%20Maghraby%20GM,%20Barry%20BW,%20Williams%20AC.%20Liposomes%20and%20skin:%20from%20drug%20delivery%20to%20model%20membranes.%20Eur%20J%20Pharm%20Sci.%202008;34:203%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR317">
<span class="label">317.</span><cite>Lee DW, Kochenderfer JN, Stetler-Stevenson M, Cui YK, Delbrook C, Feldman SA, et al. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial. Lancet. 2015;385:517–28.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(14)61403-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7065359/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25319501/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20DW,%20Kochenderfer%20JN,%20Stetler-Stevenson%20M,%20Cui%20YK,%20Delbrook%20C,%20Feldman%20SA,%20et%20al.%20T%20cells%20expressing%20CD19%20chimeric%20antigen%20receptors%20for%20acute%20lymphoblastic%20leukaemia%20in%20children%20and%20young%20adults:%20a%20phase%201%20dose-escalation%20trial.%20Lancet.%202015;385:517%E2%80%9328." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR318">
<span class="label">318.</span><cite>Silbaugh A, Vallin J, Pelaez F, Kim M, Shao Q, Lee HS, et al. Enhancing electroporation-induced liposomal drug release in suspension and solid phases. Int J Pharm. 2023;635: 122744.
</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2023.122744" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36804522/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Silbaugh%20A,%20Vallin%20J,%20Pelaez%20F,%20Kim%20M,%20Shao%20Q,%20Lee%20HS,%20et%20al.%20Enhancing%20electroporation-induced%20liposomal%20drug%20release%20in%20suspension%20and%20solid%20phases.%20Int%20J%20Pharm.%202023;635:%20122744." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR319">
<span class="label">319.</span><cite>Rangsimawong W, Opanasopit P, Rojanarata T, Panomsuk S, Ngawhirunpat T. Influence of sonophoresis on transdermal drug delivery of hydrophilic compound-loaded lipid nanocarriers. Pharm Dev Technol. 2017;22:597–605.
</cite> [<a href="https://doi.org/10.1080/10837450.2016.1221428" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27492948/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rangsimawong%20W,%20Opanasopit%20P,%20Rojanarata%20T,%20Panomsuk%20S,%20Ngawhirunpat%20T.%20Influence%20of%20sonophoresis%20on%20transdermal%20drug%20delivery%20of%20hydrophilic%20compound-loaded%20lipid%20nanocarriers.%20Pharm%20Dev%20Technol.%202017;22:597%E2%80%93605." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR320">
<span class="label">320.</span><cite>Sala M, Diab R, Elaissari A, Fessi H. Lipid nanocarriers as skin drug delivery systems: properties, mechanisms of skin interactions and medical applications. Int J Pharm. 2018;535:1–17.
</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2017.10.046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29111097/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sala%20M,%20Diab%20R,%20Elaissari%20A,%20Fessi%20H.%20Lipid%20nanocarriers%20as%20skin%20drug%20delivery%20systems:%20properties,%20mechanisms%20of%20skin%20interactions%20and%20medical%20applications.%20Int%20J%20Pharm.%202018;535:1%E2%80%9317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR321">
<span class="label">321.</span><cite>Schmieder S, Patel P, Krishnamurthy K. Research techniques made simple: drug delivery techniques, part 1: concepts in transepidermal penetration and absorption. J Invest Dermatol. 2015;135:1–5.
</cite> [<a href="https://doi.org/10.1038/jid.2015.343" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26548480/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schmieder%20S,%20Patel%20P,%20Krishnamurthy%20K.%20Research%20techniques%20made%20simple:%20drug%20delivery%20techniques,%20part%201:%20concepts%20in%20transepidermal%20penetration%20and%20absorption.%20J%20Invest%20Dermatol.%202015;135:1%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR322">
<span class="label">322.</span><cite>Otberg N, Richter H, Schaefer H, Blume-Peytavi U, Sterry W, Lademann J. Variations of hair follicle size and distribution in different body sites. J Invest Dermatol. 2004;122:14–9.
</cite> [<a href="https://doi.org/10.1046/j.0022-202X.2003.22110.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14962084/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Otberg%20N,%20Richter%20H,%20Schaefer%20H,%20Blume-Peytavi%20U,%20Sterry%20W,%20Lademann%20J.%20Variations%20of%20hair%20follicle%20size%20and%20distribution%20in%20different%20body%20sites.%20J%20Invest%20Dermatol.%202004;122:14%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR323">
<span class="label">323.</span><cite>Fang J-Y, Hwang T-L, Huang Y-L. Liposomes as vehicles for enhancing drug delivery via skin routes. Curr Nanosci. 2006;2:55–70.</cite> [<a href="https://scholar.google.com/scholar_lookup?Fang%20J-Y,%20Hwang%20T-L,%20Huang%20Y-L.%20Liposomes%20as%20vehicles%20for%20enhancing%20drug%20delivery%20via%20skin%20routes.%20Curr%20Nanosci.%202006;2:55%E2%80%9370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR324">
<span class="label">324.</span><cite>Walunj M, Doppalapudi S, Bulbake U, Khan W. Preparation, characterization, and in vivo evaluation of cyclosporine cationic liposomes for the treatment of psoriasis. J Liposome Res. 2020;30:68–79.
</cite> [<a href="https://doi.org/10.1080/08982104.2019.1593449" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30897993/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Walunj%20M,%20Doppalapudi%20S,%20Bulbake%20U,%20Khan%20W.%20Preparation,%20characterization,%20and%20in%20vivo%20evaluation%20of%20cyclosporine%20cationic%20liposomes%20for%20the%20treatment%20of%20psoriasis.%20J%20Liposome%20Res.%202020;30:68%E2%80%9379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR325">
<span class="label">325.</span><cite>Yu F, Zhang Y, Yang C, Li F, Qiu B, Ding W. Enhanced transdermal efficiency of curcumin-loaded peptide-modified liposomes for highly effective antipsoriatic therapy. J Mater Chem B. 2021;9:4846–56.
</cite> [<a href="https://doi.org/10.1039/d1tb00557j" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34047333/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu%20F,%20Zhang%20Y,%20Yang%20C,%20Li%20F,%20Qiu%20B,%20Ding%20W.%20Enhanced%20transdermal%20efficiency%20of%20curcumin-loaded%20peptide-modified%20liposomes%20for%20highly%20effective%20antipsoriatic%20therapy.%20J%20Mater%20Chem%20B.%202021;9:4846%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR326">
<span class="label">326.</span><cite>Darsow U, Raap U, Ständer S. Atopic dermatitis. Itch Mech Treat. 2014.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/24830009/" class="usa-link">PubMed</a>]</li>
<li id="CR327">
<span class="label">327.</span><cite>Kim J, Kim BE, Leung DYM. Pathophysiology of atopic dermatitis: clinical implications. Allergy Asthma Proc. 2019;40:84–92.
</cite> [<a href="https://doi.org/10.2500/aap.2019.40.4202" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6399565/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30819278/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20J,%20Kim%20BE,%20Leung%20DYM.%20Pathophysiology%20of%20atopic%20dermatitis:%20clinical%20implications.%20Allergy%20Asthma%20Proc.%202019;40:84%E2%80%9392." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR328">
<span class="label">328.</span><cite>Pragya A. Nair; Talel Badri. Psoriasis. StatPearls. 2023.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/28846344/" class="usa-link">PubMed</a>]</li>
<li id="CR329">
<span class="label">329.</span><cite>Sun M-C, Xu X-L, Lou X-F, Du Y-Z. Recent progress and future directions: the nano-drug delivery system for the treatment of vitiligo. Int J Nanomedicine. 2020;15:3267–79.
</cite> [<a href="https://doi.org/10.2147/IJN.S245326" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7217315/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32440123/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20M-C,%20Xu%20X-L,%20Lou%20X-F,%20Du%20Y-Z.%20Recent%20progress%20and%20future%20directions:%20the%20nano-drug%20delivery%20system%20for%20the%20treatment%20of%20vitiligo.%20Int%20J%20Nanomedicine.%202020;15:3267%E2%80%9379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR330">
<span class="label">330.</span><cite>Jin Z, Song Y, He L. A review of skin immune processes in acne. Front Immunol. 2023;14.</cite> [<a href="https://doi.org/10.3389/fimmu.2023.1324930" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10773853/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38193084/" class="usa-link">PubMed</a>]</li>
<li id="CR331">
<span class="label">331.</span><cite>Abraham A. Overview of Acne Scarring. ACS(I) Textb Cutan Aesthetic Surg (2 Vol. 2018;489–489.</cite>
</li>
<li id="CR332">
<span class="label">332.</span><cite>Madan S, Nehate C, Barman TK, Rathore AS, Koul V. Design, preparation, and evaluation of liposomal gel formulations for treatment of acne: in vitro and in vivo studies. Drug Dev Ind Pharm. 2019;45:395–404.
</cite> [<a href="https://doi.org/10.1080/03639045.2018.1546310" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30442066/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Madan%20S,%20Nehate%20C,%20Barman%20TK,%20Rathore%20AS,%20Koul%20V.%20Design,%20preparation,%20and%20evaluation%20of%20liposomal%20gel%20formulations%20for%20treatment%20of%20acne:%20in%20vitro%20and%20in%20vivo%20studies.%20Drug%20Dev%20Ind%20Pharm.%202019;45:395%E2%80%93404." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR333">
<span class="label">333.</span><cite>Liu C, Cheng X, Wu Y, Xu W, Xia H, Jia R, et al. Antioxidant activity of Quercetin-containing liposomes-in-gel and its effect on prevention and treatment of cutaneous eczema. Pharmaceuticals. 2023;16:1184.
</cite> [<a href="https://doi.org/10.3390/ph16081184" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10458784/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37631099/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20C,%20Cheng%20X,%20Wu%20Y,%20Xu%20W,%20Xia%20H,%20Jia%20R,%20et%20al.%20Antioxidant%20activity%20of%20Quercetin-containing%20liposomes-in-gel%20and%20its%20effect%20on%20prevention%20and%20treatment%20of%20cutaneous%20eczema.%20Pharmaceuticals.%202023;16:1184." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR334">
<span class="label">334.</span><cite>Maione-Silva L, de Castro EG, Nascimento TL, Cintra ER, Moreira LC, Cintra BAS, et al. Ascorbic acid encapsulated into negatively charged liposomes exhibits increased skin permeation, retention and enhances collagen synthesis by fibroblasts. Sci Rep. 2019;9:522.
</cite> [<a href="https://doi.org/10.1038/s41598-018-36682-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6345870/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30679479/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maione-Silva%20L,%20de%20Castro%20EG,%20Nascimento%20TL,%20Cintra%20ER,%20Moreira%20LC,%20Cintra%20BAS,%20et%20al.%20Ascorbic%20acid%20encapsulated%20into%20negatively%20charged%20liposomes%20exhibits%20increased%20skin%20permeation,%20retention%20and%20enhances%20collagen%20synthesis%20by%20fibroblasts.%20Sci%20Rep.%202019;9:522." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR335">
<span class="label">335.</span><cite>Yang T, Wang L, Zhu M, Zhang L, Yan L. Properties and molecular mechanisms of resveratrol: a review. Pharmazie. 2015;70:501–6.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/26380517/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20T,%20Wang%20L,%20Zhu%20M,%20Zhang%20L,%20Yan%20L.%20Properties%20and%20molecular%20mechanisms%20of%20resveratrol:%20a%20review.%20Pharmazie.%202015;70:501%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR336">
<span class="label">336.</span><cite>Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M, Arichi S. Effects of stilbene components of the roots of <em>polygonum cuspidatum</em> Sieb. et Zucc. on lipid metabolism. Chem Pharm Bull. 1982;30:1766–70.</cite> [<a href="https://doi.org/10.1248/cpb.30.1766" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7116511/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Arichi%20H,%20Kimura%20Y,%20Okuda%20H,%20Baba%20K,%20Kozawa%20M,%20Arichi%20S.%20Effects%20of%20stilbene%20components%20of%20the%20roots%20of%20polygonum%20cuspidatum%20Sieb.%20et%20Zucc.%20on%20lipid%20metabolism.%20Chem%20Pharm%20Bull.%201982;30:1766%E2%80%9370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR337">
<span class="label">337.</span><cite>Kwon S, Yang JH, Shin J, Park K, Huh C, Na J. Efficacy of liposome-encapsulated 4‐n‐butylresorcinol and resveratrol cream in the treatment of melasma. J Cosmet Dermatol. 2020;19:891–5.
</cite> [<a href="https://doi.org/10.1111/jocd.13080" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31347777/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kwon%20S,%20Yang%20JH,%20Shin%20J,%20Park%20K,%20Huh%20C,%20Na%20J.%20Efficacy%20of%20liposome-encapsulated%204%E2%80%90n%E2%80%90butylresorcinol%20and%20resveratrol%20cream%20in%20the%20treatment%20of%20melasma.%20J%20Cosmet%20Dermatol.%202020;19:891%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR338">
<span class="label">338.</span><cite>Ambati S, Pham T, Lewis ZA, Lin X, Meagher RB. DC-sign targets amphotericin B-loaded liposomes to diverse pathogenic fungi. Fungal Biol Biotechnol. 2021;8: 22.
</cite> [<a href="https://doi.org/10.1186/s40694-021-00126-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8709943/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34952645/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ambati%20S,%20Pham%20T,%20Lewis%20ZA,%20Lin%20X,%20Meagher%20RB.%20DC-sign%20targets%20amphotericin%20B-loaded%20liposomes%20to%20diverse%20pathogenic%20fungi.%20Fungal%20Biol%20Biotechnol.%202021;8:%2022." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR339">
<span class="label">339.</span><cite>Jiang Y, Li W, Wang Z, Lu J. Lipid-based nanotechnology: liposome. Pharmaceutics. 2023;16: 34.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics16010034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10820119/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38258045/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiang%20Y,%20Li%20W,%20Wang%20Z,%20Lu%20J.%20Lipid-based%20nanotechnology:%20liposome.%20Pharmaceutics.%202023;16:%2034." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR340">
<span class="label">340.</span><cite>Yingchoncharoen P, Kalinowski DS, Richardson DR. Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come. Barker EL, editor. Pharmacol Rev. 2016;68:701–87.</cite> [<a href="https://doi.org/10.1124/pr.115.012070" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4931871/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27363439/" class="usa-link">PubMed</a>]</li>
<li id="CR341">
<span class="label">341.</span><cite>Tenchov R, Bird R, Curtze AE, Zhou Q. Lipid nanoparticlesfrom liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano. 2021;15:16982–7015.
</cite> [<a href="https://doi.org/10.1021/acsnano.1c04996" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34181394/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tenchov%20R,%20Bird%20R,%20Curtze%20AE,%20Zhou%20Q.%20Lipid%20nanoparticlesfrom%20liposomes%20to%20mRNA%20vaccine%20delivery,%20a%20landscape%20of%20research%20diversity%20and%20advancement.%20ACS%20Nano.%202021;15:16982%E2%80%937015." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR342">
<span class="label">342.</span><cite>Nikolova MP, Kumar EM, Chavali MS. Updates on responsive drug delivery based on liposome vehicles for cancer treatment. Pharmaceutics. 2022;14:2195.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics14102195" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9608678/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36297630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nikolova%20MP,%20Kumar%20EM,%20Chavali%20MS.%20Updates%20on%20responsive%20drug%20delivery%20based%20on%20liposome%20vehicles%20for%20cancer%20treatment.%20Pharmaceutics.%202022;14:2195." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR343">
<span class="label">343.</span><cite>Kulkarni SB, Betageri GV, Singh M. Factors affecting microencapsulation of drugs in liposomes. J Microencapsul. 1995;12:229–46.
</cite> [<a href="https://doi.org/10.3109/02652049509010292" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7650588/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kulkarni%20SB,%20Betageri%20GV,%20Singh%20M.%20Factors%20affecting%20microencapsulation%20of%20drugs%20in%20liposomes.%20J%20Microencapsul.%201995;12:229%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR344">
<span class="label">344.</span><cite>Kaszás N, Budai M, Budai L, Gróf P, Zimmer A, Klebovich I. Methods to increase the encapsulation efficiency for liposomal drugs. Acta Pharm Hung. 2008;78:69–74.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/18807386/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kasz%C3%A1s%20N,%20Budai%20M,%20Budai%20L,%20Gr%C3%B3f%20P,%20Zimmer%20A,%20Klebovich%20I.%20Methods%20to%20increase%20the%20encapsulation%20efficiency%20for%20liposomal%20drugs.%20Acta%20Pharm%20Hung.%202008;78:69%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR345">
<span class="label">345.</span><cite>Lee H-J, Lee S-H. Epidermal permeability barrier defects and barrier repair therapy in atopic dermatitis. Allergy Asthma Immunol Res. 2014;6:276.
</cite> [<a href="https://doi.org/10.4168/aair.2014.6.4.276" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4077953/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24991450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20H-J,%20Lee%20S-H.%20Epidermal%20permeability%20barrier%20defects%20and%20barrier%20repair%20therapy%20in%20atopic%20dermatitis.%20Allergy%20Asthma%20Immunol%20Res.%202014;6:276." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR346">
<span class="label">346.</span><cite>Knudsen NØ, Jorgensen L, Hansen J, Vermehren C, Frokjaer S, Foged C. Targeting of liposome-associated calcipotriol to the skin: effect of liposomal membrane fluidity and skin barrier integrity. Int J Pharm. 2011;416:478–85.
</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2011.03.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21419203/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Knudsen%20N%C3%98,%20Jorgensen%20L,%20Hansen%20J,%20Vermehren%20C,%20Frokjaer%20S,%20Foged%20C.%20Targeting%20of%20liposome-associated%20calcipotriol%20to%20the%20skin:%20effect%20of%20liposomal%20membrane%20fluidity%20and%20skin%20barrier%20integrity.%20Int%20J%20Pharm.%202011;416:478%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR347">
<span class="label">347.</span><cite>Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65:36–48.
</cite> [<a href="https://doi.org/10.1016/j.addr.2012.09.037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23036225/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Allen%20TM,%20Cullis%20PR.%20Liposomal%20drug%20delivery%20systems:%20from%20concept%20to%20clinical%20applications.%20Adv%20Drug%20Deliv%20Rev.%202013;65:36%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR348">
<span class="label">348.</span><cite>Egbaria K, Weiner N. Liposomes as a topical drug delivery system. Adv Drug Deliv Rev. 1990;5:287–300.</cite> [<a href="https://scholar.google.com/scholar_lookup?Egbaria%20K,%20Weiner%20N.%20Liposomes%20as%20a%20topical%20drug%20delivery%20system.%20Adv%20Drug%20Deliv%20Rev.%201990;5:287%E2%80%93300." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR349">
<span class="label">349.</span><cite>Sudhakar K, Fuloria S, Subramaniyan V, Sathasivam KV, Azad AK, Swain SS, et al. Ultraflexible liposome nanocargo as a dermal and transdermal drug delivery system. Nanomaterials. 2021;11: 2557.
</cite> [<a href="https://doi.org/10.3390/nano11102557" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8537378/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34685005/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sudhakar%20K,%20Fuloria%20S,%20Subramaniyan%20V,%20Sathasivam%20KV,%20Azad%20AK,%20Swain%20SS,%20et%20al.%20Ultraflexible%20liposome%20nanocargo%20as%20a%20dermal%20and%20transdermal%20drug%20delivery%20system.%20Nanomaterials.%202021;11:%202557." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR350">
<span class="label">350.</span><cite>Demetzos C. Application of nanotechnology in drug delivery and targeting. Pharm Nanotechnol. Singapore: Springer Singapore; 2016. pp. 77–145.</cite> [<a href="https://scholar.google.com/scholar_lookup?Demetzos%20C.%20Application%20of%20nanotechnology%20in%20drug%20delivery%20and%20targeting.%20Pharm%20Nanotechnol.%20Singapore:%20Springer%20Singapore;%202016.%20pp.%2077%E2%80%93145." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR351">
<span class="label">351.</span><cite>Li Z, Koban KC, Schenck TL, Giunta RE, Li Q, Sun Y. Artificial intelligence in dermatology image analysis: current developments and future trends. J Clin Med. 2022;11: 6826.
</cite> [<a href="https://doi.org/10.3390/jcm11226826" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9693628/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36431301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20Z,%20Koban%20KC,%20Schenck%20TL,%20Giunta%20RE,%20Li%20Q,%20Sun%20Y.%20Artificial%20intelligence%20in%20dermatology%20image%20analysis:%20current%20developments%20and%20future%20trends.%20J%20Clin%20Med.%202022;11:%206826." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR352">
<span class="label">352.</span><cite>Carita AC, Eloy JO, Chorilli M, Lee RJ, Leonardi GR. Recent advances and perspectives in liposomes for cutaneous drug delivery. Curr Med Chem. 2018;25:606–35.
</cite> [<a href="https://doi.org/10.2174/0929867324666171009120154" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28990515/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Carita%20AC,%20Eloy%20JO,%20Chorilli%20M,%20Lee%20RJ,%20Leonardi%20GR.%20Recent%20advances%20and%20perspectives%20in%20liposomes%20for%20cutaneous%20drug%20delivery.%20Curr%20Med%20Chem.%202018;25:606%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR353">
<span class="label">353.</span><cite>Datt N, Poonuru RR, Yadav PK. Development and characterization of Griseofulvin loaded nanostructured lipid carrier gel for treating dermatophytosis. Food Hydrocolloids for Health. 2022;2: 100074.</cite> [<a href="https://scholar.google.com/scholar_lookup?Datt%20N,%20Poonuru%20RR,%20Yadav%20PK.%20Development%20and%20characterization%20of%20Griseofulvin%20loaded%20nanostructured%20lipid%20carrier%20gel%20for%20treating%20dermatophytosis.%20Food%20Hydrocolloids%20for%20Health.%202022;2:%20100074." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR354">
<span class="label">354.</span><cite>Ayatollahi Mousavi SA, Mokhtari A, Barani M, Izadi A, Amirbeigi A, Ajalli N, et al. Advances of liposomal mediated nanocarriers for the treatment of dermatophyte infections. Heliyon. 2023;9: e18960.
</cite> [<a href="https://doi.org/10.1016/j.heliyon.2023.e18960" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10424084/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37583758/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ayatollahi%20Mousavi%20SA,%20Mokhtari%20A,%20Barani%20M,%20Izadi%20A,%20Amirbeigi%20A,%20Ajalli%20N,%20et%20al.%20Advances%20of%20liposomal%20mediated%20nanocarriers%20for%20the%20treatment%20of%20dermatophyte%20infections.%20Heliyon.%202023;9:%20e18960." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR355">
<span class="label">355.</span><cite>How KN, Yap WH, Lim CLH, Goh BH, Lai ZW. Hyaluronic Acid-Mediated drug delivery system targeting for inflammatory skin diseases: A mini review. Front Pharmacol. 2020;11.</cite> [<a href="https://doi.org/10.3389/fphar.2020.01105" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7397973/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32848737/" class="usa-link">PubMed</a>]</li>
<li id="CR356">
<span class="label">356.</span><cite>Chovatiya R, Paller AS. JAK inhibitors in the treatment of atopic dermatitis. J Allergy Clin Immunol. 2021;148:927–40.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2021.08.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10166130/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34437922/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chovatiya%20R,%20Paller%20AS.%20JAK%20inhibitors%20in%20the%20treatment%20of%20atopic%20dermatitis.%20J%20Allergy%20Clin%20Immunol.%202021;148:927%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR357">
<span class="label">357.</span><cite>Ashtikar M, Nagarsekar K, Fahr A. Transdermal delivery from liposomal formulations – Evolution of the technology over the last three decades. J Control Release. 2016;242:126–40.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2016.09.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27620074/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ashtikar%20M,%20Nagarsekar%20K,%20Fahr%20A.%20Transdermal%20delivery%20from%20liposomal%20formulations%20%E2%80%93%20Evolution%20of%20the%20technology%20over%20the%20last%20three%20decades.%20J%20Control%20Release.%202016;242:126%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR358">
<span class="label">358.</span><cite>Alshaer W, Nsairat H, Lafi Z, Hourani OM, Al-Kadash A, Esawi E, et al. Quality by design approach in liposomal formulations: robust product development. Molecules. 2022;28:10.
</cite> [<a href="https://doi.org/10.3390/molecules28010010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9822211/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36615205/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alshaer%20W,%20Nsairat%20H,%20Lafi%20Z,%20Hourani%20OM,%20Al-Kadash%20A,%20Esawi%20E,%20et%20al.%20Quality%20by%20design%20approach%20in%20liposomal%20formulations:%20robust%20product%20development.%20Molecules.%202022;28:10." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Nanobiotechnology are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12951-025-03660-z"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12951_2025_Article_3660.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (9.8 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12369165/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12369165/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12369165%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369165/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12369165/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12369165/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40835930/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12369165/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40835930/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12369165/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12369165/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="rztdwyxA1E2dyRIbC9jC3rJOE906q08sZKMcog9jNLw8c5KGY4ID3ADj4RQVbtZT">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
